<!DOCTYPE html>
<html lang="en"><head>
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>PKIDB | A Curated, Annotated and Updated Database of Protein Kinase Inhibitors in Clinical Trials</title>
  <link href="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/w3.css" rel="stylesheet" type="text/css">
  <link href="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/gautier.css" rel="stylesheet" type="text/css">
  <link href="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/fabrice.css" rel="stylesheet" type="text/css">
  <link href="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/sbg.css" rel="stylesheet" type="text/css">
  <link rel="stylesheet" href="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/bootstrap.css">
  <link rel="icon" href="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/icoa_sans_fond.png">
  <script src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/jquery-3.js"></script>
  <script src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/bootstrap.js"></script>

  <script type="text/javascript" src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/jquery-latest.js"></script>
  <script type="text/javascript" src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/__jquery.js"></script>
  <script type="text/javascript" src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/tablefilter.js"></script>

<link id="customers_style" type="text/css" rel="stylesheet" href="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/tablefilter.css"></head>

<body>
  <div class="w3-top">
    <div class="w3-bar w3-green w3-padding w3-card">
      <div class="w3-left">
        <a href="http://sbc.icoa.fr/" class="w3-bar-item w3-button w3-hover-green">
          <h4>SB&amp;C Platform</h4>
        </a>
      </div>
      <div class="w3-right w3-hide-small">
        <a href="http://www.icoa.fr/">
          <img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/icoa_sans_fond.png" style="height : 55px" class="w3-bar-item" alt="icoa-logo.png">
        </a>
      </div>
      <div class="w3-right w3-hide-small">
        <a href="http://www.icoa.fr/fr/bonnet/" class="w3-bar-item w3-button w3-hover-green">
          <h4>Team</h4>
        </a>
      </div>
      <div class="w3-right w3-hide-small">
        <a href="http://www.icoa.fr/pkidb/about.html" class="w3-bar-item w3-button w3-hover-green">
          <h4>About</h4>
        </a>
      </div>
      <div class="w3-right w3-hide-small">
        <a href="http://www.icoa.fr/pkidb/quick_start.html" class="w3-bar-item w3-button w3-hover-green">
          <h4>Quick start</h4>
        </a>
      </div>
      <div class="w3-right w3-hide-small">
        <a href="http://www.icoa.fr/pkidb/notes.html" class="w3-bar-item w3-button w3-hover-green">
          <h4>Notes</h4>
        </a>
      </div>
      
      <div class="w3-right w3-hide-small">
          <a href="http://www.icoa.fr/pkidb/contact.html" class="w3-bar-item w3-button w3-hover-green">
              <h4>Contact</h4>
          </a>
      </div>
      <div class="w3-left w3-hide-small">
        <a href="http://www.icoa.fr/pkidb/index.html" class="w3-bar-item w3-button w3-hover-green">
          <h4>PKIDB</h4>
        </a>
      </div>
    </div>
  </div>


  <div id="main_container">
    <!-- Page content -->
    <div class="w3-content w3-padding" style="max-width:95%">
      <div class="w3-container w3-padding-16" id="DF">
          <h1>PKIDB: A Curated, Annotated and Updated Database of Protein Kinase
          Inhibitors in Clinical Trials <img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/logoRegionCentreValDeLoire.jpg" alt="funded by Région Centre Val de Loire" width="150"></h1>
          <h4>How to cite PKIDB:</h4>
              Carles, F., Bourg, S., Meyer, C., and Bonnet, P. (2018). PKIDB: A
              Curated, Annotated and Updated Database of Protein Kinase Inhibitors in
              Clinical Trials. Molecules 23, 908.
              <a href="http://www.mdpi.com/1420-3049/23/4/908">DOI:10.3390/molecules23040908</a> <br>
          <p>Latest update: 2019-12-11</p>
          <p>Last approved inhibitors: <b>Pexidartinib, Entrectinib, Fedratinib, Upadacitinib, Alpelisib</b></p>
          <p>New inhibitors this month: <b>Ceralasertib, Derazantinib, Lazertinib, Pralsetinib, Ripretinib, Rivoceranib, Samotolisib</b></p>
          <p>Links to KinoMine data: 
                <a href="http://kinomine.icoa.fr/biodata/selectivity_pkidb">Bioactivities</a>, 
                <a href="http://kinomine.icoa.fr/biodata/IFP_pkidb">3D structures and binding mode</a>
          </p>

          <!-- Données de bioactivité et fingerprints d'interaction -->
<!--      
          <div class="w3-row-padding">
            <div class="w3-col" style="min-width:200px;  padding: 1% 0;">
              <div class="w3-display-container">
                <center>
                  <table>
                    <tr>
                      <td>
                        <h1 class="w3-xlarge w3-text-white" style="max-width:100%;">
                          <span class="w3-padding w3-text-black">Kinomine data:</span>
                        </h1>
                      </td>
                      <td><a href='http://kinomine.icoa.fr/biodata/selectivity_pkidb'><button class="btn btn-default w3-blue w3-hover-light-blue" type="button">Bioactivities</button></a></td>
                      <td><a href='http://kinomine.icoa.fr/biodata/IFP_pkidb'><button class="btn btn-default w3-blue w3-hover-light-blue" type="button">3D structures and binding mode</button></a></td>
                    </tr>
                  </table>
                </center>
              </div>
            </div>
          </div>
-->

<table id="customers" class="tablesorter TF"><caption><div class="inf"><div class="ldiv"><div class="tot"><span>Rows: </span><span>218</span></div></div><div class="rdiv"><span><div class="helpCont">Use
 the filters above each column to filter and limit table data. Advanced 
searches can be performed by using the following operators: <br><b>&lt;</b>, <b>&lt;=</b>, <b>&gt;</b>, <b>&gt;=</b>, <b>=</b>, <b>*</b>, <b>!</b>, <b>{</b>, <b>}</b>, <b>||</b>,<b>&amp;&amp;</b>, <b>[empty]</b>, <b>[nonempty]</b>, <b>rgx:</b><br><a href="https://github.com/koalyptus/TableFilter/wiki/4.-Filter-operators" target="_blank">Learn more</a><hr><div class="helpFooter"><h4>TableFilter v0.6.21</h4><a href="http://koalyptus.github.io/TableFilter/" target="_blank">http://koalyptus.github.io/TableFilter/</a><br><span>©2015-2020 Max Guglielmi</span><div style="margin-top:8px;" align="center"><a href="javascript:void(0);" class="close">Close</a></div></div></div><a href="javascript:void(0);" class="helpBtn">?</a></span></div><div class="mdiv"></div></div></caption>
  <thead>
    <tr class="fltrow"><td><input id="flt0_customers" type="text" ct="0" class="flt"></td><td><input id="flt1_customers" type="text" ct="1" class="flt"></td><td><input id="flt2_customers" type="text" ct="2" class="flt"></td><td><input id="flt3_customers" type="text" ct="3" class="flt"></td><td><input id="flt4_customers" type="text" ct="4" class="flt"></td><td><input id="flt5_customers" type="text" ct="5" class="flt"></td><td><input id="flt6_customers" type="text" ct="6" class="flt"></td><td><input id="flt7_customers" type="text" ct="7" class="flt"></td><td><input id="flt8_customers" type="text" ct="8" class="flt"></td><td><input id="flt9_customers" type="text" ct="9" class="flt"></td><td><input id="flt10_customers" type="text" ct="10" class="flt"></td><td><input id="flt11_customers" type="text" ct="11" class="flt"></td><td><input id="flt12_customers" type="text" ct="12" class="flt"></td><td><input id="flt13_customers" type="text" ct="13" class="flt"></td><td><input id="flt14_customers" type="text" ct="14" class="flt"></td><td><input id="flt15_customers" type="text" ct="15" class="flt"></td><td><input id="flt16_customers" type="text" ct="16" class="flt"></td><td><input id="flt17_customers" type="text" ct="17" class="flt"></td><td><input id="flt18_customers" type="text" ct="18" class="flt"></td><td><input id="flt19_customers" type="text" ct="19" class="flt"></td><td><input id="flt20_customers" type="text" ct="20" class="flt"></td><td><input id="flt21_customers" type="text" ct="21" class="flt"></td><td><input id="flt22_customers" type="text" ct="22" class="flt"></td><td><input id="flt23_customers" type="text" ct="23" class="flt"></td><td><input id="flt24_customers" type="text" ct="24" class="flt"></td></tr><tr style="text-align: right;">
      <th class="header headerSortDown">INN_Name</th>
      <th class="header">BrandName</th>
      <th class="header headerSortUp">Phase</th>
      <th class="header">Applicants</th>
      <th class="header">Links</th>
      <th class="header">LigID</th>
      <th class="header">pdbID</th>
      <th class="header">Type</th>
      <th class="header">RoF</th>
      <th class="header">MW</th>
      <th class="header">LogP</th>
      <th class="header">TPSA</th>
      <th class="header">HBA</th>
      <th class="header">HBD</th>
      <th class="header">NRB</th>
      <th class="header">Indications</th>
      <th class="header">Targets</th>
      <th class="header">Kinase families</th>
      <th class="header">Canonical_Smiles_InChiKey</th>
      <th class="header">First_Approval</th>
      <th class="header">SC_Patent</th>
      <th class="header">Chirality</th>
      <th class="header">Synonyms</th>
      <th class="header">FDA approved</th>
      <th class="header">Melting points (°C)</th>
    </tr>
  </thead>
  <tbody>
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
  <tr class="odd">
      <td><b>Abemaciclib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Abemaciclib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Verzenio</td>
      <td>4</td>
      <td>Eli Lilly</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.29340700.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3301610">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/46220502">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12001">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=6ZV">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/6ZV">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7382">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000072318121">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=60UAB198HK">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50110183">BindingDB</a><br></td>
      <td>'6ZV'</td>
      <td>5l2s</td>
      <td>1</td>
      <td>1</td>
      <td>506.3</td>
      <td>4.9</td>
      <td>75</td>
      <td>8</td>
      <td>1</td>
      <td>7</td>
      <td><input type="checkbox" class="read-more-state" id="post-662984151"><p class="read-more-wrap">On
 September 28, 2017, the Food and Drug Administration approved 
abemaciclib (VERZENIO, Eli Lilly and Company) in combination with 
fulvestrant for wom<span class="read-more-target">en with HR-positive, 
HER2-negative advanced or metastatic breast cancer with disease 
progression following endocrine therapy. In addition, abemaciclib was 
approved as monotherapy for  women and men with HR-positive, 
HER2-negative advanced or metastatic breast cancer with disease 
progression following endocrine therapy and prior chemotherapy in the 
metastatic setting.</span></p><label for="post-662984151" class="read-more-trigger"></label></td>
      <td>CDK4<br>CDK6</td>
      <td>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CCN1CCN(CC1)Cc2ccc(nc2)Nc3ncc(c(n3)c4cc5c(c(c4)F)nc(n5C(C)C)C)F<br><b>InChiKey</b>=UZWDCWONPYILKI-UHFFFAOYSA-N</td>
      <td>2017</td>
      <td>US-7855211-B2</td>
      <td>Achiral Molecule</td>
      <td>Verzenio <br> Abemaciclib <br> LY-2835219</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Abivertinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Abivertinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>ACEA Biosciences</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.57490375.html">ChemSpider</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/72734520">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB15327">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10044">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000142081723">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=CER0OPG92L">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294480">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>487.2</td>
      <td>4.5</td>
      <td>98.4</td>
      <td>7</td>
      <td>3</td>
      <td>7</td>
      <td><input type="checkbox" class="read-more-state" id="post-304985607"><p class="read-more-wrap">AC0010
 is an orally active, irreversible EGFR inhibitor that selectively 
targets mutated EGFRs, and was designed to overcome T790M-induced 
resistance <span class="read-more-target">in tumours [<a href='javascript:callRef("ReferenceDisplayForward?referenceId=35960&amp;displayId=2", 960, 600)' title="2. Xu X, Mao L, Xu W, Tang W, Zhang X, Xi B, Xu R, Fang X, Liu J, Fang C et al.. (2016) Mol. Cancer Ther. 15 (11): 2586-2597">2</a>]. It may also inhibit BTK, thus offering extended clinical utility [<a href='javascript:callRef("ReferenceDisplayForward?referenceId=35961&amp;displayId=3", 960, 600)' title="3. Yan X, Zhou Y, Huang S, Li X, Yu M, Huang J, Wang J, Ma Z, Jin J, Pan J et al.. (2018) J. Cancer Res. Clin. Oncol. 144 (4): 697-706">3</a>]. We show the structure for the free base form of the compound.</span></p><label for="post-304985607" class="read-more-trigger"></label></td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN1CCN(CC1)c2ccc(cc2F)Nc3nc4c(cc[nH]4)c(n3)Oc5cccc(c5)NC(=O)C=C<br><b>InChiKey</b>=UOFYSRZSLXWIQB-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td>AC0010 <br> Avitinib</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Acalabrutinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Acalabrutinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Calquence</td>
      <td>4</td>
      <td>Astrazeneca</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.36764951.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3707348">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/71226662">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11703">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8912">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000208774715">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=I42748ELQW">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50175583">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>465.2</td>
      <td>3.3</td>
      <td>118.5</td>
      <td>7</td>
      <td>2</td>
      <td>4</td>
      <td>Acalabrutinib is currently indicated for the treatment of 
adult patients with Mantle Cell Lymphoma (MCL) who have received at 
least one prior therapy</td>
      <td>BTK</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC#CC(=O)N1CCC[C@H]1c2nc(c3n2ccnc3N)c4ccc(cc4)C(=O)Nc5ccccn5<br><b>InChiKey</b>=WDENQIQQYWYTPO-IBGZPJMESA-N</td>
      <td>2017</td>
      <td>US-9290504-B2</td>
      <td>Single Stereoisomer</td>
      <td>Calquence <br> ACP-196 <br> Acalabrutinib</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Acalisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Acalisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Gilead Sciences</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9793017.html">ChemSpider</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11618268">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB15407">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10096">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000035943170">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=OVW60IDW1D">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=217352">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>401.1</td>
      <td>3.4</td>
      <td>101.4</td>
      <td>7</td>
      <td>2</td>
      <td>4</td>
      <td>nan</td>
      <td>PIK3CA</td>
      <td>Atypical</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C[C@@H](c1nc2ccc(cc2c(=O)n1c3ccccc3)F)Nc4c5c(nc[nH]5)ncn4<br><b>InChiKey</b>=DOCINCLJNAXZQF-LBPRGKRZSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td><br>CAL-120</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Acumapimod</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Acumapimod.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Mereo BioPharma</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9513071.html">ChemSpider</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11338127">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB15448">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9203">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000116024237">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=2F16KW647L">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>385.2</td>
      <td>2.8</td>
      <td>113.8</td>
      <td>6</td>
      <td>2</td>
      <td>5</td>
      <td>nan</td>
      <td>MAPK14<br>MAPK11<br>MAPK13<br>MAPK12</td>
      <td>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1ccc(cc1n2c(c(cn2)C(=O)c3cccc(c3)C#N)N)C(=O)NC4CC4<br><b>InChiKey</b>=VGUSQKZDZHAAEE-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td></td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Adavosertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Adavosertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Astrazeneca</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.24808590.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1976040">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/24856436">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11740">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=8X7">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/8X7">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7702">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000063539231">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=K2T6HJX3I3">FDA SRS</a><br></td>
      <td>'8X7'</td>
      <td>5v5y 5vd0 5vdk</td>
      <td>1</td>
      <td>1</td>
      <td>500.3</td>
      <td>2.9</td>
      <td>104.3</td>
      <td>10</td>
      <td>2</td>
      <td>7</td>
      <td>nan</td>
      <td>WEE1</td>
      <td>Other</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC(C)(c1cccc(n1)n2c3c(cnc(n3)Nc4ccc(cc4)N5CCN(CC5)C)c(=O)n2CC=C)O<br><b>InChiKey</b>=BKWJAKQVGHWELA-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td>AZD-1775 <br> MK-1775</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Afatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Afatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Gilotrif</td>
      <td>4</td>
      <td>Boehringer Ingelheim</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.8360155.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1173655">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/10184653">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB08916">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=0WM">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/0WM">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5667">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC03976838">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=41UD74L59M">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50322823">BindingDB</a><br></td>
      <td>'0WM'</td>
      <td>4g5j</td>
      <td>1</td>
      <td>0</td>
      <td>485.2</td>
      <td>4.4</td>
      <td>88.6</td>
      <td>7</td>
      <td>2</td>
      <td>8</td>
      <td><input type="checkbox" class="read-more-state" id="post-593657247"><p class="read-more-wrap">Afatinib
 is a kinase inhibitor indicated for the first-line treatment of patient
 with metastatic non-small cell lung cancer (NSCLC) whose tumours have<span class="read-more-target">
 epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 
(L858R) substitution mutations as detected by an FDA-approved test.</span></p><label for="post-593657247" class="read-more-trigger"></label></td>
      <td>EGFR<br>ERBB2<br>ERBB4</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN(C)C/C=C/C(=O)Nc1cc2c(cc1O[C@H]3CCOC3)ncnc2Nc4ccc(c(c4)Cl)F<br><b>InChiKey</b>=ULXXDDBFHOBEHA-CWDCEQMOSA-N</td>
      <td>2013</td>
      <td>US-6251912-B1</td>
      <td>Single Stereoisomer</td>
      <td>Giotrif;Gilotrif <br> Afatinib <br> BIBW-2992</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Afuresertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Afuresertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>GlaxoSmithKline</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.28651809.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2219422">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/46843057">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11648">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7890">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000043197674">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=8739X25QI3">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>426</td>
      <td>3.9</td>
      <td>72.9</td>
      <td>5</td>
      <td>2</td>
      <td>6</td>
      <td>nan</td>
      <td>AKT1<br>AKT2<br>AKT3</td>
      <td>AGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cn1c(c(cn1)Cl)c2cc(sc2Cl)C(=O)N[C@@H](Cc3cccc(c3)F)CN<br><b>InChiKey</b>=AFJRDFWMXUECEW-LBPRGKRZSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>GSK2110183 <br> Afuresertib <br> GSK2110183C</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Alectinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Alectinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Alecensa</td>
      <td>4</td>
      <td>Hoffmann-La Roche</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.26326738.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1738797">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/49806720">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11363">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=EMH">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/EMH">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7739">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000066166864">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=LIJ4CT1Z3Y">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50362781">BindingDB</a><br></td>
      <td>'EMH'</td>
      <td>3aox 5xv7</td>
      <td>1</td>
      <td>0</td>
      <td>482.3</td>
      <td>4.8</td>
      <td>72.4</td>
      <td>5</td>
      <td>1</td>
      <td>3</td>
      <td><input type="checkbox" class="read-more-state" id="post-543684495"><p class="read-more-wrap">Alectinib
 is a kinase inhibitor indicated for the treatment of patients with 
anaplastic lymphoma kinase (ALK)-positive, metastatic non-small cell 
lung<span class="read-more-target"> cancer (NSCLC) who have progressed 
on or are intolerant to crizotinib. This indication is approved under 
accelerated approval based on tumor response rate and duration of 
response. Continued approval for this indication may be contingent upon 
verification and description of clinical benefit in confirmatory trials.</span></p><label for="post-543684495" class="read-more-trigger"></label></td>
      <td>ALK</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CCc1cc2c(cc1N3CCC(CC3)N4CCOCC4)C(c5c(c6ccc(cc6[nH]5)C#N)C2=O)(C)C<br><b>InChiKey</b>=KDGFLJKFZUIJMX-UHFFFAOYSA-N</td>
      <td>2015</td>
      <td>US-9126931-B2</td>
      <td>Achiral Molecule</td>
      <td>Alectinib <br> CH-5424802 <br> AF-802</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Alisertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Alisertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Millennium Pharmaceuticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.24700147.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL483158">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/24771867">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB05220">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=A5B">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/A5B">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7790">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC40939534">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=T66ES73M18">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50277545">BindingDB</a><br></td>
      <td>'A5B'</td>
      <td>5ia0</td>
      <td>1</td>
      <td>2</td>
      <td>518.1</td>
      <td>5.7</td>
      <td>105.9</td>
      <td>7</td>
      <td>2</td>
      <td>6</td>
      <td>For the treatment of various forms of cancer.</td>
      <td>AURKA</td>
      <td>Other</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=COc1cccc(c1C2=NCc3cnc(nc3-c4c2cc(cc4)Cl)Nc5ccc(c(c5)OC)C(=O)O)F<br><b>InChiKey</b>=ZLHFILGSQDJULK-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>MLN-8237 <br> Alisertib</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Allitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Allitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>1</td>
      <td>Allist Pharmaceuticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.25027184.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1947204">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/24739943">PubChem</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9912">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000052509434">ZINC</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>448.1</td>
      <td>5.9</td>
      <td>76.1</td>
      <td>5</td>
      <td>2</td>
      <td>7</td>
      <td>nan</td>
      <td>ERBB2<br>EGFR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C=CC(=O)Nc1ccc2c(c1)c(ncn2)Nc3ccc(c(c3)Cl)OCc4cccc(c4)F<br><b>InChiKey</b>=MVZGYPSXNDCANY-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td>AST-1306 <br> ALL-3</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Alpelisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Alpelisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Piqray</td>
      <td>4</td>
      <td>Novartis</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.28424123.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2396661">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/56649450">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12015">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=1LT">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/1LT">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7955">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000068198368">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=08W5N2C97Q">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50436459">BindingDB</a><br></td>
      <td>'1LT'</td>
      <td>4jps</td>
      <td>nan</td>
      <td>0</td>
      <td>441.1</td>
      <td>3.8</td>
      <td>101.2</td>
      <td>5</td>
      <td>2</td>
      <td>4</td>
      <td>On may 2019, FDA approved alpelisib to treat breast cancer</td>
      <td>PIK3CA</td>
      <td>Atypical</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1c(sc(n1)NC(=O)N2CCC[C@H]2C(=O)N)c3ccnc(c3)C(C)(C)C(F)(F)F<br><b>InChiKey</b>=STUWGJZDJHPWGZ-LBPRGKRZSA-N</td>
      <td>2019</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>NVP-BYL719 <br> Alpelisib <br> BYL-719</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Altiratinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Altiratinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>1</td>
      <td>Deciphera Pharmaceuticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.33427355.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545365">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/54576299">PubChem</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9174">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000113198271">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=T678746713">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50193395">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>510.2</td>
      <td>5</td>
      <td>109.4</td>
      <td>5</td>
      <td>3</td>
      <td>8</td>
      <td>nan</td>
      <td>MET<br>TEK<br>KDR<br>NTRK1</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1cc(ccc1NC(=O)C2(CC2)C(=O)Nc3cc(c(cc3F)Oc4ccnc(c4)NC(=O)C5CC5)F)F<br><b>InChiKey</b>=GNNDEPIMDAZHRQ-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>DCC-2701 <br> Altiratinib <br> DP-5164</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Alvocidib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Alvocidib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Sanofi</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.4450222.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL428690">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/5287969">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB03496">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=CPB">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/CPB">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5680">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000021288966">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=45AD6X575G">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=5655">BindingDB</a><br></td>
      <td>'CPB'</td>
      <td>1c8k 1e1y 3blr 3ebp 4o71</td>
      <td>nan</td>
      <td>0</td>
      <td>401.1</td>
      <td>3.3</td>
      <td>94.1</td>
      <td>6</td>
      <td>3</td>
      <td>2</td>
      <td>Investigated for use/treatment in esophageal cancer, leukemia (lymphoid), lung cancer, liver cancer, and lymphoma (unspecified).</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN1CC[C@@H]([C@@H](C1)O)c2c(cc(c3c2oc(cc3=O)c4ccccc4Cl)O)O<br><b>InChiKey</b>=BIIVYFLTOXDAOV-YVEFUNNKSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>L-86-8275 <br> Flavopiridol <br> MDL-107826A <br> HL-275 <br> HMR-1275 <br> Alvocidib <br> NSC-649890 <br> L-868275</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Amcasertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Amcasertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Boston Biomedical</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.44208821.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3707349">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/25190990">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB14866">DrugBank</a><br><a href="http://zinc15.docking.org/substances/ZINC000059029686">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=GLY8ABW25V">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>2</td>
      <td>539.2</td>
      <td>6</td>
      <td>90.1</td>
      <td>5</td>
      <td>3</td>
      <td>9</td>
      <td>nan</td>
      <td>PDGFRA</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CCN(CC)CCNC(=O)c1c(c([nH]c1C)/C=C\2/c3cc(ccc3NC2=O)c4csc(n4)c5ccccc5)C<br><b>InChiKey</b>=QDWKGEFGLQMDAM-ULJHMMPZSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>BBI-503 <br> Amcasertib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Amuvatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Amuvatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Supergen</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9457280.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2103851">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11282283">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12742">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7932">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC34951302">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=SO9S6QZB4R">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50172081">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>447.1</td>
      <td>3.3</td>
      <td>75.9</td>
      <td>7</td>
      <td>1</td>
      <td>3</td>
      <td><input type="checkbox" class="read-more-state" id="post-126174313"><p class="read-more-wrap">Amuvatinib
 is a selective multi-targeted tyrosine kinase inhibitor that suppresses
 c-MET, c-RET and the mutant forms of c-KIT, PDGFR and FLT3. Amuvati<span class="read-more-target">nib also suppresses Rad51 protein, a critical comp\nonent of double-stranded DNA repair in cancer cells.</span></p><label for="post-126174313" class="read-more-trigger"></label></td>
      <td>KIT<br>MET<br>RET<br>FLT3<br>PDGFRB</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1ccc2c(c1)c3c(o2)c(ncn3)N4CCN(CC4)C(=S)NCc5ccc6c(c5)OCO6<br><b>InChiKey</b>=FOFDIMHVKGYHRU-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>MP-470 <br> HPK56 <br> Amuvatinib <br> HPK-56</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Anlotinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Anlotinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>4</td>
      <td>Advenchen Laboratories</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.45743493.html">ChemSpider</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/25017411">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11885">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9601">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000117924202">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=GKF8S4C432">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>407.2</td>
      <td>4.8</td>
      <td>82.4</td>
      <td>5</td>
      <td>2</td>
      <td>6</td>
      <td><input type="checkbox" class="read-more-state" id="post-857483661"><p class="read-more-wrap">Anlotinib
 (AL3818) is a non-selective inhibitor of multiple receptor tyrosine 
kinases, including vascular endothelial growth factor receptor type 2 (V<span class="read-more-target">EGFR-2,
 FLT1) and type 3 (VEGFR-3, FLT4). It is being investigated for 
antineoplastic and anti-angiogenic potential. The dihydrochloride has 
PubChem CID: 57380530. Preparation and crystallisation of AL3818 is 
described in patent WO2016179123.</span></p><label for="post-857483661" class="read-more-trigger"></label></td>
      <td>KDR<br>FLT4</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1cc2c([nH]1)ccc(c2F)Oc3ccnc4c3cc(c(c4)OCC5(CC5)N)OC<br><b>InChiKey</b>=KSMZEXLVHXZPEF-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td>ALTN<br><br>APCII<br>AL3818<br>ATC I<br>FU KE WEI<br>APC I<br>ATCII<br>ANLOTINIB</td>
      <td>N</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Apatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Apatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>4</td>
      <td>Bukwang Pharmaceutical</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.34980756.html">ChemSpider</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/66577012">PubChem</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7648">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000083291412">ZINC</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>397.2</td>
      <td>5.1</td>
      <td>90.7</td>
      <td>5</td>
      <td>2</td>
      <td>5</td>
      <td><input type="checkbox" class="read-more-state" id="post-350691899"><p class="read-more-wrap">Apatinib
 mesylate is an orally bioavailable, small-molecule receptor tyrosine 
kinase inhibitor with potential antiangiogenic and antineoplastic activi<span class="read-more-target">ties.
 The free-base form is also known as Rivoceranib. Apatinib selectively 
binds to and inhibits vascular endothelial growth factor receptor 2, 
which may inhibit VEGF-stimulated endothelial cell migration and 
proliferation and decrease tumor microvessel density. In addition, this 
agent mildly inhibits c-Kit and c-SRC tyrosine kinases.</span></p><label for="post-350691899" class="read-more-trigger"></label></td>
      <td>KDR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=N#CC1(CCCC1)c1ccc(cc1)NC(=O)c1cccnc1Nc1cnccc1C<br><b>InChiKey</b>=MGZNERAVOCFMCU-UHFFFAOYSA-N</td>
      <td>2014</td>
      <td>nan</td>
      <td>nan</td>
      <td><br>NO.<br>STUDY DRUG<br>5-FLUOROURACIL<br>VP-16<br>ALBUMIN PACLITAXEL<br>AITAN<br>DOCETAXEL<br>EGAFUR<br>EMOZOLOMIDE（TMZ）<br>PLATINU<br>NAVELBINE+AITAN<br>PEMETREXED<br>H20140103<br>S1<br>ARGET THERAPY<br>SPA<br>YN968D1<br>CARBOPLATIN<br>ARM A<br>PACLITAXOL<br>XELOX<br>APATINIB GROUP<br>S-1<br>ATAN<br>AI TAN<br>APATINIB<br>REATMENT GROUP<br>CAPECITABINE<br>YEW<br>APATINIB MESYLATE<br>ESYLATE APATINIB<br>APATINIB TABLETS<br>OXALIPLATIN<br>YN968D1,(AITAN®</td>
      <td>N</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Apitolisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Apitolisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Hoffmann-La Roche</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.26325996.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1922094">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/25254071">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12180">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=980">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/980">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7888">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000059224388">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=1C854K1MIJ">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50358204">BindingDB</a><br></td>
      <td>'980'</td>
      <td>3tl5</td>
      <td>nan</td>
      <td>1</td>
      <td>498.2</td>
      <td>0.9</td>
      <td>133.8</td>
      <td>11</td>
      <td>2</td>
      <td>5</td>
      <td>nan</td>
      <td>PIK3CA<br>MTOR</td>
      <td>Atypical</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1c(sc2c1nc(nc2N3CCOCC3)c4cnc(nc4)N)CN5CCN(CC5)C(=O)[C@H](C)O<br><b>InChiKey</b>=YOVVNQKCSKSHKT-HNNXBMFYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>GDC-0980.1 <br> RG-7422 <br> G-038390.1 <br> GDC-0980 <br> Apitolisib <br> G-038390</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Asciminib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Asciminib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Novartis</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.52085218.html">ChemSpider</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/72165228">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12597">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=AY7">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/AY7">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8962">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000150275965">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=L1F3R18W77">FDA SRS</a><br></td>
      <td>'AY7'</td>
      <td>5mo4</td>
      <td>nan</td>
      <td>0</td>
      <td>449.1</td>
      <td>3.5</td>
      <td>103.4</td>
      <td>6</td>
      <td>3</td>
      <td>6</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1cc(ccc1NC(=O)c2cc(c(nc2)N3CC[C@H](C3)O)c4ccn[nH]4)OC(F)(F)Cl<br><b>InChiKey</b>=VOVZXURTCKPRDQ-CQSZACIVSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td><br>ASCIMINIB</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Avapritinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Avapritinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Blueprint Medicines</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.58828673.html">ChemSpider</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/118023034">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB15233">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10368">Guide to Pharmacology</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=513P80B4YJ">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>498.2</td>
      <td>2.6</td>
      <td>106.3</td>
      <td>10</td>
      <td>1</td>
      <td>5</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C[C@](c1ccc(cc1)F)(c2cnc(nc2)N3CCN(CC3)c4c5cc(cn5ncn4)c6cnn(c6)C)N<br><b>InChiKey</b>=DWYRIWUZIJHQKQ-SANMLTNESA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td><br>BLU-285</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Axitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Axitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Inlyta</td>
      <td>4</td>
      <td>Pfizer</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.4953153.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1289926">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/6450551">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB06626">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=AXI">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/AXI">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5659">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC03816287">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=C9LVQ0YUXG">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25117">BindingDB</a><br></td>
      <td>'AXI'</td>
      <td>4ag8 4agc 4twp 4wa9</td>
      <td>2</td>
      <td>0</td>
      <td>386.1</td>
      <td>4.6</td>
      <td>70.7</td>
      <td>4</td>
      <td>2</td>
      <td>5</td>
      <td>Used in kidney cell cancer and investigated for use/treatment in pancreatic and thyroid cancer.</td>
      <td>FLT1<br>KDR<br>FLT4</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CNC(=O)c1ccccc1Sc2ccc3c(c2)[nH]nc3/C=C/c4ccccn4<br><b>InChiKey</b>=RITAVMQDGBJQJZ-FMIVXFBMSA-N</td>
      <td>2012</td>
      <td>US-6534524-B1</td>
      <td>Achiral Molecule</td>
      <td>Inlyta <br> AG-13736 <br> Axitinib <br> AG-013736</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Bafetinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Bafetinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Innovive Pharmaceuticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9562515.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL206834">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11387605">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11851">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=406">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/406">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7906">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000022940637">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=NVW4Z03I9B">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50178612">BindingDB</a><br></td>
      <td>'406'</td>
      <td>2e2b</td>
      <td>2</td>
      <td>2</td>
      <td>576.3</td>
      <td>5.4</td>
      <td>99.2</td>
      <td>8</td>
      <td>2</td>
      <td>8</td>
      <td>nan</td>
      <td>LYN<br>ABL1</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1ccc(cc1Nc2nccc(n2)c3cncnc3)NC(=O)c4ccc(c(c4)C(F)(F)F)CN5CC[C@@H](C5)N(C)C<br><b>InChiKey</b>=ZGBAJMQHJDFTQJ-DEOSSOPVSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>CNS-9 <br> Bafetinib <br> NS-187 <br> INNO-406</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Balamapimod</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Balamapimod.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>1</td>
      <td>Wyeth</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9653509.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2104954">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11478684">PubChem</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9925">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000011726212">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=7Y0IV7N95Q">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>2</td>
      <td>573.2</td>
      <td>6.5</td>
      <td>82.2</td>
      <td>9</td>
      <td>1</td>
      <td>7</td>
      <td>nan</td>
      <td>RAF1<br>MAP2K1<br>MAP2K2</td>
      <td>TKL<br>STE</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cn1ccnc1Sc2ccc(cc2Cl)Nc3c4cc(c(cc4ncc3C#N)N5CCC(CC5)N6CCCC6)OC<br><b>InChiKey</b>=CVAKNHIXTWLGJO-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>MKI-833 <br> Balamapimod</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Barasertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Barasertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Astrazeneca</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9672789.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL415049">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11497983">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11747">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7332">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000043129461">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=16XC2U7W8N">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50241089">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>587.2</td>
      <td>3.6</td>
      <td>174.8</td>
      <td>9</td>
      <td>5</td>
      <td>15</td>
      <td>nan</td>
      <td>AURKB</td>
      <td>Other</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CCN(CCCOc1ccc2c(c1)ncnc2Nc3cc(n[nH]3)CC(=O)Nc4cccc(c4)F)CCOP(=O)(O)O<br><b>InChiKey</b>=GBJVVSCPOBPEIT-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>Barasertib <br> AZD-1152</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Baricitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Baricitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Olumiant</td>
      <td>4</td>
      <td>Eli Lilly</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.26373084.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2105759">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/44205240">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11817">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=3JW">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/3JW">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7792">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000073069247">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=ISP4442I3Y">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50021656">BindingDB</a><br></td>
      <td>'3JW'</td>
      <td>4w9x</td>
      <td>1</td>
      <td>0</td>
      <td>371.1</td>
      <td>1.1</td>
      <td>120.6</td>
      <td>7</td>
      <td>1</td>
      <td>5</td>
      <td><input type="checkbox" class="read-more-state" id="post-629136195"><p class="read-more-wrap">Indicated
 for the treatment of moderate to severe active rheumatoid arthritis in 
adult patients who have responded inadequately to, or who are intoler<span class="read-more-target">ant to one or more disease-modifying anti-rheumatic drugs as monotherapy or in combination with methotrexate.</span></p><label for="post-629136195" class="read-more-trigger"></label></td>
      <td>JAK1<br>JAK2</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CCS(=O)(=O)N1CC(C1)(CC#N)n2cc(cn2)c3c4cc[nH]c4ncn3<br><b>InChiKey</b>=XUZMWHLSFXCVMG-UHFFFAOYSA-N</td>
      <td>2017</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>Baricitinib <br> LY-3009104 <br> INCB-28050 <br> INCB-028050</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Bemcentinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Bemcentinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>BerGenBio</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.28637805.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3809489">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/46215462">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12411">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10478">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000051951669">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=0ICW2LX8AS">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50172079">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>506.3</td>
      <td>4.9</td>
      <td>97.8</td>
      <td>8</td>
      <td>2</td>
      <td>4</td>
      <td>nan</td>
      <td>AXL</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1ccc-2c(c1)CCCc3c2nnc(c3)n4c(nc(n4)Nc5ccc6c(c5)CC[C@H](CC6)N7CCCC7)N<br><b>InChiKey</b>=KXMZDGSRSGHMMK-VWLOTQADSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td>BGB324; KEYTRUDA<br><br>BEMCENTINIB</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Bentamapimod</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Bentamapimod.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>PregLem</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.8370750.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545213">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/10195250">PubChem</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9926">Guide to Pharmacology</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>457.2</td>
      <td>4.2</td>
      <td>84.2</td>
      <td>8</td>
      <td>0</td>
      <td>7</td>
      <td>nan</td>
      <td>MAPK8<br>MAPK9</td>
      <td>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=N#CC(c1nc2ccccc2s1)c5nc(OCc3ccc(cc3)CN4CCOCC4)ncc5<br><b>InChiKey</b>=XCPPIJCBCWUBNT-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Racemic Mixture</td>
      <td>PGL-5001 <br> Bentamapimod <br> AS-602801</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Berzosertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Berzosertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Vertex Pharmaceuticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.30773968.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3989870">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/59472121">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11794">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8003">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000096170459">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=L423PRV3V3">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50226746">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>463.2</td>
      <td>3.9</td>
      <td>124</td>
      <td>8</td>
      <td>2</td>
      <td>7</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC(C)S(=O)(=O)c1ccc(cc1)c2cnc(c(n2)c3cc(no3)c4ccc(cc4)CNC)N<br><b>InChiKey</b>=JZCWLJDSIRUGIN-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>VX-970 <br> Berzosertib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Bimiralisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Bimiralisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Piqur Therapeutics</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.35033288.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4084907">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/58507717">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB14846">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=A3W">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/A3W">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8383">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000068203488">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=6Z3QHB00LB">FDA SRS</a><br></td>
      <td>'A3W'</td>
      <td>5oq4</td>
      <td>nan</td>
      <td>0</td>
      <td>411.2</td>
      <td>1</td>
      <td>103.2</td>
      <td>8</td>
      <td>2</td>
      <td>3</td>
      <td><input type="checkbox" class="read-more-state" id="post-241378381"><p class="read-more-wrap">Bimiralisib
 (PQR309) is a novel dual inhibitor of phosphoinositol 3-kinase (PI3K) 
and mechanistic target of rapamycin (mTOR) kinases, with expected ut<span class="read-more-target">ility as an anti-cancer agent.</span></p><label for="post-241378381" class="read-more-trigger"></label></td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1c(c(c[nH]c1=N)c2nc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F<br><b>InChiKey</b>=ADGGYDAFIHSYFI-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td><br>PQR309<br>BIMIRALISIB</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Binimetinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Binimetinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Mektovi</td>
      <td>4</td>
      <td>Novartis</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.8463660.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3187723">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/10288191">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11967">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7921">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000038460704">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=181R97MR71">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>440</td>
      <td>3</td>
      <td>88.4</td>
      <td>6</td>
      <td>3</td>
      <td>6</td>
      <td><input type="checkbox" class="read-more-state" id="post-864695250"><p class="read-more-wrap">On
 June 27, 2018, the Food and Drug Administration approved encorafenib 
and binimetinib in combination patients with unresectable or metastatic 
melano<span class="read-more-target">ma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test.</span></p><label for="post-864695250" class="read-more-trigger"></label></td>
      <td>MAP2K1</td>
      <td>STE</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cn1cnc2c1cc(c(c2F)Nc3ccc(cc3F)Br)C(=O)NOCCO<br><b>InChiKey</b>=ACWZRVQXLIRSDF-UHFFFAOYSA-N</td>
      <td>2018</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>ARRY-162 <br> NVP-MEK162 <br> Binimetinib <br> MEK-162 <br> ARRY-438162</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Bosutinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Bosutinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Bosulif</td>
      <td>4</td>
      <td>Wyeth</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.4486102.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL288441">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/5328940">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB06616">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=DB8">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/DB8">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5710">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000022448983">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=5018V4AEZ0">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4552">BindingDB</a><br></td>
      <td>'DB8'</td>
      <td>3soa 3ue4 4mxo 4mxx 4mxy 4mxz 4qmn 5ajq 5i9x 5vc3 5vcy 6fdy 6op9</td>
      <td>1</td>
      <td>2</td>
      <td>529.2</td>
      <td>5.2</td>
      <td>82.9</td>
      <td>8</td>
      <td>1</td>
      <td>9</td>
      <td><input type="checkbox" class="read-more-state" id="post-584992652"><p class="read-more-wrap">Treatment
 of chronic, accelerated, or blast phase Philadelphia 
chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with 
resistance or intoler<span class="read-more-target">ance to prior therapy in adult patients.</span></p><label for="post-584992652" class="read-more-trigger"></label></td>
      <td>BCR<br>ABL1<br>LYN<br>HCK<br>SRC<br>CDK2<br>MAP2K1<br>MAP2K2<br>MAP3K2<br>CAMK2G</td>
      <td>Atypical<br>Tyr<br>STE<br>CAMK<br>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN1CCN(CC1)CCCOc2cc3c(cc2OC)c(c(cn3)C#N)Nc4cc(c(cc4Cl)Cl)OC<br><b>InChiKey</b>=UBPYILGKFZZVDX-UHFFFAOYSA-N</td>
      <td>2012</td>
      <td>US-6002008-A</td>
      <td>Achiral Molecule</td>
      <td>Bosulif <br> Bosutinib Monohydrate <br> Bosutinib <br> SKI-606</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Brigatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Brigatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Alunbrig</td>
      <td>4</td>
      <td>Ariad Pharmaceuticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.34982928.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545311">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/68165256">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12267">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=6GY">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/6GY">PDBe</a><br><a href="http://zinc15.docking.org/substances/ZINC000148723177">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=HYW8DB273J">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50185140">BindingDB</a><br></td>
      <td>'6GY'</td>
      <td>6mx8</td>
      <td>1</td>
      <td>2</td>
      <td>583.3</td>
      <td>5.1</td>
      <td>85.9</td>
      <td>9</td>
      <td>2</td>
      <td>8</td>
      <td><input type="checkbox" class="read-more-state" id="post-579604923"><p class="read-more-wrap">The
 anaplastic lymphoma kinase positive, metastatic non-small cell lung 
cancer (ALK+ NSCLC), represents only 3-5% of the NSCLC cancer cases, but
 the A<span class="read-more-target">LK mutation, overexpression and 
presence in several oncogenic fusion proteins in solid and hematologic 
tumors have pointed out the importance as well as its potential as a 
cancer therapy target. The ALK-related cases of NSCLC are associated 
with the presence of the fusion gene EML4-ALK which fused the ALK 
protein with the echinoderm microtubule-associated protein like-4 whose 
original function is the correct formation of microtubules. The presence
 of the aberrant fusion protein results in abnormal signaling that 
provokes increased cell growth, proliferation and survival. Crizotinib 
is indicated for the treatment of such cases but the presence of ALK 
kinase domain mutations confer resistance to the treatment. Thus, 
brigatinib is indicated for the treatment of patients with ALK+ NSCLC 
with intolerance to Crizotinib.</span></p><label for="post-579604923" class="read-more-trigger"></label></td>
      <td>ALK<br>EGFR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN1CCN(CC1)C2CCN(CC2)c3ccc(c(c3)OC)Nc4ncc(c(n4)Nc5ccccc5P(=O)(C)C)Cl<br><b>InChiKey</b>=AILRADAXUVEEIR-UHFFFAOYSA-N</td>
      <td>2017</td>
      <td>US-9012462-B2</td>
      <td>Achiral Molecule</td>
      <td>Alunbrig <br> AP-26113 <br> Brigatinib</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Brivanib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Brivanib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Bristol Myers Squibb</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9409099.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL377300">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11234052">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11958">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5671">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC13684256">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=DDU33B674I">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50184807">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>370.1</td>
      <td>3.5</td>
      <td>84.7</td>
      <td>6</td>
      <td>2</td>
      <td>5</td>
      <td>nan</td>
      <td>KDR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1cc2c([nH]1)ccc(c2F)Oc3c4c(c(cn4ncn3)OC[C@@H](C)O)C<br><b>InChiKey</b>=WCWUXEGQKLTGDX-LLVKDONJSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>Brivanib <br> BMS-540215</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Buparlisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Buparlisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Novartis</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.17588300.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2017974">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/16654980">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11666">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=SD5">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/SD5">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7878">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC43154039">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=0ZM2Z182GD">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380363">BindingDB</a><br></td>
      <td>'SD5'</td>
      <td>3sd5 5m7e</td>
      <td>1</td>
      <td>0</td>
      <td>410.2</td>
      <td>1.8</td>
      <td>89.6</td>
      <td>8</td>
      <td>1</td>
      <td>3</td>
      <td>nan</td>
      <td>PIK3CA</td>
      <td>Atypical</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1c(c(cnc1N)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F<br><b>InChiKey</b>=CWHUFRVAEUJCEF-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>NVP-BKM120 <br> BKM-120 <br> Buparlisib <br> BKM120-NX</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Cabozantinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Cabozantinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Cabometyx;Cometriq</td>
      <td>4</td>
      <td>Exelixis</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.25948202.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2105717">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/25102847">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB08875">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5887">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000070466416">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=1C39JW444G">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50021574">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>2</td>
      <td>2</td>
      <td>501.2</td>
      <td>5.5</td>
      <td>98.8</td>
      <td>6</td>
      <td>2</td>
      <td>8</td>
      <td><input type="checkbox" class="read-more-state" id="post-123027218"><p class="read-more-wrap">For
 the treatment of metastatic medullary thyroid cancer and for the 
treatment of patients with advanced renal cell carcinoma (RCC) who have 
received <span class="read-more-target">prior anti-angiogenic therapy.</span></p><label for="post-123027218" class="read-more-trigger"></label></td>
      <td>MET<br>KDR<br>RET</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=COc1cc2c(ccnc2cc1OC)Oc3ccc(cc3)NC(=O)C4(CC4)C(=O)Nc5ccc(cc5)F<br><b>InChiKey</b>=ONIQOQHATWINJY-UHFFFAOYSA-N</td>
      <td>2012</td>
      <td>US-7579473-B2</td>
      <td>Achiral Molecule</td>
      <td>Cabometyx;Cometriq <br> XL-184 <br> Cabozantinib <br> BMS-907351</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Canertinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Canertinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Pfizer</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.137741.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL31965">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/156414">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB05424">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5675">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC27439698">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=C78W1K5ASF">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4779">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>485.2</td>
      <td>4.4</td>
      <td>88.6</td>
      <td>7</td>
      <td>2</td>
      <td>9</td>
      <td>Investigated for use/treatment in breast cancer and lung cancer.</td>
      <td>EGFR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C=CC(=O)Nc1cc2c(cc1OCCCN3CCOCC3)ncnc2Nc4ccc(c(c4)Cl)F<br><b>InChiKey</b>=OMZCMEYTWSXEPZ-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>CI-1033 <br> Canertinib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Capivasertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Capivasertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Astrazeneca</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.28189073.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2325741">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/25227436">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12218">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=0XZ">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/0XZ">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7709">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000043204023">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=WFR23M21IE">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50427349">BindingDB</a><br></td>
      <td>'0XZ'</td>
      <td>4gv1</td>
      <td>nan</td>
      <td>0</td>
      <td>428.2</td>
      <td>2.1</td>
      <td>120.2</td>
      <td>6</td>
      <td>4</td>
      <td>6</td>
      <td>nan</td>
      <td>AKT1</td>
      <td>AGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1cc(ccc1[C@H](CCO)NC(=O)C2(CCN(CC2)c3c4cc[nH]c4ncn3)N)Cl<br><b>InChiKey</b>=JDUBGYFRJFOXQC-KRWDZBQOSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td>AZD-5363</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Capmatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Capmatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Novartis</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.25069712.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3188267">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/25145656">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11791">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7904">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000043195321">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=TY34L4F9OZ">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50146167">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>412.1</td>
      <td>3.4</td>
      <td>85.1</td>
      <td>6</td>
      <td>1</td>
      <td>4</td>
      <td>nan</td>
      <td>MET</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CNC(=O)c1ccc(cc1F)c2cnc3ncc(n3n2)Cc4ccc5c(c4)cccn5<br><b>InChiKey</b>=LIOLIMKSCNQPLV-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>INC280 <br> Capmatinib <br> INCB-28060 <br> NVP-INC280 <br> NYP-INC280-NX <br> INC-280</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Cediranib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Cediranib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Recentin</td>
      <td>3</td>
      <td>Astrazeneca</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.8109103.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL491473">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/9933475">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB04849">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5664">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000003948085">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=NQU9IPY4K9">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50331096">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>450.2</td>
      <td>5.2</td>
      <td>72.5</td>
      <td>6</td>
      <td>1</td>
      <td>8</td>
      <td>For the treatment of liver cancer, advanced non-small cell 
lung cancer (NSCLC), advanced colorectal cancer (CRC) and other solid 
tumors.</td>
      <td>KDR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1cc2c([nH]1)ccc(c2F)Oc3c4cc(c(cc4ncn3)OCCCN5CCCC5)OC<br><b>InChiKey</b>=XXJWYDDUDKYVKI-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>Recentin <br> ZD-2171 <br> AZD-2171 <br> Cediranib</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Cenisertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Cenisertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>1</td>
      <td>EMD Serono</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9744737.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1614709">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11569967">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB06347">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9927">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000063298059">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=5277GPA358">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50389967">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>451.2</td>
      <td>2.5</td>
      <td>99.4</td>
      <td>7</td>
      <td>3</td>
      <td>6</td>
      <td>nan</td>
      <td>AURKA<br>AURKB<br>AURKC</td>
      <td>Other</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1cc(ccc1N2CCN(CC2)C)Nc3ncc(c(n3)N[C@@H]4[C@@H]5C[C@H]([C@@H]4C(=O)N)C=C5)F<br><b>InChiKey</b>=KSOVGRCOLZZTPF-QMKUDKLTSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Racemic Mixture</td>
      <td>R-763 <br> AS-703569</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Ceralasertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Ceralasertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Astrazeneca</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.64879993.html">ChemSpider</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/76189946">PubChem</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>412.2</td>
      <td>2.9</td>
      <td>107.8</td>
      <td>7</td>
      <td>2</td>
      <td>4</td>
      <td><input type="checkbox" class="read-more-state" id="post-940128547"><p class="read-more-wrap">Ceralasertib,
 also known as AZD6738, is an orally available 
morpholino-pyrimidine-based inhibitor of ataxia telangiectasia and rad3 
related (ATR) kina<span class="read-more-target">se, with potential 
antineoplastic activity. Upon oral administration, ATR kinase inhibitor 
Ceralasertib selectively inhibits ATR activity by blocking the 
downstream phosphorylation of the serine/threonine protein kinase CHK1. 
This prevents ATR-mediated signaling, and results in the inhibition of 
DNA damage checkpoint activation, disruption of DNA damage repair, and 
the induction of tumor cell apoptosis.</span></p><label for="post-940128547" class="read-more-trigger"></label></td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC1COCCN1c2cc(nc(n2)c3cncc4c3cc[nH]4)C5(CC5)S(=N)(=O)C<br><b>InChiKey</b>=DTTJKLNXNZAVSM-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td><br>AZD6738</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Cerdulatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Cerdulatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2.5</td>
      <td>Portola pharmaceuticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.32822046.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4116008">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/44595079">PubChem</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8957">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000114483165">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=D1LXQ45S1O">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>445.2</td>
      <td>1.4</td>
      <td>133.6</td>
      <td>8</td>
      <td>3</td>
      <td>8</td>
      <td>nan</td>
      <td>JAK1<br>SYK</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CCS(=O)(=O)N1CCN(CC1)c2ccc(cc2)Nc3ncc(c(n3)NC4CC4)C(=O)N<br><b>InChiKey</b>=BGLPECHZZQDNCD-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>PRT-062070</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Ceritinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Ceritinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Zykadia</td>
      <td>4</td>
      <td>Novartis</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.29315053.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2403108">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/57379345">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB09063">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=4MK">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/4MK">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7397">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000096272772">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=K418KG2GET">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50436850">BindingDB</a><br></td>
      <td>'4MK'</td>
      <td>4mkc</td>
      <td>1</td>
      <td>2</td>
      <td>557.2</td>
      <td>6.4</td>
      <td>105.2</td>
      <td>8</td>
      <td>3</td>
      <td>9</td>
      <td><input type="checkbox" class="read-more-state" id="post-273120720"><p class="read-more-wrap">Ceritinib
 is a kinase inhibitor indicated for the treatment of patients with 
anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung
 <span class="read-more-target">cancer (NSCLC) who have progressed on or
 are intolerant to crizotinib. This indication is approved under 
accelerated approval based on tumor response rate and duration of 
response. An improvement in survival or disease-related symptoms has not
 been established. Continued approval for this indication may be 
contingent upon verification and description of clinical benefit in 
confirmatory trials.</span></p><label for="post-273120720" class="read-more-trigger"></label></td>
      <td>ALK</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1cc(c(cc1C2CCNCC2)OC(C)C)Nc3ncc(c(n3)Nc4ccccc4S(=O)(=O)C(C)C)Cl<br><b>InChiKey</b>=VERWOWGGCGHDQE-UHFFFAOYSA-N</td>
      <td>2014</td>
      <td>US-7153964-B2</td>
      <td>Achiral Molecule</td>
      <td>Zykadia <br> Ceritinib <br> NVP-LDK378-NX</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Cobimetinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Cobimetinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Cotellic</td>
      <td>4</td>
      <td>Hoffmann-La Roche</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.17349374.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2146883">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/16222096">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB05239">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=EUI">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/EUI">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7626">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000060325170">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=ER29L26N1X">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50391802">BindingDB</a><br></td>
      <td>'EUI'</td>
      <td>4an2 4lmn</td>
      <td>3</td>
      <td>1</td>
      <td>531.1</td>
      <td>3.8</td>
      <td>64.6</td>
      <td>4</td>
      <td>3</td>
      <td>4</td>
      <td><input type="checkbox" class="read-more-state" id="post-623083654"><p class="read-more-wrap">For
 the treatment of patients with unresectable or metastatic melanoma with
 a BRAF V600E or V600K mutation. Cobimetinib is used in combination with
 ve<span class="read-more-target">murafenib, a BRAF inhibitor.</span></p><label for="post-623083654" class="read-more-trigger"></label></td>
      <td>MAP2K1</td>
      <td>STE</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1c(cc(c(c1)Nc2c(c(ccc2C(=O)N3C[C@@](C3)(O)[C@H]4NCCCC4)F)F)F)I<br><b>InChiKey</b>=BSMCAPRUBJMWDF-KRWDZBQOSA-N</td>
      <td>2015</td>
      <td>US-7803839-B2</td>
      <td>Single Stereoisomer</td>
      <td>Cotellic <br> RG-7421 <br> GDC-0973 <br> RG-7420 <br> XL-518 <br> Cobimetinib</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Copanlisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Copanlisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Aliqopa</td>
      <td>4</td>
      <td>Bayer</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.25069683.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3218576">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/24989044">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12483">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=6E2">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/6E2">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7875">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000068247389">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=WI6V529FZ9">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50204093">BindingDB</a><br></td>
      <td>'6E2'</td>
      <td>5g2n</td>
      <td>1</td>
      <td>1</td>
      <td>480.2</td>
      <td>0.7</td>
      <td>139.8</td>
      <td>11</td>
      <td>2</td>
      <td>7</td>
      <td>Indicated for the treatment of adult patients with relapsed 
follicular lymphoma (FL) who have received at least two prior systemic 
therapies.</td>
      <td>PIK3CA<br>PIK3CB</td>
      <td>Atypical</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=COc1c(ccc2c1N=C(N3C2=NCC3)NC(=O)c4cnc(nc4)N)OCCCN5CCOCC5<br><b>InChiKey</b>=PZBCKZWLPGJMAO-UHFFFAOYSA-N</td>
      <td>2017</td>
      <td>US-7511041-B2</td>
      <td>Achiral Molecule</td>
      <td>Copanlisib <br> BAY 80-6946 <br> BAY-80-6946</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Crenolanib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Crenolanib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Arog Pharmaceuticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.8541584.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2105728">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/10366136">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11832">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=6T2">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/6T2">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7882">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000003820043">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=LQF7I567TQ">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=185149">BindingDB</a><br></td>
      <td>'6T2'</td>
      <td>5lby 6bqp</td>
      <td>1</td>
      <td>0</td>
      <td>443.2</td>
      <td>3.9</td>
      <td>78.4</td>
      <td>7</td>
      <td>1</td>
      <td>5</td>
      <td>nan</td>
      <td>FLT3<br>PDGFRA<br>PDGFRB</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC1(COC1)COc2ccc3c(c2)ncn3c4ccc5cccc(c5n4)N6CCC(CC6)N<br><b>InChiKey</b>=DYNHJHQFHQTFTP-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>CP-868596 <br> ARO-002 <br> Crenolanib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Crizotinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Crizotinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Xalkori</td>
      <td>4</td>
      <td>Pfizer</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9801307.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL601719">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11626560">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB08865">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=VGH">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/VGH">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4903">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000035902489">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=53AH36668S">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50306682">BindingDB</a><br></td>
      <td>'VGH'</td>
      <td>2wgj 2xp2 2yfx 3zbf 4anq 4ans 4c9w 5aaa 5aab 5aac 6imz</td>
      <td>1</td>
      <td>1</td>
      <td>449.1</td>
      <td>5</td>
      <td>78</td>
      <td>6</td>
      <td>2</td>
      <td>5</td>
      <td><input type="checkbox" class="read-more-state" id="post-299274831"><p class="read-more-wrap">Crizotinib
 is used for the treatment of locally advanced or metastatic non-small 
cell lung cancer (NSCLC) that is anaplastic-lymphoma kinase (ALK)-pos<span class="read-more-target">itive as detected by a FDA-approved test.</span></p><label for="post-299274831" class="read-more-trigger"></label></td>
      <td>ALK<br>MET</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C[C@H](c1c(ccc(c1Cl)F)Cl)Oc2cc(cnc2N)c3cnn(c3)C4CCNCC4<br><b>InChiKey</b>=KTEIFNKAUNYNJU-GFCCVEGCSA-N</td>
      <td>2011</td>
      <td>US-7230098-B2</td>
      <td>Single Stereoisomer</td>
      <td>Xalkori <br> Crizotinib <br> PF-2341066</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Dabrafenib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Dabrafenib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Tafinlar</td>
      <td>4</td>
      <td>GlaxoSmithKline</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.25948204.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2028663">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/44462760">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB08912">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=P06">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/P06">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6494">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000068153186">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=QGP4HA4G1B">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50428286">BindingDB</a><br></td>
      <td>'P06'</td>
      <td>4xv2 5csw 5hie</td>
      <td>1.5</td>
      <td>2</td>
      <td>519.1</td>
      <td>5.4</td>
      <td>110.9</td>
      <td>7</td>
      <td>2</td>
      <td>5</td>
      <td><input type="checkbox" class="read-more-state" id="post-799049895"><p class="read-more-wrap">Dabrafenib
 is indicated for the treatment of patients with unresectable or 
metastatic melanoma with BRAF V600E mutation as detected by an 
FDA-approved<span class="read-more-target"> test.</span></p><label for="post-799049895" class="read-more-trigger"></label></td>
      <td>BRAF<br>RAF1<br>SIK1<br>NEK11<br>LIMK1</td>
      <td>NEK<br>TKL<br>CAMK</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC(C)(C)c1nc(c(s1)c2ccnc(n2)N)c3cccc(c3F)NS(=O)(=O)c4c(cccc4F)F<br><b>InChiKey</b>=BFSMGDJOXZAERB-UHFFFAOYSA-N</td>
      <td>2013</td>
      <td>US-7994185-B2</td>
      <td>Achiral Molecule</td>
      <td>Tafinlar <br> GSK2118436A <br> Dabrafenib</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Dacomitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Dacomitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Vizimpro</td>
      <td>4</td>
      <td>Pfizer</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9685914.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2110732">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11511120">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11963">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=1C9">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/1C9">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7422">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000072266312">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=2XJX250C20">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=112499">BindingDB</a><br></td>
      <td>'1C9'</td>
      <td>4i23 4i24</td>
      <td>1</td>
      <td>1</td>
      <td>469.2</td>
      <td>5.2</td>
      <td>79.4</td>
      <td>6</td>
      <td>2</td>
      <td>7</td>
      <td>On october 27, 2018, the FDA approved dacomitinib to treat metastatic non-small-cell lung cancer</td>
      <td>EGFR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=COc1cc2c(cc1NC(=O)/C=C/CN3CCCCC3)c(ncn2)Nc4ccc(c(c4)Cl)F<br><b>InChiKey</b>=LVXJQMNHJWSHET-AATRIKPKSA-N</td>
      <td>2018</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>Dacomitinib <br> PF-00299804</td>
      <td>Y</td>
      <td>184-187</td>
    </tr><tr class="odd">
      <td><b>Dactolisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Dactolisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Novartis</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.10151099.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1879463">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11977753">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11651">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7950">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC24760115">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=RUJ6Z9Y0DT">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=92862">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>469.2</td>
      <td>5.9</td>
      <td>76.5</td>
      <td>6</td>
      <td>0</td>
      <td>3</td>
      <td>nan</td>
      <td>PIK3CA<br>PIK3CB<br>PIK3CG<br>PIK3CD<br>MTOR</td>
      <td>Atypical</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC(C)(C#N)c1ccc(cc1)n2c3c4cc(ccc4ncc3n(c2=O)C)c5cc6ccccc6nc5<br><b>InChiKey</b>=JOGKUKXHTYWRGZ-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>Dactolisib <br> NVP-BEZ235-NX <br> BEZ-235 <br> NVP-BEZ235</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Danusertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Danusertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Nerviano Medical Sciences</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9617754.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL402548">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11442891">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11778">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=627">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/627">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7937">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000006718723">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=M3X659D0FY">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=209858">BindingDB</a><br></td>
      <td>'627'</td>
      <td>2j50 2v7a 4qo9 5i9z</td>
      <td>1</td>
      <td>0</td>
      <td>474.2</td>
      <td>2.6</td>
      <td>93.8</td>
      <td>6</td>
      <td>2</td>
      <td>6</td>
      <td>nan</td>
      <td>AURKA<br>AURKB<br>AURKC</td>
      <td>Other</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN1CCN(CC1)c2ccc(cc2)C(=O)Nc3c4c([nH]n3)CN(C4)C(=O)[C@@H](c5ccccc5)OC<br><b>InChiKey</b>=XKFTZKGMDDZMJI-HSZRJFAPSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>Danusertib <br> PHA-739358</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Dasatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Dasatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Sprycel</td>
      <td>4</td>
      <td>Bristol Myers Squibb</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.2323020.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1421">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/3062316">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB01254">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=1N1">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/1N1">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5678">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC21982951">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=X78UG0A0RN">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13216">BindingDB</a><br></td>
      <td>'1N1'</td>
      <td>2gqg 2y6o 2zva 3g5d 3k54 3lfa 3oct 3oht 3qlg 3sxr 4qms 4xey 4xli 5bvw 5h2u 5i9y 5owr 5vcv 6bsd 6fnm</td>
      <td>1</td>
      <td>0</td>
      <td>487.2</td>
      <td>3.3</td>
      <td>106.5</td>
      <td>9</td>
      <td>3</td>
      <td>7</td>
      <td><input type="checkbox" class="read-more-state" id="post-214002226"><p class="read-more-wrap">For
 the treatment of adults with chronic, accelerated, or myeloid or 
lymphoid blast phase chronic myeloid leukemia with resistance or 
intolerance to p<span class="read-more-target">rior therapy. Also 
indicated for the treatment of adults with Philadelphia 
chromosome-positive acute lymphoblastic leukemia with resistance or 
intolerance to prior therapy.</span></p><label for="post-214002226" class="read-more-trigger"></label></td>
      <td>ABL1<br>SRC<br>EPHA2<br>LCK<br>YES1<br>KIT<br>PDGFRB<br>ABL2<br>FYN</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1cccc(c1NC(=O)c2cnc(s2)Nc3cc(nc(n3)C)N4CCN(CC4)CCO)Cl<br><b>InChiKey</b>=ZBNZXTGUTAYRHI-UHFFFAOYSA-N</td>
      <td>2006</td>
      <td>US-6596746-B1</td>
      <td>Achiral Molecule</td>
      <td>Sprycel;Dasatinib <br> BMS-354825-03 <br> BMS-354825 <br> Dasatinib</td>
      <td>Y</td>
      <td>280-286</td>
    </tr><tr class="even">
      <td><b>Decernotinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Decernotinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Vertex Pharmaceuticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.30843790.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3039513">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/59422203">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12566">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=VJK">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/VJK">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8309">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000096941867">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=MZK2GP0RHK">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50021655">BindingDB</a><br></td>
      <td>'VJK'</td>
      <td>4yti</td>
      <td>1</td>
      <td>0</td>
      <td>392.2</td>
      <td>3.3</td>
      <td>95.6</td>
      <td>5</td>
      <td>3</td>
      <td>6</td>
      <td>nan</td>
      <td>JAK3</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC[C@](C)(C(=O)NCC(F)(F)F)Nc1ccnc(n1)c2c[nH]c3c2cccn3<br><b>InChiKey</b>=ASUGUQWIHMTFJL-QGZVFWFLSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>VRT-831509 <br> Adelatinib <br> VX-509 <br> Decernotinib</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Defactinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Defactinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Verastem</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.32695161.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3137331">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/25117126">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12282">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=7KD">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/7KD">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7910">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000103297739">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=53O87HA2QU">FDA SRS</a><br></td>
      <td>'7KD'</td>
      <td>5mah</td>
      <td>1</td>
      <td>1</td>
      <td>510.1</td>
      <td>2.4</td>
      <td>142.1</td>
      <td>9</td>
      <td>3</td>
      <td>8</td>
      <td>nan</td>
      <td>PTK2<br>PTK2B</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CNC(=O)c1ccc(cc1)Nc2ncc(c(n2)NCc3c(nccn3)N(C)S(=O)(=O)C)C(F)(F)F<br><b>InChiKey</b>=FWLMVFUGMHIOAA-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>PF-04554878 <br> VS-6063 <br> Defactinib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Derazantinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Derazantinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>1.5</td>
      <td>ArQule</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.59718644.html">ChemSpider</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/46834118">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB14889">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9785">Guide to Pharmacology</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=N9B0H171MJ">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>468.2</td>
      <td>5.5</td>
      <td>59.1</td>
      <td>5</td>
      <td>2</td>
      <td>9</td>
      <td>Derazantinib (ARQ087) is an orally bioavailable, non-selective FGFR inhibitor being investigated for antineoplastic activity.</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=COCCNCCc1cccc(c1)Nc2ncc3c(n2)-c4ccccc4[C@@H](C3)c5ccccc5F<br><b>InChiKey</b>=KPJDVVCDVBFRMU-AREMUKBSSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Dezapelisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Dezapelisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>0</td>
      <td>Incyte Corporation</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.28651137.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2216863">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/58111426">PubChem</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9728">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000095564453">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=2K59L7G59M">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50004547">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>421.1</td>
      <td>3.7</td>
      <td>100.9</td>
      <td>8</td>
      <td>2</td>
      <td>4</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1csc2n1c(=O)c(c(n2)[C@H](C)Nc3c4c([nH]cn4)ncn3)c5cccc(c5)F<br><b>InChiKey</b>=RSIWALKZYXPAGW-NSHDSACASA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>INCB040093 <br> Dezapelisib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Dilmapimod</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Dilmapimod.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>GlaxoSmithKline</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.8473450.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2103838">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/10297982">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12140">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7815">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000034997404">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=Q3238VQW0N">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>456.1</td>
      <td>2.9</td>
      <td>100.3</td>
      <td>7</td>
      <td>3</td>
      <td>6</td>
      <td><input type="checkbox" class="read-more-state" id="post-315529590"><p class="read-more-wrap">Dilmapimod
 has been used in trials studying the treatment and diagnostic of Nerve 
Trauma, Inflammation, Pain, Neuropathic, Arthritis, Rheumatoid, and <span class="read-more-target">Coronary Heart Disease, among others.</span></p><label for="post-315529590" class="read-more-trigger"></label></td>
      <td>MAPK14<br>MAPK11<br>MAPK13<br>MAPK12</td>
      <td>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1cc(ccc1c2c3ccc(=O)n(c3nc(n2)NC(CO)CO)c4c(cccc4F)F)F<br><b>InChiKey</b>=ORVNHOYNEHYKJG-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>Dilmapimod <br> GW681323 <br> SB-681323</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Dinaciclib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Dinaciclib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Schering-Plough</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.25027387.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2103840">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/46926350">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12021">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7379">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000034894449">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=4V8ECV0NBQ">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50139171">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>396.2</td>
      <td>2.3</td>
      <td>92.6</td>
      <td>7</td>
      <td>2</td>
      <td>7</td>
      <td>nan</td>
      <td>CDK4<br>CDK6<br>BRDT</td>
      <td>(*)<br>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CCc1cnn2c1nc(cc2NCc3ccc[n+](c3)[O-])N4CCCC[C@H]4CCO<br><b>InChiKey</b>=PIMQWRZWLQKKBJ-SFHVURJKSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>MK-7965 <br> SCH-727965 <br> Dinaciclib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Doramapimod</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Doramapimod.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Boehringer Ingelheim</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.137746.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL103667">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/156422">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB03044">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=B96">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/B96">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5668">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC24044436">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=HO1A8B3YVV">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13533">BindingDB</a><br></td>
      <td>'B96'</td>
      <td>1kv2 3fzs 3npc 4jvg 4twn 5n66 6gtt</td>
      <td>2</td>
      <td>2</td>
      <td>527.3</td>
      <td>6</td>
      <td>80.7</td>
      <td>6</td>
      <td>2</td>
      <td>7</td>
      <td>nan</td>
      <td>MAPK14</td>
      <td>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1ccc(cc1)n2c(cc(n2)C(C)(C)C)NC(=O)Nc3ccc(c4c3cccc4)OCCN5CCOCC5<br><b>InChiKey</b>=MVCOAUNKQVWQHZ-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>Doramapimod <br> BIRB-796</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Dovitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Dovitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Novartis</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.11530944.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL522892">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/135398510">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB05928">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=38O">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/38O">PDBe</a><br><a href="http://zinc15.docking.org/substances/ZINC000003816310">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=I35H55G906">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25118">BindingDB</a><br></td>
      <td>'38O'</td>
      <td>4tyi 5a46 5am6 5am7 5owq</td>
      <td>1</td>
      <td>0</td>
      <td>392.2</td>
      <td>2.5</td>
      <td>94</td>
      <td>5</td>
      <td>3</td>
      <td>2</td>
      <td>nan</td>
      <td>FGFR3<br>VEGFA<br>FGFR1<br>PDGFRA<br>KIT<br>CSF1R</td>
      <td>(*)<br>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN1CCN(CC1)c2ccc3c(c2)[nH]c(n3)c4c(c5c(cccc5F)[nH]c4=O)N<br><b>InChiKey</b>=PIQCTGMSNWUMAF-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>GFKI-258 <br> TKI-258 <br> CHIR-258 <br> NVP-TKI258 <br> Dovitinib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Duvelisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Duvelisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Copiktra</td>
      <td>4</td>
      <td>Infinity Pharmacueticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.28637766.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3039502">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/50905713">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11952">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7795">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000088346058">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=610V23S0JI">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50193013">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>416.1</td>
      <td>4.5</td>
      <td>88.5</td>
      <td>6</td>
      <td>2</td>
      <td>4</td>
      <td><input type="checkbox" class="read-more-state" id="post-332842663"><p class="read-more-wrap">On
 october 27, 2018, the FDA approved duvelisib to treat relapsed or 
refractory chronic lymphocytic leukemia, small lymphocytic lymphoma and 
follicula<span class="read-more-target">r lymphoma</span></p><label for="post-332842663" class="read-more-trigger"></label></td>
      <td>PIK3CD<br>PIK3CG</td>
      <td>Atypical</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C[C@@H](c1cc2cccc(c2c(=O)n1c3ccccc3)Cl)Nc4c5c([nH]cn5)ncn4<br><b>InChiKey</b>=SJVQHLPISAIATJ-ZDUSSCGKSA-N</td>
      <td>2018</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>INK-1197 <br> INK-1147 <br> IPI-145 <br> Duvelisib</td>
      <td>Y</td>
      <td>&gt;190</td>
    </tr><tr class="odd">
      <td><b>Encorafenib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Encorafenib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Braftovi</td>
      <td>4</td>
      <td>Novartis</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.28536139.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3301612">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/50922675">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11718">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7908">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000068249103">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=8L7891MRB6">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221688">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>539.2</td>
      <td>3.9</td>
      <td>140.1</td>
      <td>9</td>
      <td>3</td>
      <td>9</td>
      <td><input type="checkbox" class="read-more-state" id="post-263273106"><p class="read-more-wrap">On
 June 27, 2018, the Food and Drug Administration approved encorafenib 
and binimetinib in combination patients with unresectable or metastatic 
melano<span class="read-more-target">ma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test.</span></p><label for="post-263273106" class="read-more-trigger"></label></td>
      <td>BRAF</td>
      <td>TKL</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C[C@@H](CNc1nccc(n1)c2cn(nc2c3cc(cc(c3F)NS(=O)(=O)C)Cl)C(C)C)NC(=O)OC<br><b>InChiKey</b>=CMJCXYNUCSMDBY-ZDUSSCGKSA-N</td>
      <td>2018</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>NVP-LGX818-NXA <br> LGX-818 <br> Encorafenib <br> NVP-LGX818</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Ensartinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Ensartinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Xcovery</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.58828042.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4113131">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/56960363">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB14860">DrugBank</a><br><a href="http://zinc15.docking.org/substances/ZINC000199407645">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=SMA5ZS5B22">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179297">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>560.2</td>
      <td>4.7</td>
      <td>122.5</td>
      <td>7</td>
      <td>3</td>
      <td>6</td>
      <td>nan</td>
      <td>ALK</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C[C@@H]1CN(C[C@@H](N1)C)C(=O)c2ccc(cc2)NC(=O)c3cc(c(nn3)N)O[C@H](C)c4c(ccc(c4Cl)F)Cl<br><b>InChiKey</b>=GLYMPHUVMRFTFV-QLFBSQMISA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td><br>X-396<br>X396<br>X-396 CAPSULES<br>ENSARTINIB</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Entospletinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Entospletinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Gilead Sciences</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.31042596.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3265032">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/59473233">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12121">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=CG9">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/CG9">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7889">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000098208742">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=6I3O3W6O3B">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50015448">BindingDB</a><br></td>
      <td>'CG9'</td>
      <td>4puz</td>
      <td>1</td>
      <td>0</td>
      <td>411.2</td>
      <td>3.9</td>
      <td>83.4</td>
      <td>7</td>
      <td>2</td>
      <td>4</td>
      <td>nan</td>
      <td>SYK</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1cc(ccc1Nc2c3nccn3cc(n2)c4ccc5cn[nH]c5c4)N6CCOCC6<br><b>InChiKey</b>=XSMSNFMDVXXHGJ-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>GS-9973 <br> Entospletinib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Entrectinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Entrectinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Rozlytrek</td>
      <td>4</td>
      <td>Ignyta</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.24808589.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1983268">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/25141092">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11986">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=YMX">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/YMX">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8290">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000043204146">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=L5ORF0AN1I">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=158154">BindingDB</a><br></td>
      <td>'YMX'</td>
      <td>5fto 5kvt</td>
      <td>1</td>
      <td>2</td>
      <td>560.3</td>
      <td>5</td>
      <td>85.5</td>
      <td>6</td>
      <td>3</td>
      <td>7</td>
      <td><input type="checkbox" class="read-more-state" id="post-682334672"><p class="read-more-wrap">On
 august 2019, FDA approved entrectinib to treat adult patients with 
metastatic non-small cell lung cancer (NSCLC) whose tumors are 
ROS1-positive and<span class="read-more-target"> to treat adult and pediatric patients 12 years of age and older with solid tumors</span></p><label for="post-682334672" class="read-more-trigger"></label></td>
      <td>NTRK1<br>NTRK2<br>NTRK3<br>ROS1<br>ALK</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN1CCN(CC1)c2ccc(c(c2)NC3CCOCC3)C(=O)Nc4c5cc(ccc5[nH]n4)Cc6cc(cc(c6)F)F<br><b>InChiKey</b>=HAYYBYPASCDWEQ-UHFFFAOYSA-N</td>
      <td>2019</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>Entrectinib <br> RXDX-101 <br> NMS-E628</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Enzastaurin</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Enzastaurin.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Eli Lilly</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.153463.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL300138">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/176167">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB06486">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5693">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000001494900">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=UC96G28EQF">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50128285">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>515.2</td>
      <td>4.9</td>
      <td>72.2</td>
      <td>6</td>
      <td>1</td>
      <td>5</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cn1cc(c2c1cccc2)C3=C(C(=O)NC3=O)c4cn(c5c4cccc5)C6CCN(CC6)Cc7ccccn7<br><b>InChiKey</b>=AXRCEOKUDYDWLF-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>LY-317615 <br> Enzastaurin</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Erdafitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Erdafitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Balversa</td>
      <td>4</td>
      <td>Janssen</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.35308353.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545376">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/67462786">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12147">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=5SF">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/5SF">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9039">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000168520308">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=890E37NHMV">FDA SRS</a><br></td>
      <td>'5SF'</td>
      <td>5ew8</td>
      <td>1</td>
      <td>0</td>
      <td>446.2</td>
      <td>4.2</td>
      <td>77.3</td>
      <td>8</td>
      <td>1</td>
      <td>9</td>
      <td>On april 2019, FDA approved erdafitinib to treat adult patients with locally advanced or metastatic bladder cancer</td>
      <td>FGFR1</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC(C)NCCN(c1ccc2c(c1)nc(cn2)c3cnn(c3)C)c4cc(cc(c4)OC)OC<br><b>InChiKey</b>=OLAHOMJCDNXHFI-UHFFFAOYSA-N</td>
      <td>2019</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>Erdafitinib <br> JNJ-42756493</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Erlotinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Erlotinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Tarceva</td>
      <td>4</td>
      <td>Osi Pharmaceuticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.154044.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL553">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/176870">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB00530">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=AQ4">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/AQ4">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4920">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC01546066">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=J4T82NDH7E">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=5446">BindingDB</a><br></td>
      <td>'AQ4'</td>
      <td>1m17 4hjo 6dwn</td>
      <td>1.5</td>
      <td>0</td>
      <td>393.2</td>
      <td>3.4</td>
      <td>74.7</td>
      <td>7</td>
      <td>1</td>
      <td>10</td>
      <td><input type="checkbox" class="read-more-state" id="post-296586203"><p class="read-more-wrap">For
 the treatment of patients with locally advanced or metastatic non-small
 cell lung cancer after failure of at least one prior chemotherapy 
regimen.<span class="read-more-target"> Also for use, in combination 
with gemcitabine, as the first-line treatment of patients with locally 
advanced, unresectable or metastatic pancreatic cancer.</span></p><label for="post-296586203" class="read-more-trigger"></label></td>
      <td>EGFR<br>NR1I2</td>
      <td>(*)<br>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=COCCOc1cc2c(cc1OCCOC)ncnc2Nc3cccc(c3)C#C<br><b>InChiKey</b>=AAKJLRGGTJKAMG-UHFFFAOYSA-N</td>
      <td>2004</td>
      <td>US-5747498-A</td>
      <td>Achiral Molecule</td>
      <td>Tarceva <br> Erlotinib <br> OSI-774 <br> RG-1415 <br> CP-358774 <br> R-1415 <br> Ro-508231</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Evobrutinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Evobrutinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Merck</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.58827807.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4072833">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/71479709">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB15170">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=MZJ">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/MZJ">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9752">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000205623965">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=ZA45457L1K">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=291522">BindingDB</a><br></td>
      <td>'MZJ'</td>
      <td>6omu</td>
      <td>nan</td>
      <td>0</td>
      <td>429.2</td>
      <td>4.4</td>
      <td>93.4</td>
      <td>6</td>
      <td>2</td>
      <td>7</td>
      <td>nan</td>
      <td>BTK</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C=CC(=O)N1CCC(CC1)CNc2c(c(ncn2)N)c3ccc(cc3)Oc4ccccc4<br><b>InChiKey</b>=QUIWHXQETADMGN-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td><br>EVOBRUTINIB</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Famitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Famitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Jiangsu Hengrui Medicine</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.17595500.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1278146">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/16662431">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11741">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7886">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000064453767">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=768FW21J3L">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50331023">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>410.2</td>
      <td>3.3</td>
      <td>68.4</td>
      <td>3</td>
      <td>2</td>
      <td>6</td>
      <td>nan</td>
      <td>KIT<br>KDR<br>FLT4<br>PDGFRA<br>PDGFRB<br>FLT1<br>FLT3</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CCN(CC)CCN1CCc2c(c(c([nH]2)/C=C\3/c4cc(ccc4NC3=O)F)C)C1=O<br><b>InChiKey</b>=GKEYKDOLBLYGRB-LGMDPLHJSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td>SHR-1020</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Fasudil</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Fasudil.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>4</td>
      <td>Asahi Kasei Pharma Corp</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.3426.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL38380">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/3547">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB08162">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=M77">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/M77">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5181">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000000006486">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=Q0CH43PGXS">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14027">BindingDB</a><br></td>
      <td>'M77'</td>
      <td>1q8w 2esm 2f2u 2gni 3tku 5lcp 5nw8 5o0e 5ok3 5vef 6em2 6emb 6ers 6erw 6i2a 6i2c</td>
      <td>nan</td>
      <td>0</td>
      <td>291.1</td>
      <td>1.2</td>
      <td>62.3</td>
      <td>4</td>
      <td>1</td>
      <td>2</td>
      <td>Fasudil is a potent inhibitor of the Rho-kinases ROCK1 and ROCK2.</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1cc2cnccc2c(c1)S(=O)(=O)N3CCCNCC3<br><b>InChiKey</b>=NGOGFTYYXHNFQH-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>HA-1077 <br> Fasudil <br> ZK-258594 <br> AT-877</td>
      <td>N</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Fedratinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Fedratinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Inrebic</td>
      <td>4</td>
      <td>Sanofi</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.17626393.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1287853">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/16722836">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12500">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=2TA">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/2TA">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5716">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000019862646">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=6L1XP550I6">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332294">BindingDB</a><br></td>
      <td>'2TA'</td>
      <td>4ogj 4ps5</td>
      <td>nan</td>
      <td>1</td>
      <td>524.3</td>
      <td>4.8</td>
      <td>108.5</td>
      <td>8</td>
      <td>3</td>
      <td>10</td>
      <td>On august 2019, FDA approved fedratinib to treat adult 
patients with intermediate-2 or high-risk primary or secondary 
myelofibrosis</td>
      <td>JAK2<br>FLT3<br>BRD4</td>
      <td>(*)<br>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1cnc(nc1Nc2cccc(c2)S(=O)(=O)NC(C)(C)C)Nc3ccc(cc3)OCCN4CCCC4<br><b>InChiKey</b>=JOOXLOJCABQBSG-UHFFFAOYSA-N</td>
      <td>2019</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>SAR-302503 <br> Fedratinib <br> TG101348 <br> TG-101348</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Filgotinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Filgotinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Galapagos</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.28189566.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3301607">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/49831257">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB14845">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=2HB">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/2HB">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7913">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000096174616">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=3XVL385Q0M">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=103727">BindingDB</a><br></td>
      <td>'2HB'</td>
      <td>4p7e 5ut5</td>
      <td>1</td>
      <td>0</td>
      <td>425.2</td>
      <td>2</td>
      <td>96.7</td>
      <td>7</td>
      <td>1</td>
      <td>5</td>
      <td>nan</td>
      <td>JAK1</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1cc(n2c(c1)nc(n2)NC(=O)C3CC3)c4ccc(cc4)CN5CCS(=O)(=O)CC5<br><b>InChiKey</b>=RIJLVEAXPNLDTC-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>G-146034 <br> GLPG-0634 <br> Filgotinib</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Flumatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Flumatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Jiangsu Hengrui Medicine</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.25069687.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545413">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/46848036">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11904">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9913">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000068244727">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=R4009Y24AI">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>2</td>
      <td>562.2</td>
      <td>5</td>
      <td>99.2</td>
      <td>8</td>
      <td>2</td>
      <td>7</td>
      <td>nan</td>
      <td>BCR<br>ABL1<br>PDGFRB<br>KIT</td>
      <td>Atypical<br>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1c(cc(cn1)NC(=O)c2ccc(c(c2)C(F)(F)F)CN3CCN(CC3)C)Nc4nccc(n4)c5cccnc5<br><b>InChiKey</b>=BJCJYEYYYGBROF-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>HHGV-678 <br> Flumatinib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Foretinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Foretinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>GlaxoSmithKline</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.24608641.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1230609">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/42642645">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12307">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=88Z">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/88Z">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5679">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC43204048">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=81FH7VK1C4">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50399540">BindingDB</a><br></td>
      <td>'88Z'</td>
      <td>3lq8 5ia4 6i2y 6sd9 6sdc</td>
      <td>2</td>
      <td>2</td>
      <td>632.2</td>
      <td>5.8</td>
      <td>111.2</td>
      <td>8</td>
      <td>2</td>
      <td>12</td>
      <td>nan</td>
      <td>MET<br>KDR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=COc1cc2c(ccnc2cc1OCCCN3CCOCC3)Oc4ccc(cc4F)NC(=O)C5(CC5)C(=O)Nc6ccc(cc6)F<br><b>InChiKey</b>=CXQHYVUVSFXTMY-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>EXEL-2880 <br> Foretinib <br> GSK1363089G <br> GSK1363089 <br> GSK-1363089 <br> XL-880 <br> GSK089</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Fostamatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Fostamatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Tavalisse</td>
      <td>4</td>
      <td>Rigel Pharmaceuticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9846198.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2103830">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11671467">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12010">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=2RC">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/2RC">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7796">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000043131420">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=SQ8A3S5101">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50431381">BindingDB</a><br></td>
      <td>'2RC'</td>
      <td>4o75</td>
      <td>nan</td>
      <td>2</td>
      <td>580.1</td>
      <td>3.1</td>
      <td>186.7</td>
      <td>12</td>
      <td>4</td>
      <td>10</td>
      <td>Indicated for the treatment of chronic immune thrombocytopenia
 (ITP) in adult patients who have had an insufficient response to a 
previous treatment</td>
      <td>SYK</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC1(C(=O)N(c2c(ccc(n2)Nc3c(cnc(n3)Nc4cc(c(c(c4)OC)OC)OC)F)O1)COP(=O)(O)O)C<br><b>InChiKey</b>=GKDRMWXFWHEQQT-UHFFFAOYSA-N</td>
      <td>2018</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>R-935788 <br> R-788 Free acid <br> R-935788 Free acid <br> Fostamatinib <br> R-788</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Fruquintinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Fruquintinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Hutchison MediPharma</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.39625837.html">ChemSpider</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/44480399">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11679">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9428">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000114898570">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=49DXG3M5ZW">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>393.1</td>
      <td>3.9</td>
      <td>95.7</td>
      <td>7</td>
      <td>1</td>
      <td>5</td>
      <td>nan</td>
      <td>FLT1<br>KDR<br>FLT4</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1c(c2ccc(cc2o1)Oc3c4cc(c(cc4ncn3)OC)OC)C(=O)NC<br><b>InChiKey</b>=BALLNEJQLSTPIO-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>HMP-013<br><br>HMPL-013</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Galunisertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Galunisertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Eli Lilly</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.8266022.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2364611">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/10090485">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11911">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7797">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC03959536">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=3OKH1W5LZE">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50015640">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>369.2</td>
      <td>3.5</td>
      <td>86.7</td>
      <td>5</td>
      <td>1</td>
      <td>3</td>
      <td>nan</td>
      <td>TGFBR1</td>
      <td>TKL</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1cccc(n1)c2c(c3n(n2)CCC3)c4ccnc5c4cc(cc5)C(=O)N<br><b>InChiKey</b>=IVRXNBXKWIJUQB-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>Galunisertib <br> LY-2157299</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Gandotinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Gandotinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Eli Lilly</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.25027412.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2107823">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/46213929">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB13040">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7909">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC68245097">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=ANC71R916O">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>469.2</td>
      <td>4</td>
      <td>83.4</td>
      <td>7</td>
      <td>2</td>
      <td>6</td>
      <td>nan</td>
      <td>JAK2</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1cc(n[nH]1)Nc2cc(c3nc(c(n3n2)Cc4ccc(cc4F)Cl)C)CN5CCOCC5<br><b>InChiKey</b>=SQSZANZGUXWJEA-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>LY-2784544 <br> Gandotinib</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Gedatolisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Gedatolisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Pfizer</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.24644946.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL592445">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/44516953">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11896">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7940">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000049757175">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=96265TNH2R">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50308135">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>615.3</td>
      <td>3</td>
      <td>128.3</td>
      <td>10</td>
      <td>2</td>
      <td>7</td>
      <td>nan</td>
      <td>PIK3CA<br>PIK3CB<br>PIK3CG<br>PIK3CD<br>MTOR</td>
      <td>Atypical</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN(C)C1CCN(CC1)C(=O)c2ccc(cc2)NC(=O)Nc3ccc(cc3)c4nc(nc(n4)N5CCOCC5)N6CCOCC6<br><b>InChiKey</b>=DWZAEMINVBZMHQ-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>PKI-587 <br> Gedatolisib <br> PF-05212384</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Gefitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Gefitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Iressa</td>
      <td>4</td>
      <td>Astrazeneca</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.110217.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL939">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/123631">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB07998">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=IRE">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/IRE">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4941">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC19632614">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=S65743JHBS">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=5447">BindingDB</a><br></td>
      <td>'IRE'</td>
      <td>2ito 2ity 2itz 3ug2 4i22 4wkq 5y7z 5y80</td>
      <td>1.5</td>
      <td>0</td>
      <td>446.2</td>
      <td>4.3</td>
      <td>68.7</td>
      <td>7</td>
      <td>1</td>
      <td>8</td>
      <td><input type="checkbox" class="read-more-state" id="post-810580389"><p class="read-more-wrap">For
 the continued treatment of patients with locally advanced or metastatic
 non-small cell lung cancer after failure of either platinum-based or 
docet<span class="read-more-target">axel chemotherapies.</span></p><label for="post-810580389" class="read-more-trigger"></label></td>
      <td>EGFR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=COc1cc2c(cc1OCCCN3CCOCC3)c(ncn2)Nc4ccc(c(c4)Cl)F<br><b>InChiKey</b>=XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>
      <td>2003</td>
      <td>US-5770599-A</td>
      <td>Achiral Molecule</td>
      <td>Iressa <br> Gefitinib <br> Iressa <br> ZD-1839</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Gilteritinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Gilteritinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Xospata</td>
      <td>4</td>
      <td>Astellas Pharma</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.32055842.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3301622">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/49803313">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12141">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=C6F">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/C6F">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8708">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000113476229">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=66D92MGC8M">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=144315">BindingDB</a><br></td>
      <td>'C6F'</td>
      <td>6jqr</td>
      <td>nan</td>
      <td>1</td>
      <td>552.4</td>
      <td>2.7</td>
      <td>121.1</td>
      <td>10</td>
      <td>3</td>
      <td>9</td>
      <td>On november 28, 2018, the FDA approved gilteritinib to treat 
patients who have relapsed or refractory acute myeloid leukemia (AML)</td>
      <td>FLT3<br>AXL<br>ALK</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CCc1c(nc(c(n1)C(=O)N)Nc2ccc(c(c2)OC)N3CCC(CC3)N4CCN(CC4)C)NC5CCOCC5<br><b>InChiKey</b>=GYQYAJJFPNQOOW-UHFFFAOYSA-N</td>
      <td>2018</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>ASP-2215 <br> Gilteritinib</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Glesatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Glesatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Mirati Therapeutics</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.52084900.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3989914">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/25181472">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB06302">DrugBank</a><br><a href="http://zinc15.docking.org/substances/ZINC000113139653">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=7Q29OXD98N">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>2</td>
      <td>619.2</td>
      <td>6.2</td>
      <td>97.4</td>
      <td>8</td>
      <td>3</td>
      <td>11</td>
      <td>nan</td>
      <td>MET<br>TEK<br>FLT1<br>KDR<br>FLT4<br>MST1R</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=COCCNCc1ccc(nc1)c2cc3c(s2)c(ccn3)Oc4ccc(cc4F)NC(=S)NC(=O)Cc5ccc(cc5)F<br><b>InChiKey</b>=YRCHYHRCBXNYNU-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>MG90265H9 <br> MG90265gly <br> MGCD265 <br> MG90265 <br> MG90265X <br> Glesatinib</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Golvatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Golvatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Eisai</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.17275597.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3039525">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/16118392">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11977">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=GV0">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/GV0">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7956">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000043195317">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=516Z3YP58E">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50100615">BindingDB</a><br></td>
      <td>'GV0'</td>
      <td>5ia5</td>
      <td>2</td>
      <td>1</td>
      <td>633.3</td>
      <td>4.8</td>
      <td>119.1</td>
      <td>7</td>
      <td>3</td>
      <td>8</td>
      <td>nan</td>
      <td>MET<br>KDR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN1CCN(CC1)C2CCN(CC2)C(=O)Nc3cc(ccn3)Oc4ccc(c(c4)F)NC(=O)C5(CC5)C(=O)Nc6ccc(cc6)F<br><b>InChiKey</b>=UQRCJCNVNUFYDX-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>E-7050 <br> Golvatinib <br> E7050</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Henatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Henatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>1</td>
      <td>Jiangsu Hengrui Medicine</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.26354883.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1277072">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/25116064">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB13019">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9930">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000064454147">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=TE20GB753F">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50331032">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>468.2</td>
      <td>2</td>
      <td>97.9</td>
      <td>5</td>
      <td>3</td>
      <td>5</td>
      <td>nan</td>
      <td>KDR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1c([nH]c2c1C(=O)N(CCC2)C[C@@H](CN3CCOCC3)O)/C=C\4/c5cc(ccc5NC4=O)F<br><b>InChiKey</b>=MCTXSDCWFQAGFS-UEXNTNOUSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td></td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Ibrutinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Ibrutinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Imbruvica</td>
      <td>4</td>
      <td>Pharmacyclics</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.26637187.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1873475">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/24821094">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB09053">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=1E8">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/1E8">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6912">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC35328014">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=1X70OSD4VX">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50357312">BindingDB</a><br></td>
      <td>'1E8'</td>
      <td>4ifg 4rz7 5p9i 5yu9</td>
      <td>1.5</td>
      <td>0</td>
      <td>440.2</td>
      <td>4.2</td>
      <td>99.2</td>
      <td>7</td>
      <td>1</td>
      <td>5</td>
      <td><input type="checkbox" class="read-more-state" id="post-461232033"><p class="read-more-wrap">Ibrutinib
 was approved by the FDA for the treatment of mantle cell lymphoma, and 
later in February 2014 for the treatment of chronic lymphocytic leuke<span class="read-more-target">mia</span></p><label for="post-461232033" class="read-more-trigger"></label></td>
      <td>BTK</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C=CC(=O)N1CCC[C@H](C1)n2c3c(c(n2)c4ccc(cc4)Oc5ccccc5)c(ncn3)N<br><b>InChiKey</b>=XYFPWWZEPKGCCK-GOSISDBHSA-N</td>
      <td>2013</td>
      <td>US-7514444-B2</td>
      <td>Single Stereoisomer</td>
      <td>Imbruvica <br> PCI-32765 <br> PCI-32765-00 <br> Ibrutinib <br> CRA-032765</td>
      <td>Y</td>
      <td>149-158</td>
    </tr><tr class="even">
      <td><b>Icotinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Icotinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>4</td>
      <td>Zhejiang Beta Pharma</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.10762174.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2087361">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/22024915">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11737">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7641">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000043207566">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=9G6U5L461Q">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50391089">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>391.2</td>
      <td>3.2</td>
      <td>74.7</td>
      <td>7</td>
      <td>1</td>
      <td>2</td>
      <td><input type="checkbox" class="read-more-state" id="post-826480647"><p class="read-more-wrap">Icotinib
 hydrochloride is a novel epidermal growth factor receptor 
(EGFR)–tyrosine kinase inhibitor, exhibits encouraging efficacy and 
tolerability in<span class="read-more-target"> patients with advanced non-small-cell lung cancer (NSCLC) who failed previous chemotherapy.</span></p><label for="post-826480647" class="read-more-trigger"></label></td>
      <td>EGFR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C#Cc1cccc(c1)Nc2c3cc4c(cc3ncn2)OCCOCCOCCO4<br><b>InChiKey</b>=QQLKULDARVNMAL-UHFFFAOYSA-N</td>
      <td>2011</td>
      <td>nan</td>
      <td>nan</td>
      <td>BPI-2009H</td>
      <td>N</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Idelalisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Idelalisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Zydelig</td>
      <td>4</td>
      <td>Gilead Sciences</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9800565.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2216870">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11625818">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB09054">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=40L">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/40L">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6741">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC13986658">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=YG57I8T5M0">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50403068">BindingDB</a><br></td>
      <td>'40L'</td>
      <td>4xe0</td>
      <td>1</td>
      <td>0</td>
      <td>415.2</td>
      <td>3.8</td>
      <td>101.4</td>
      <td>7</td>
      <td>2</td>
      <td>5</td>
      <td><input type="checkbox" class="read-more-state" id="post-310116631"><p class="read-more-wrap">Idelalisib
 is indicated in the treatment of chronic lymphocytic leukemia (CLL), 
relapsed follicular B-cell non-Hodgkin lymphoma (FL), and relapsed sma<span class="read-more-target">ll
 lymphocytic lymphoma (SLL). For the treatment of relapsed CLL, it is 
currently indicated as a second-line agent in combination with rituximab
 in patients for whom rituximab alone would be considered appropriate 
therapy due to other co-morbidities, while in the treatment of FL and 
SLL it is intended to be used in patients who have received at least two
 prior systemic therapies.</span></p><label for="post-310116631" class="read-more-trigger"></label></td>
      <td>PIK3CD</td>
      <td>Atypical</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC[C@@H](c1nc2cccc(c2c(=O)n1c3ccccc3)F)Nc4c5c([nH]cn5)ncn4<br><b>InChiKey</b>=IFSDAJWBUCMOAH-HNNXBMFYSA-N</td>
      <td>2014</td>
      <td>US-6800620-B2</td>
      <td>Single Stereoisomer</td>
      <td>Zydelig <br> GS-1101 <br> GS-11CAL-101 <br> Idelalisib <br> CAL-101</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Ilorasertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Ilorasertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Abbott Laboratories</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.24809095.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1980297">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/46207586">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11694">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9914">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000063298074">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=6L5D03D975">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50381716">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>488.1</td>
      <td>5.2</td>
      <td>118.1</td>
      <td>7</td>
      <td>4</td>
      <td>6</td>
      <td>nan</td>
      <td>AURKA<br>AURKB<br>AURKC<br>FLT1<br>PDGFRA<br>PDGFRB</td>
      <td>Tyr<br>Other</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1cc(cc(c1)F)NC(=O)Nc2ccc(cc2)c3csc4c3c(ncc4c5cnn(c5)CCO)N<br><b>InChiKey</b>=WPHKIQPVPYJNAX-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>A-968660 <br> ABT-348 <br> Ilorasertib</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Imatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Imatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Gleevec</td>
      <td>4</td>
      <td>Novartis</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.5101.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL941">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/5291">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB03261">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=STI">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/STI">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5687">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC19632618">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=BKJ8M8G5HI">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13530">BindingDB</a><br></td>
      <td>'STI'</td>
      <td>1iep 1opj 1t46 1xbb 2hyy 2oiq 2pl0 3fw1 3gvu 3hec 3k5v 3ms9 3mss 3oez 3pyy 4bkj 4csv 4r7i 5mqt 6hd4 6hd6 6npe 6npu 6npv</td>
      <td>2</td>
      <td>0</td>
      <td>493.3</td>
      <td>4.6</td>
      <td>86.3</td>
      <td>7</td>
      <td>2</td>
      <td>7</td>
      <td><input type="checkbox" class="read-more-state" id="post-738104932"><p class="read-more-wrap">For
 the treatment of Philadelphia chromosome positive chronic myeloid 
leukemia (Ph+ CML), Ph+ acute lymphoblastic leukaemia, 
myelodysplastic/myeloprol<span class="read-more-target">iferative 
diseases, aggressive systemic mastocytosis, hypereosinophilic syndrome 
and/or chronic eosinophilic leukemia (CEL), dermatofibrosarcoma 
protuberans, and malignant gastrointestinal stromal tumors (GIST).</span></p><label for="post-738104932" class="read-more-trigger"></label></td>
      <td>KIT<br>RET<br>NTRK1<br>CSF1R<br>PDGFRA<br>DDR1<br>ABL1<br>PDGFRB</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1ccc(cc1Nc2nccc(n2)c3cccnc3)NC(=O)c4ccc(cc4)CN5CCN(CC5)C<br><b>InChiKey</b>=KTUFNOKKBVMGRW-UHFFFAOYSA-N</td>
      <td>2001</td>
      <td>US-6894051-B1</td>
      <td>Achiral Molecule</td>
      <td>Gleevec <br> Imatinib <br> STI-571</td>
      <td>Y</td>
      <td>226</td>
    </tr><tr class="even">
      <td><b>Infigratinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Infigratinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Novartis</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.26333103.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1852688">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/53235510">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11886">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=07J">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/07J">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7877">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000072105034">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=A4055ME1VK">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355393">BindingDB</a><br></td>
      <td>'07J'</td>
      <td>3tt0</td>
      <td>1</td>
      <td>2</td>
      <td>559.2</td>
      <td>5.4</td>
      <td>95.1</td>
      <td>8</td>
      <td>2</td>
      <td>8</td>
      <td>nan</td>
      <td>FGFR1<br>FGFR2<br>FGFR3</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CCN1CCN(CC1)c2ccc(cc2)Nc3cc(ncn3)N(C)C(=O)Nc4c(c(cc(c4Cl)OC)OC)Cl<br><b>InChiKey</b>=QADPYRIHXKWUSV-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td>BGJ-398 <br> NVP-BGJ398</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Ipatasertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Ipatasertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Hoffmann-La Roche</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.28189084.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2177390">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/24788740">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11743">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=0RF">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/0RF">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7887">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000068250459">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=524Y3IB4HQ">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50398379">BindingDB</a><br></td>
      <td>'0RF'</td>
      <td>4ekl</td>
      <td>1</td>
      <td>0</td>
      <td>457.2</td>
      <td>3.1</td>
      <td>81.6</td>
      <td>6</td>
      <td>2</td>
      <td>6</td>
      <td>nan</td>
      <td>AKT1<br>AKT2<br>AKT3</td>
      <td>AGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C[C@@H]1C[C@H](c2c1c(ncn2)N3CCN(CC3)C(=O)[C@H](CNC(C)C)c4ccc(cc4)Cl)O<br><b>InChiKey</b>=GRZXWCHAXNAUHY-NSISKUIASA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>GDC-0068 <br> Ipatasertib <br> RG-7440</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Itacitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Itacitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Incyte Corporation</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.35033258.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3622820">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/53380437">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12154">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8364">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000118795962">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=19J3781LPM">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=246868">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>553.2</td>
      <td>3.6</td>
      <td>119.6</td>
      <td>8</td>
      <td>1</td>
      <td>5</td>
      <td>nan</td>
      <td>JAK1</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1cnc-2[nH]cnc(c12)c3cnn(c3)C4(CN(C4)C5CCN(CC5)C(=O)c6ccnc(c6F)C(F)(F)F)CC#N<br><b>InChiKey</b>=KTBSXLIQKWEBRB-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>INCB-039110 <br> INCB-39110 <br> Itacitinib <br> INCB039110</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Lapatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Lapatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Tykerb</td>
      <td>4</td>
      <td>GlaxoSmithKline</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.181006.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL554">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/208908">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB02584">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=FMM">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/FMM">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5692">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000001550477">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=0VUA21238F">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=5445">BindingDB</a><br></td>
      <td>'FMM'</td>
      <td>1xkk 3bbt</td>
      <td>1.5</td>
      <td>2</td>
      <td>580.1</td>
      <td>6.1</td>
      <td>106.4</td>
      <td>8</td>
      <td>2</td>
      <td>11</td>
      <td><input type="checkbox" class="read-more-state" id="post-310888449"><p class="read-more-wrap">Indicated
 in combination with capecitabine for the treatment of patients with 
advanced or metastatic breast cancer whose tumors overexpress the human <span class="read-more-target">epidermal
 receptor type 2 (HER2) protein and who have received prior therapy 
including an anthracycline, a taxane, and trastuzuma.</span></p><label for="post-310888449" class="read-more-trigger"></label></td>
      <td>EGFR<br>ERBB2</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CS(=O)(=O)CCNCc1ccc(o1)c2ccc3c(c2)c(ncn3)Nc4ccc(c(c4)Cl)OCc5cccc(c5)F<br><b>InChiKey</b>=BCFGMOOMADDAQU-UHFFFAOYSA-N</td>
      <td>2007</td>
      <td>US-6391874-B1</td>
      <td>Achiral Molecule</td>
      <td>Tyverb <br> GW-2016 <br> GW-572016 <br> Lapatinib</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Larotrectinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Larotrectinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Vitrakvi</td>
      <td>4</td>
      <td>Array BioPharma</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.44210503.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3889654">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/46188928">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB14723">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8909">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000118399834">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=PF9462I9HX">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=136597">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>428.2</td>
      <td>2.9</td>
      <td>86</td>
      <td>6</td>
      <td>2</td>
      <td>3</td>
      <td>On november 26, 2018, the FDA approved larotrectinib to treat patients whose cancers have a specific genetic feature (biomarker)</td>
      <td>NTRK1<br>NTRK2<br>NTRK3</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1cc(c(cc1F)[C@H]2CCCN2c3ccn4c(n3)c(cn4)NC(=O)N5CC[C@@H](C5)O)F<br><b>InChiKey</b>=NYNZQNWKBKUAII-KBXCAEBGSA-N</td>
      <td>2018</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>Larotrectinib <br> LOXO-101</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Lazertinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Lazertinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>1</td>
      <td>Genosco</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.64835231.html">ChemSpider</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/121269225">PubChem</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10136">Guide to Pharmacology</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=4A2Y23XK11">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>554.3</td>
      <td>4.1</td>
      <td>109.7</td>
      <td>10</td>
      <td>2</td>
      <td>10</td>
      <td><input type="checkbox" class="read-more-state" id="post-175169762"><p class="read-more-wrap">Lazertinib
 (YH-25448, GNS-1480) is an inhibitor of the aberrant activity of EGFR 
mutant kinases, that was originally developed by Yuhan Corporation fo<span class="read-more-target">r
 antineoplastic potential in cancers with (acquired) resistance to 
existing EGFR tyrosine kinase inhibitors, in particular for EGFR 
mutation positive, advanced non-small cell lung cancer (NSCLC). In 
addition to predicted efficacy for the treatment of primary lung and 
extracranial lesions, lazertinib is expected to be beneficial for NSCLC 
brain metastases as it is able to cross the blood brain barrier.</span></p><label for="post-175169762" class="read-more-trigger"></label></td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN(C)Cc1cn(nc1c2ccccc2)c3ccnc(n3)Nc4cc(c(cc4OC)N5CCOCC5)NC(=O)C=C<br><b>InChiKey</b>=RRMJMHOQSALEJJ-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Leniolisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Leniolisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>0</td>
      <td>Novartis</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.52083264.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3643413">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/57495353">PubChem</a><br><a href="http://www.rcsb.org/pdb/lig/nand/ligandsummary.do?hetId=9NQ">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/9NQ">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9424">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/sub/nstances/ZINC000113570569">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=L2\n2772Z9CP">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=118299">BindingDB</a><br></td>
      <td>'9NQ'</td>
      <td>5o83</td>
      <td>nan</td>
      <td>0</td>
      <td>450.2</td>
      <td>2.9</td>
      <td>83.5</td>
      <td>7</td>
      <td>1</td>
      <td>5</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CCC(=O)N1CC[C@@H](C1)Nc2c3c(ncn2)CCN(C3)c4cc(c(nc4)OC)C(F)(F)F<br><b>InChiKey</b>=MWKYMZXCGYXLPL-ZDUSSCGKSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>CDZ173-NX <br> Leniolisib</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Lenvatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Lenvatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Kisplyx;Lenvima</td>
      <td>4</td>
      <td>Eisai</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.7999567.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1289601">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/9823820">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB09078">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=LEV">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/LEV">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7426">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC03816292">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=EE083865G2">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50331094">BindingDB</a><br></td>
      <td>'LEV'</td>
      <td>3wzd 5zv2</td>
      <td>1.5</td>
      <td>0</td>
      <td>426.1</td>
      <td>4.1</td>
      <td>115.6</td>
      <td>5</td>
      <td>3</td>
      <td>6</td>
      <td><input type="checkbox" class="read-more-state" id="post-865475303"><p class="read-more-wrap">Lenvatinib
 is indicated for the treatment of patients with locally recurrent or 
metastatic, progressive, radioactive iodine-refractory differentiated <span class="read-more-target">thyroid cancer.</span></p><label for="post-865475303" class="read-more-trigger"></label></td>
      <td>FLT1<br>KDR<br>FLT4<br>FGFR1<br>FGFR2<br>FGFR3<br>FGFR4<br>KIT</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=COc1cc2c(cc1C(=O)N)c(ccn2)Oc3ccc(c(c3)Cl)NC(=O)NC4CC4<br><b>InChiKey</b>=WOSKHXYHFSIKNG-UHFFFAOYSA-N</td>
      <td>2015</td>
      <td>US-7253286-B2</td>
      <td>Achiral Molecule</td>
      <td>Lenvima;Kisplyx <br> ER-203492-00 <br> Lenvatinib</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Lestaurtinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Lestaurtinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Cephalon</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.112457.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL603469">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/126565">PubChem</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5672">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC03781738">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=DO989GC5D1">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50308060">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>439.2</td>
      <td>3.5</td>
      <td>88.7</td>
      <td>6</td>
      <td>3</td>
      <td>1</td>
      <td>nan</td>
      <td>FLT3</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C[C@@]12[C@](C[C@@H](O1)n3c4ccccc4c5c3c6n2c7ccccc7c6c8c5C(=O)NC8)(CO)O<br><b>InChiKey</b>=UIARLYUEJFELEN-LROUJFHJSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>KT-5555 <br> KT-555 <br> Lestaurtinib <br> SPM-924 <br> SP-924 <br> A-154475 <br> CEP-701 <br> Cep-701 <br> SP924 <br> A-1544750</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Linifanib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Linifanib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Abbott Laboratories</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9660475.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL223360">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11485656">PubChem</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5657">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC06718813">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=CO93X137CW">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21079">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>375.1</td>
      <td>4.9</td>
      <td>95.8</td>
      <td>3</td>
      <td>4</td>
      <td>3</td>
      <td>nan</td>
      <td>FLT3<br>CSF1R<br>KDR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1ccc(c(c1)NC(=O)Nc2ccc(cc2)c3cccc4c3c(n[nH]4)N)F<br><b>InChiKey</b>=MPVGZUGXCQEXTM-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>ABT-869 <br> RG-3635 <br> Linifanib <br> AL-39324</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Linsitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Linsitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Osi Pharmaceuticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.21391708.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1091644">ChEMBL</a><br><a href="http://www.drugbank.ca/drugs/DB06075">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7423">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000100071817">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=15A52GPT8T">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50315887">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>421.2</td>
      <td>4.8</td>
      <td>89.3</td>
      <td>6</td>
      <td>2</td>
      <td>3</td>
      <td>nan</td>
      <td>IGF1R</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C[C@]1(C[C@@H](C1)c2n3c(c(ncc3)N)c(n2)c4cc5nc(ccc5cc4)c6ccccc6)O<br><b>InChiKey</b>=PKCDDUHJAFVJJB-VLZXCDOPSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>Linsitinib <br> ASP-7487 <br> OSI-906 <br> OSI-906AA</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Lorlatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Lorlatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Lorbrena</td>
      <td>4</td>
      <td>Pfizer</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.32813339.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3286830">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/71731823">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12130">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=5P8">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/5P8">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7476">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000098208524">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=OSP71S83EU">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50018830">BindingDB</a><br></td>
      <td>'5P8'</td>
      <td>4cli 4clj 4uxl 5a9u 5aa8 5aa9</td>
      <td>1</td>
      <td>0</td>
      <td>406.2</td>
      <td>2.8</td>
      <td>110.1</td>
      <td>7</td>
      <td>1</td>
      <td>0</td>
      <td><input type="checkbox" class="read-more-state" id="post-786930161"><p class="read-more-wrap">On
 november 2, 2018, the FDA approved lorlatinib to treat patients with 
anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung
 cance<span class="read-more-target">r</span></p><label for="post-786930161" class="read-more-trigger"></label></td>
      <td>ALK<br>ROS1</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C[C@@H]1c2cc(ccc2C(=O)N(Cc3c(c(n(n3)C)C#N)-c4cc(c(nc4)N)O1)C)F<br><b>InChiKey</b>=IIXWYSCJSQVBQM-LLVKDONJSA-N</td>
      <td>2018</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>Lorlatinib <br> PF-06463922</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Losmapimod</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Losmapimod.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>GlaxoSmithKline</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9727484.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1088752">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11552706">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12270">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7835">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000035793138">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=F2DQF16BXE">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50418610">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>383.2</td>
      <td>3.9</td>
      <td>71.1</td>
      <td>3</td>
      <td>2</td>
      <td>5</td>
      <td>nan</td>
      <td>MAPK14<br>MAPK11<br>MAPK13<br>MAPK12</td>
      <td>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1c(cc(cc1F)C(=O)NC2CC2)c3ccc(cn3)C(=O)NCC(C)(C)C<br><b>InChiKey</b>=KKYABQBFGDZVNQ-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>GSKAHAB <br> GW856553 <br> GW856553X <br> Losmapimod</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Lucitanib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Lucitanib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Clovis Oncology</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.28189586.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2220486">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/25031915">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11845">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=3ZC">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/3ZC">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7649">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000077024213">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=PP449XA4BH">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50399539">BindingDB</a><br></td>
      <td>'3ZC'</td>
      <td>4rwl</td>
      <td>1</td>
      <td>0</td>
      <td>443.2</td>
      <td>4.4</td>
      <td>95.7</td>
      <td>6</td>
      <td>2</td>
      <td>7</td>
      <td>nan</td>
      <td>FLT1<br>KDR<br>FLT4<br>FGFR1<br>FGFR2</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CNC(=O)c1cccc2c1ccc(c2)Oc3ccnc4c3cc(c(c4)OCC5(CC5)N)OC<br><b>InChiKey</b>=CUDVHEFYRIWYQD-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>E-3810 <br> CO-3810 <br> Lucitanib <br> S-80881 <br> AL-3810</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Masitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Masitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Kinavet;Masivet</td>
      <td>3</td>
      <td>AB Science</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.8250179.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1908391">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/10074640">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11526">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=G65">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/G65">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5656">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC34177219">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=M59NC4E26P">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355495">BindingDB</a><br></td>
      <td>'G65'</td>
      <td>5mql</td>
      <td>nan</td>
      <td>1</td>
      <td>498.2</td>
      <td>5.3</td>
      <td>73.4</td>
      <td>7</td>
      <td>2</td>
      <td>7</td>
      <td>nan</td>
      <td>KIT<br>PDGFRA<br>PDGFRB<br>FGFR1<br>FGFR2<br>FGFR3</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1ccc(cc1Nc2nc(cs2)c3cccnc3)NC(=O)c4ccc(cc4)CN5CCN(CC5)C<br><b>InChiKey</b>=WJEOLQLKVOPQFV-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>Masivet;Kinavet <br> Masitinib <br> AB-1010</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Mavelertinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Mavelertinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>0</td>
      <td>Pfizer</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.49070873.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3989970">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/91668194">PubChem</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9765">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000231225813">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=YXX2180047">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>415.2</td>
      <td>0.7</td>
      <td>115</td>
      <td>10</td>
      <td>2</td>
      <td>6</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cn1cc(c(n1)OC)Nc2c3c(nc(n2)N4C[C@H]([C@@H](C4)F)NC(=O)C=C)n(cn3)C<br><b>InChiKey</b>=JYIUNVOCEFIUIU-GHMZBOCLSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>PF-06747775 <br> Mavelertinib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Merestinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Merestinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Eli Lilly</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.29361338.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545307">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/44603533">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12381">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=L1X">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/L1X">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9841">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000095926668">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=5OGS5K699E">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50172078">BindingDB</a><br></td>
      <td>'L1X'</td>
      <td>4eev</td>
      <td>2</td>
      <td>2</td>
      <td>552.2</td>
      <td>5.7</td>
      <td>106.8</td>
      <td>7</td>
      <td>2</td>
      <td>6</td>
      <td>nan</td>
      <td>MET</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1ccc(c(=O)n1c2ccc(cc2)F)C(=O)Nc3ccc(c(c3)F)Oc4cc5cnn(c5cc4c6c[nH]nc6)C<br><b>InChiKey</b>=QHADVLVFMKEIIP-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>Merestinib <br> LY-2801653</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Midostaurin</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Midostaurin.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Rydapt</td>
      <td>4</td>
      <td>Novartis Pharmaceuticals Corp</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.8005258.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL608533">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/9829523">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB06595">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=2K2">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/2K2">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5702">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000100013130">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=ID912S5VON">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50326053">BindingDB</a><br></td>
      <td>'2K2'</td>
      <td>4nct</td>
      <td>nan</td>
      <td>2</td>
      <td>570.2</td>
      <td>5.9</td>
      <td>77.7</td>
      <td>6</td>
      <td>1</td>
      <td>3</td>
      <td>On april 28 , 2017, the FDA approved midostaurin to  treat acute myeloid leukemia</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C[C@@]12[C@@H]([C@@H](C[C@@H](O1)n3c4ccccc4c5c3c6n2c7ccccc7c6c8c5C(=O)NC8)N(C)C(=O)c9ccccc9)OC<br><b>InChiKey</b>=BMGQWWVMWDBQGC-IIFHNQTCSA-N</td>
      <td>2017</td>
      <td>US-7973031-B2</td>
      <td>Single Stereoisomer</td>
      <td>Rydapt <br> Midostaurin <br> NVP-PKC412 <br> PKC-412 <br> CGP-41251</td>
      <td>Y</td>
      <td>235-260</td>
    </tr><tr class="even">
      <td><b>Milciclib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Milciclib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Nerviano Medical Sciences</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.16788113.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL564829">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/16718576">PubChem</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=P48">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/P48">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7938">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000053119602">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=688000M8S8">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31545">BindingDB</a><br></td>
      <td>'P48'</td>
      <td>2wih 5vc6 5vd1</td>
      <td>1</td>
      <td>0</td>
      <td>460.3</td>
      <td>2.6</td>
      <td>91.2</td>
      <td>8</td>
      <td>2</td>
      <td>4</td>
      <td>nan</td>
      <td>CDK1<br>NTRK1</td>
      <td>Tyr<br>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC1(Cc2cnc(nc2-c3c1c(nn3C)C(=O)NC)Nc4ccc(cc4)N5CCN(CC5)C)C<br><b>InChiKey</b>=RXZMYLDMFYNEIM-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>PHA-848125 <br> Milciclib</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Momelotinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Momelotinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Ym Biosciences Australia</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.24676202.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1078178">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/25062766">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11763">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=C87">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/C87">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7791">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC43199890">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=6O01GMS00P">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50311017">BindingDB</a><br></td>
      <td>'C87'</td>
      <td>6fdz</td>
      <td>nan</td>
      <td>0</td>
      <td>414.2</td>
      <td>3</td>
      <td>103.2</td>
      <td>7</td>
      <td>2</td>
      <td>6</td>
      <td>nan</td>
      <td>JAK1<br>JAK2<br>JAK3</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1cc(ccc1c2ccnc(n2)Nc3ccc(cc3)N4CCOCC4)C(=O)NCC#N<br><b>InChiKey</b>=ZVHNDZWQTBEVRY-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>CYT-11387 <br> GS-0387 <br> Momelotinib <br> CYT-387</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Motesanib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Motesanib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Amgen</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9842625.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL572881">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11667893">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB05575">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=706">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/706">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5660">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC18710082">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=U1JK633AYI">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24773">BindingDB</a><br></td>
      <td>'706'</td>
      <td>3efl</td>
      <td>2</td>
      <td>0</td>
      <td>373.2</td>
      <td>4</td>
      <td>78.9</td>
      <td>5</td>
      <td>3</td>
      <td>5</td>
      <td>nan</td>
      <td>FLT1<br>KDR<br>FLT4<br>PDGFRA<br>PDGFRB<br>KIT<br>RET</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC1(CNc2c1ccc(c2)NC(=O)c3cccnc3NCc4ccncc4)C<br><b>InChiKey</b>=RAHBGWKEPAQNFF-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>AMG-706 <br> Motesanib</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Mubritinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Mubritinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>1</td>
      <td>Takeda</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.4948554.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1614707">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/6444692">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12682">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6011">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC11679877">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=V734AZP9BR">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>468.2</td>
      <td>6.1</td>
      <td>66</td>
      <td>6</td>
      <td>0</td>
      <td>10</td>
      <td>nan</td>
      <td>EGFR<br>ERBB2</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1cc(ccc1CCCCn2ccnn2)OCc3coc(n3)/C=C/c4ccc(cc4)C(F)(F)F<br><b>InChiKey</b>=ZTFBIUXIQYRUNT-MDWZMJQESA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>TAK-165 <br> Mubritinib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Naquotinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Naquotinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Astellas Pharma</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.44210447.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3663929">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/71667668">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12036">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=8RC">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/8RC">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9248">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000205341959">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=47DD4548PB">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=170514">BindingDB</a><br></td>
      <td>'8RC'</td>
      <td>5y9t</td>
      <td>nan</td>
      <td>1</td>
      <td>562.3</td>
      <td>2.3</td>
      <td>120.2</td>
      <td>9</td>
      <td>2</td>
      <td>9</td>
      <td>nan</td>
      <td>EGFR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CCc1c(nc(c(n1)C(=O)N)Nc2ccc(cc2)N3CCC(CC3)N4CCN(CC4)C)O[C@@H]5CCN(C5)C(=O)C=C<br><b>InChiKey</b>=QKDCLUARMDUUKN-XMMPIXPASA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>Naquotinib <br> ASP8273</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Nazartinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Nazartinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Novartis</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.35308229.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3787344">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/72703790">PubChem</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9204">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000210610738">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=KE7K32EME8">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50160870">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>494.2</td>
      <td>4.3</td>
      <td>83.4</td>
      <td>6</td>
      <td>1</td>
      <td>6</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1cc(ccn1)C(=O)Nc2nc3cccc(c3n2[C@@H]4CCCCN(C4)C(=O)/C=C/CN(C)C)Cl<br><b>InChiKey</b>=IOMMMLWIABWRKL-WUTDNEBXSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td>NAZARTINIB<br></td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Neflamapimod</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Neflamapimod.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>EIP Pharma</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.2302086.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL119385">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/3038525">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB07138">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=52P">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/52P">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5719">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC13493055">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=TYL52QM320">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=15244">BindingDB</a><br></td>
      <td>'52P'</td>
      <td>3fc1 3hp5 3zsi</td>
      <td>nan</td>
      <td>1</td>
      <td>435</td>
      <td>5.5</td>
      <td>47.3</td>
      <td>5</td>
      <td>0</td>
      <td>3</td>
      <td>nan</td>
      <td>MAPK14</td>
      <td>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1cc(c(c(c1)Cl)c2c3ccc(nn3cnc2=O)Sc4ccc(cc4F)F)Cl<br><b>InChiKey</b>=VEPKQEUBKLEPRA-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>Neflamapimod <br> VD-31 <br> VRT-031745 <br> VX-745 <br> 745</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Nemiralisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Nemiralisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>0</td>
      <td>GlaxosmithKline</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.28651123.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2216859">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/49784002">PubChem</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=VVX">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/VVX">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9425">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000095564436">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=OEP8JJ3OZR">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50004529">BindingDB</a><br></td>
      <td>'VVX'</td>
      <td>5ae8</td>
      <td>nan</td>
      <td>0</td>
      <td>440.2</td>
      <td>4.9</td>
      <td>77</td>
      <td>5</td>
      <td>2</td>
      <td>5</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC(C)N1CCN(CC1)Cc2cnc(o2)c3cc(cc4c3cn[nH]4)c5cccc6c5cc[nH]6<br><b>InChiKey</b>=MCIDWGZGWVSZMK-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>GSK2269557A <br> GSK-2269557 <br> Nemiralisib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Neratinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Neratinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Nerlynx</td>
      <td>4</td>
      <td>Puma Biotechnology</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.8091392.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL180022">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/9915743">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11828">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5686">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000003916214">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=JJH94R3PWB">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50161957">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>2</td>
      <td>556.2</td>
      <td>5.9</td>
      <td>112.4</td>
      <td>8</td>
      <td>2</td>
      <td>11</td>
      <td><input type="checkbox" class="read-more-state" id="post-453975725"><p class="read-more-wrap">For
 use as an extended adjuvant treatment in adult patients with early 
stage HER2-overexpressed/amplified breast cancer, to follow adjuvant 
trastuzuma<span class="read-more-target">b-based therapy</span></p><label for="post-453975725" class="read-more-trigger"></label></td>
      <td>ERBB2<br>EGFR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CCOc1cc2c(cc1NC(=O)/C=C/CN(C)C)c(c(cn2)C#N)Nc3ccc(c(c3)Cl)OCc4ccccn4<br><b>InChiKey</b>=JWNPDZNEKVCWMY-VQHVLOKHSA-N</td>
      <td>2017</td>
      <td>US-6288082-B1</td>
      <td>Achiral Molecule</td>
      <td>WAY-179272 <br> CDP-820 <br> Neratinib <br> HKI-272</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Netarsudil</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Netarsudil.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Rhopressa</td>
      <td>4</td>
      <td>Aerie Pharmaceutical</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.34980598.html">ChemSpider</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/66599893">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB13931">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9322">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000113149554">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=W6I5QDT7QI">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>453.2</td>
      <td>4.9</td>
      <td>94.3</td>
      <td>5</td>
      <td>2</td>
      <td>7</td>
      <td>On december 18, 2017, the FDA approved netarsudil to treat glaucoma or ocular hypertension</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1ccc(c(c1)C)C(=O)OCc2ccc(cc2)[C@@H](CN)C(=O)Nc3ccc4cnccc4c3<br><b>InChiKey</b>=OURRXQUGYQRVML-AREMUKBSSA-N</td>
      <td>2017</td>
      <td>nan</td>
      <td>Racemic Mixture</td>
      <td>AR-13324</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Nilotinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Nilotinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Tasigna</td>
      <td>4</td>
      <td>Novartis</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.559260.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL255863">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/644241">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB04868">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=NIL">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/NIL">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5697">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC06716957">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=F41401512X">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50237710">BindingDB</a><br></td>
      <td>'NIL'</td>
      <td>3cs9 3gp0 5mo4</td>
      <td>2</td>
      <td>2</td>
      <td>529.2</td>
      <td>6.4</td>
      <td>97.6</td>
      <td>7</td>
      <td>2</td>
      <td>6</td>
      <td>For the potential treatment of various leukemias, including chronic myeloid leukemia (CML).</td>
      <td>ABL1<br>KIT</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1ccc(cc1Nc2nccc(n2)c3cccnc3)C(=O)Nc4cc(cc(c4)n5cc(nc5)C)C(F)(F)F<br><b>InChiKey</b>=HHZIURLSWUIHRB-UHFFFAOYSA-N</td>
      <td>2007</td>
      <td>US-7169791-B2</td>
      <td>Achiral Molecule</td>
      <td>Tasigna <br> Nilotinib <br> AMN-107</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Ningetinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Ningetinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>1.5</td>
      <td>HEC Pharm</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.61719564.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3984441">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/60165029">PubChem</a><br><a href="http://zinc15.docking.org/substances/ZINC000143426755">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=PW3Q92Z6A4">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180270">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>2</td>
      <td>556.2</td>
      <td>5.4</td>
      <td>107.6</td>
      <td>8</td>
      <td>2</td>
      <td>8</td>
      <td>Ningetinib, also known as CT-053 or DE-120, is a VEGF and PDGF
 inhibitor potentially for the treatment of wet age-related macular 
degeneration.</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1c(c(=O)n(n1C)c2ccccc2)C(=O)Nc3ccc(c(c3)F)Oc4ccnc5c4ccc(c5)OCC(C)(C)O<br><b>InChiKey</b>=VQYYQSZNRVQLIS-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td><br>NINGETINIB</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Nintedanib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Nintedanib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Ofev;Vargatef</td>
      <td>4</td>
      <td>Boehringer Ingelheim</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.7985471.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL502835">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/9809715">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB09079">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=XIN">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/XIN">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5936">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000100014909">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=G6HRD2P839">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50026612">BindingDB</a><br></td>
      <td>'XIN'</td>
      <td>3c7q 5maf 5te0 6nec</td>
      <td>1</td>
      <td>1</td>
      <td>539.3</td>
      <td>3.6</td>
      <td>94.2</td>
      <td>7</td>
      <td>2</td>
      <td>7</td>
      <td>Nintedanib is indicated for the treatment of idiopathic pulmonary fibrosis (IPF).</td>
      <td>FLT1<br>KDR<br>FLT4<br>FGFR1<br>FGFR2<br>FGFR3<br>FLT3<br>LCK<br>LYN<br>SRC</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN1CCN(CC1)CC(=O)N(C)c2ccc(cc2)N/C(=C\3/c4ccc(cc4NC3=O)C(=O)OC)/c5ccccc5<br><b>InChiKey</b>=XZXHXSATPCNXJR-ZIADKAODSA-N</td>
      <td>2014</td>
      <td>US-6762180-B1</td>
      <td>Achiral Molecule</td>
      <td>Ofev;Vargatef <br> Nintedanib <br> BIBF-1120</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Oclacitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Oclacitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>0</td>
      <td>Pfizer</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.28528036.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2103874">ChEMBL</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9696">Guide to Pharmacology</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=99GS5XTB51">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=185700">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>337.2</td>
      <td>1.5</td>
      <td>91</td>
      <td>5</td>
      <td>2</td>
      <td>5</td>
      <td>nan</td>
      <td>JAK1<br>JAK2<br>JAK3</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CNS(=O)(=O)C[C@H]1CC[C@@H](CC1)N(c2ncnc3c2cc[nH]3)C<br><b>InChiKey</b>=HJWLJNBZVZDLAQ-HAQNSBGRSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>Oclacitinib <br> JAKI <br> PF-03394197</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Olmutinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Olmutinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Hanmi Pharmaceutical</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.45743494.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3786343">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/54758501">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB13164">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9196">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000198970879">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=CHL9B67L95">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50160871">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>486.2</td>
      <td>5.1</td>
      <td>82.6</td>
      <td>8</td>
      <td>2</td>
      <td>7</td>
      <td>For use in treatment of metastatic T790M mutation positive non-small cell lung cancer</td>
      <td>EGFR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN1CCN(CC1)c2ccc(cc2)Nc3nc4ccsc4c(n3)Oc5cccc(c5)NC(=O)C=C<br><b>InChiKey</b>=FDMQDKQUTRLUBU-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>BI 1482694 <br> Olmutinib <br> HM61713 <br> HM-61713</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Omipalisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Omipalisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>1</td>
      <td>GlaxosmithKline</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.25027388.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1236962">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/25167777">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12703">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=ZIG">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/ZIG">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8974">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC43208634">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=1X8F5A3NA0">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50145416">BindingDB</a><br></td>
      <td>'ZIG'</td>
      <td>3l08</td>
      <td>1</td>
      <td>1</td>
      <td>505.1</td>
      <td>4.8</td>
      <td>107</td>
      <td>7</td>
      <td>1</td>
      <td>6</td>
      <td>nan</td>
      <td>PIK3CA<br>MTOR</td>
      <td>Atypical</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=COc1c(cc(cn1)c2ccc3c(c2)c(ccn3)c4ccnnc4)NS(=O)(=O)c5ccc(cc5F)F<br><b>InChiKey</b>=CGBJSGAELGCMKE-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>Omipalisib <br> GSK2126458</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Orantinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Orantinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Pfizer</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.4486261.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL274654">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/5329099">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12072">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=SU6">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/SU6">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7816">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000003834032">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=9RL37ZZ665">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4811">BindingDB</a><br></td>
      <td>'SU6'</td>
      <td>4jlc 5yvc</td>
      <td>1</td>
      <td>0</td>
      <td>310.1</td>
      <td>3.1</td>
      <td>82.2</td>
      <td>2</td>
      <td>3</td>
      <td>4</td>
      <td>nan</td>
      <td>KDR<br>PDGFRB<br>FGFR1</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1c(c([nH]c1/C=C\2/c3ccccc3NC2=O)C)CCC(=O)O<br><b>InChiKey</b>=NHFDRBXTEDBWCZ-ZROIWOOFSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>TSU-68 <br> SU-6668 <br> Orantinib</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Osimertinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Osimertinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Tagrisso</td>
      <td>4</td>
      <td>Astrazeneca</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.31042598.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3353410">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/71496458">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB09330">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=YY3">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/YY3">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7719">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000098023177">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=3C06JJ0Z2O">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50029668">BindingDB</a><br></td>
      <td>'YY3'</td>
      <td>4zau</td>
      <td>1</td>
      <td>0</td>
      <td>499.3</td>
      <td>4.5</td>
      <td>87.6</td>
      <td>8</td>
      <td>2</td>
      <td>10</td>
      <td><input type="checkbox" class="read-more-state" id="post-645223234"><p class="read-more-wrap">Osimertinib
 is indicated for the treatment of patients with metastatic epidermal 
growth factor receptor (EGFR) T790M mutation-positive non-small cell <span class="read-more-target">lung cancer (NSCLC), as detected by an FDA- approved test, who have progressed on or after EGFR-TKI therapy.</span></p><label for="post-645223234" class="read-more-trigger"></label></td>
      <td>EGFR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cn1cc(c2c1cccc2)c3ccnc(n3)Nc4cc(c(cc4OC)N(C)CCN(C)C)NC(=O)C=C<br><b>InChiKey</b>=DUYJMQONPNNFPI-UHFFFAOYSA-N</td>
      <td>2015</td>
      <td>US-8946235-B2</td>
      <td>Achiral Molecule</td>
      <td>Tagrisso <br> Osimertinib <br> AZD-9291</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Pacritinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Pacritinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Cell Therapeutics</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.28518965.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2035187">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/46216796">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11697">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=6T3">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/6T3">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7793">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000043153645">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=G22N65IL3O">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50210177">BindingDB</a><br></td>
      <td>'6T3'</td>
      <td>5lbz</td>
      <td>nan</td>
      <td>0</td>
      <td>472.2</td>
      <td>5</td>
      <td>68.7</td>
      <td>7</td>
      <td>1</td>
      <td>4</td>
      <td>nan</td>
      <td>JAK2</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1cc2cc(c1)-c3ccnc(n3)Nc4ccc(c(c4)COC/C=C/COC2)OCCN5CCCC5<br><b>InChiKey</b>=HWXVIOGONBBTBY-ONEGZZNKSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>ONX-0803 <br> SB-1518 <br> SB1518 <br> Pacritinib</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Palbociclib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Palbociclib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Ibrance</td>
      <td>4</td>
      <td>Pfizer</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.4487437.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL189963">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/5330286">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB09073">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=LQQ">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/LQQ">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7380">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000003938686">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=G9ZF61LE7G">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6309">BindingDB</a><br></td>
      <td>'LQQ'</td>
      <td>2euf 5l2i</td>
      <td>1</td>
      <td>0</td>
      <td>447.2</td>
      <td>3</td>
      <td>105</td>
      <td>9</td>
      <td>2</td>
      <td>5</td>
      <td><input type="checkbox" class="read-more-state" id="post-690600726"><p class="read-more-wrap">Palbociclib
 is indicated in combination with letrozole for the treatment of 
postmenopausal women with estrogen receptor (ER)-positive, human 
epidermal<span class="read-more-target"> growth factor receptor 2 
(HER2)-negative advanced breast cancer as initial endocrine-based 
therapy for their metastatic disease. This indication is approved under 
accelerated approval based on progression-free survival (PFS). Continued
 approval for this indication may be contingent upon verification and 
description of clinical benefit in a confirmatory trial.</span></p><label for="post-690600726" class="read-more-trigger"></label></td>
      <td>CDK4<br>CDK6</td>
      <td>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1c2cnc(nc2n(c(=O)c1C(=O)C)C3CCCC3)Nc4ccc(cn4)N5CCNCC5<br><b>InChiKey</b>=AHJRHEGDXFFMBM-UHFFFAOYSA-N</td>
      <td>2015</td>
      <td>US-6936612-B2</td>
      <td>Achiral Molecule</td>
      <td>Ibrance <br> Palbociclib <br> PD-0332991</td>
      <td>Y</td>
      <td>263-266</td>
    </tr><tr class="even">
      <td><b>Pamapimod</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Pamapimod.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Hoffmann-La Roche</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.17347490.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1090089">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/16220188">PubChem</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=FLW">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/FLW">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9915">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC30691792">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=8S2C9V11K4">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50314070">BindingDB</a><br></td>
      <td>'FLW'</td>
      <td>3flw</td>
      <td>1</td>
      <td>0</td>
      <td>406.1</td>
      <td>1.9</td>
      <td>109.5</td>
      <td>8</td>
      <td>3</td>
      <td>8</td>
      <td>nan</td>
      <td>MAPK14<br>MAPK11</td>
      <td>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cn1c2c(cc(c1=O)Oc3ccc(cc3F)F)cnc(n2)NC(CCO)CCO<br><b>InChiKey</b>=JYYLVUFNAHSSFE-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>R-1503 <br> JTT-705 <br> Pamapimod <br> Ro-4402257</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Panulisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Panulisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>1</td>
      <td>Piramal Enterprises</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.29165869.html">ChemSpider</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/56947515">PubChem</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9916">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000301055099">ZINC</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>527.2</td>
      <td>4.8</td>
      <td>134.5</td>
      <td>9</td>
      <td>1</td>
      <td>3</td>
      <td>nan</td>
      <td>PIK3CA<br>MTOR</td>
      <td>Atypical</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC(C)(C#N)c1ccc(cn1)n2c3c4cc(ccc4ncc3n(c2=NC#N)C)c5cc(c(nc5)N)C(F)(F)F<br><b>InChiKey</b>=VJLRLTSXTLICIR-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td></td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Parsaclisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Parsaclisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Incyte Corporation</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.64835232.html">ChemSpider</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/86677874">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB14867">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10098">Guide to Pharmacology</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=OS7097575K">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=272573">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>432.1</td>
      <td>3.1</td>
      <td>107.9</td>
      <td>7</td>
      <td>2</td>
      <td>5</td>
      <td><input type="checkbox" class="read-more-state" id="post-516418222"><p class="read-more-wrap">Parsaclisib
 (INCB050465) is a PI3Kδ inhibitor that was developed by Incyte 
Corporation as an antineoplastic and immunomodulatory agent, as claim<span class="read-more-target">ed in their patent WO2014134426A1 [<a href='javascript:callRef("ReferenceDisplayForward?referenceId=36232&amp;displayId=1", 960, 600)' title="1. Li Y-L, Yao W, Combs AP, Yue EW, Mei S, Zhu W, Glenn J Jr, Maduskuie TP, Sparks RB, Douty B, He C. (2014) USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3Kδ RELATED DISORDERS. Patent no. WO2014134426A1.">1</a>].
 The chemical structure is one of those claimed in patent 
WO2013033569A1, but it is not clear which example it is from a mixture 
of diastereoisomers 345-348 (although 347 and 348 had the highest 
inhibitory potency <i>vs</i>. PI3Kδ and 347 was tested <i>in vivo</i> [<a href='javascript:callRef("ReferenceDisplayForward?referenceId=36233&amp;displayId=2", 960, 600)' title="2. Li Y-L, Yao W, Combs AP, Yue EW, Mei S, Zhu W, Glenn J, Maduskuie TP Jr, Sparks RB, Douty B. (2013) Heterocyclylamines as pi3k inhibitors. Patent no. WO2013033569A1.">2</a>].</span></p><label for="post-516418222" class="read-more-trigger"></label></td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CCOc1c(cc(c(c1[C@H]2CC(=O)NC2)F)Cl)[C@H](C)n3c4c(c(n3)C)c(ncn4)N<br><b>InChiKey</b>=ZQPDJCIXJHUERQ-QWRGUYRKSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td><br>INCB050465</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Pazopanib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Pazopanib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Votrient</td>
      <td>4</td>
      <td>GlaxoSmithKline</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.8289501.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL477772">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/10113978">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB06589">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5698">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000011617039">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=7RN5DR86CK">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26474">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>1</td>
      <td>0</td>
      <td>437.2</td>
      <td>3.1</td>
      <td>119</td>
      <td>8</td>
      <td>2</td>
      <td>5</td>
      <td>Treatment of advanced renal cell cancer and advanced soft tissue sarcoma (in patients previously treated with chemotherapy)</td>
      <td>FLT1<br>KDR<br>FLT4<br>PDGFRA<br>PDGFRB<br>KIT<br>FGFR3<br>ITK<br>FGFR1</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1ccc(cc1S(=O)(=O)N)Nc2nccc(n2)N(C)c3ccc4c(n(nc4c3)C)C<br><b>InChiKey</b>=CUIHSIWYWATEQL-UHFFFAOYSA-N</td>
      <td>2009</td>
      <td>US-7105530-B2</td>
      <td>Achiral Molecule</td>
      <td>Votrient <br> Pazopanib <br> GW786034</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Peficitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Peficitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Astellas Pharma</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.32742439.html">ChemSpider</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=9T6">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/9T6">PDBe</a><br><a href="http://zinc15.docking.org/substances/ZINC000146784326">ZINC</a><br></td>
      <td>'9T6'</td>
      <td>6aah 6aaj 6aak 6aam</td>
      <td>nan</td>
      <td>0</td>
      <td>326.2</td>
      <td>2</td>
      <td>104</td>
      <td>4</td>
      <td>4</td>
      <td>3</td>
      <td>nan</td>
      <td>JAK1<br>JAK2<br>JAK3<br>TYK2</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1c[nH]c2c1c(c(cn2)C(=O)N)N[C@@H]3[C@@H]4C[C@@H]5C[C@H]3C[C@@](C5)(C4)O<br><b>InChiKey</b>=DREIJXJRTLTGJC-ZKVNVPQCSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Racemic Mixture</td>
      <td><br>ASP015K<br> ASP015K hydrobromide</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Pelitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Pelitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Wyeth</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.4949255.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL607707">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/6445562">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB05524">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=93J">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/93J">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7644">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000000602803">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=X5DWL380Z6">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=31090">BindingDB</a><br></td>
      <td>'93J'</td>
      <td>5vcw</td>
      <td>1</td>
      <td>1</td>
      <td>467.2</td>
      <td>5.1</td>
      <td>90.3</td>
      <td>6</td>
      <td>2</td>
      <td>8</td>
      <td>nan</td>
      <td>EGFR<br>ERBB2</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CCOc1cc2c(cc1NC(=O)/C=C/CN(C)C)c(c(cn2)C#N)Nc3ccc(c(c3)Cl)F<br><b>InChiKey</b>=WVUNYSQLFKLYNI-AATRIKPKSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>WAY-EKB-569 <br> EKB-569 <br> Pelitinib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Pexidartinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Pexidartinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Turalio</td>
      <td>4</td>
      <td>Daiichi Sankyo</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.35308322.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3813873">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/25151352">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12978">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=P31">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/P31">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8710">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000115705166">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=6783M2LV5X">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50177716">BindingDB</a><br></td>
      <td>'P31'</td>
      <td>4r7h</td>
      <td>2</td>
      <td>1</td>
      <td>417.1</td>
      <td>5.2</td>
      <td>66.5</td>
      <td>4</td>
      <td>2</td>
      <td>5</td>
      <td>On august 2019, FDA approved pexidartinib to treat adult patients with symptomatic tenosynovial giant cell tumor</td>
      <td>FLT3<br>KIT<br>CSF1R</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1cc(ncc1Cc2c[nH]c3c2cc(cn3)Cl)NCc4ccc(nc4)C(F)(F)F<br><b>InChiKey</b>=JGWRKYUXBBNENE-UHFFFAOYSA-N</td>
      <td>2019</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>CML-261 <br> Pexidartinib <br> PLX3397</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Pexmetinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Pexmetinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>1</td>
      <td>Array BioPharma</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.32702049.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3991932">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/24765037">PubChem</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9917">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000041747181">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=3750D0U8B5">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>2</td>
      <td>556.3</td>
      <td>6.1</td>
      <td>106.2</td>
      <td>7</td>
      <td>3</td>
      <td>8</td>
      <td>nan</td>
      <td>MAPK14<br>TEK</td>
      <td>Tyr<br>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1ccc(cc1)n2c(cc(n2)C(C)(C)C)NC(=O)NCc3cc(ccc3Oc4ccc5c(c4)cnn5CCO)F<br><b>InChiKey</b>=LNMRSSIMGCDUTP-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td></td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Pictilisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Pictilisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Hoffmann-La Roche</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.21437049.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL521851">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/17755052">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11663">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=GD9">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/GD9">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5682">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC16052714">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=ICY00EMP8P">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25028">BindingDB</a><br></td>
      <td>'GD9'</td>
      <td>2wxp 2y3a 3dbs</td>
      <td>1</td>
      <td>1</td>
      <td>513.2</td>
      <td>2.1</td>
      <td>107.6</td>
      <td>9</td>
      <td>1</td>
      <td>5</td>
      <td>nan</td>
      <td>PIK3CA<br>PIK3CB<br>PIK3CD<br>PIK3CG</td>
      <td>Atypical</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CS(=O)(=O)N1CCN(CC1)Cc2cc3c(s2)c(nc(n3)c4cccc5c4cn[nH]5)N6CCOCC6<br><b>InChiKey</b>=LHNIIDJUOCFXAP-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>RG-7321 <br> GDC-0941 <br> Pictilisib</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Pilaralisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Pilaralisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Sanofi</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.29340997.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3360203">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/56599306">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11772">DrugBank</a><br><a href="http://zinc15.docking.org/substances/ZINC000100472223">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=60ES45KTMK">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50197062">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>540.1</td>
      <td>4.5</td>
      <td>148.3</td>
      <td>8</td>
      <td>4</td>
      <td>8</td>
      <td>nan</td>
      <td>PIK3CA<br>PIK3CB<br>PIK3CD<br>PIK3CG</td>
      <td>Atypical</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC(C)(C(=O)Nc1cccc(c1)S(=O)(=O)Nc2c(nc3ccccc3n2)Nc4cc(ccc4Cl)OC)N<br><b>InChiKey</b>=QINPEPAQOBZPOF-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>Pilaralisib <br> SAR-245408 <br> XL-147</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Pimasertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Pimasertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Merck</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.24747378.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2107832">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/44187362">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB14904">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7872">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC38226009">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=6ON9RK82AL">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50014412">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>431</td>
      <td>1.7</td>
      <td>94.5</td>
      <td>5</td>
      <td>4</td>
      <td>6</td>
      <td>nan</td>
      <td>MAP2K1<br>MAP2K2</td>
      <td>STE</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1cc(c(cc1I)F)Nc2cnccc2C(=O)NC[C@@H](CO)O<br><b>InChiKey</b>=VIUAUNHCRHHYNE-JTQLQIEISA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>MSC1936369A; AS703026; EMD 1036239 <br> AS-703026 <br> MSC-1936369B <br> EMD 1036239  <br> Pimasertib</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Ponatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Ponatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Iclusig</td>
      <td>4</td>
      <td>Ariad Pharmaceuticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.24747381.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1171837">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/24826799">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB08901">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=0LI">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/0LI">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5890">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC36701290">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=4340891KFS">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50322535">BindingDB</a><br></td>
      <td>'0LI'</td>
      <td>3ik3 3oxz 3zos 4c8b 4qrc 4tyj 4u0i 4uxq 4v01 4v04 6eg9</td>
      <td>2</td>
      <td>1</td>
      <td>532.2</td>
      <td>4.5</td>
      <td>65.8</td>
      <td>6</td>
      <td>1</td>
      <td>4</td>
      <td><input type="checkbox" class="read-more-state" id="post-795353123"><p class="read-more-wrap">Ponatinib
 is indicated for the treatment of adult patients with chronic phase, 
accelerated phase, or blast phase chronic myeloid leukemia (CML) that i<span class="read-more-target">s
 resistant or intolerant to prior tyrosine kinase inhibitor therapy or 
Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) 
that is resistant or intolerant to prior tyrosine kinase inhibitor 
therapy.</span></p><label for="post-795353123" class="read-more-trigger"></label></td>
      <td>ABL1<br>BCR<br>KIT<br>RET<br>TEK<br>FLT3<br>FGFR1<br>FGFR2<br>FGFR3<br>FGFR4<br>LCK<br>SRC<br>LYN<br>KDR<br>PDGFRA</td>
      <td>Atypical<br>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1ccc(cc1C#Cc2cnc3n2nccc3)C(=O)Nc4ccc(c(c4)C(F)(F)F)CN5CCN(CC5)C<br><b>InChiKey</b>=PHXJVRSECIGDHY-UHFFFAOYSA-N</td>
      <td>2012</td>
      <td>US-8114874-B2</td>
      <td>Achiral Molecule</td>
      <td>Iclusig <br> AP-24534 <br> Ponatinib</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Poziotinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Poziotinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Hanmi Pharmaceutical</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.30687714.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545154">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/25127713">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12114">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7903">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000095930125">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=OEI6OOU6IK">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>490.1</td>
      <td>5.4</td>
      <td>76.6</td>
      <td>6</td>
      <td>1</td>
      <td>6</td>
      <td>nan</td>
      <td>EGFR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=COc1cc2c(cc1OC3CCN(CC3)C(=O)C=C)c(ncn2)Nc4ccc(c(c4F)Cl)Cl<br><b>InChiKey</b>=LPFWVDIFUFFKJU-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>NOV-120101 <br> Poziotinib <br> HM-781-36B</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Pralsetinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Pralsetinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>1.5</td>
      <td>Blueprint Medicines</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.71060332.html">ChemSpider</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=1WPE73O1WV">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>533.3</td>
      <td>4.2</td>
      <td>135.5</td>
      <td>9</td>
      <td>3</td>
      <td>8</td>
      <td><input type="checkbox" class="read-more-state" id="post-648505301"><p class="read-more-wrap">Pralsetinib,
 also known as BLU-667, is a highly potent, selective, next generation 
RET inhibitor. BLU-667 is a potent and selective inhibitor of RET m<span class="read-more-target">utations,
 fusions, and predicted resistant mutants. RET fusions are key drivers 
of multiple cancers, including lung and thyroid cancer, and our research
 suggests that RET also plays a key role in some colon and breast 
cancers. By simultaneously targeting the primary driver and predicted 
resistant mutants that render cancer cells insensitive to treatment with
 currently approved drugs</span></p><label for="post-648505301" class="read-more-trigger"></label></td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1[nH]nc(c1)Nc2nc(nc(c2)C)[C@H]3CC[C@@](CC3)(OC)C(=O)N[C@H](c4cnc(cc4)n5ncc(c5)F)C<br><b>InChiKey</b>=GBLBJPZSROAGMF-BATDWUPUSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td><br>BLU-667</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Prexasertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Prexasertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Eli Lilly</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.32738771.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3544911">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/46700756">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12008">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9549">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000095837013">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=820NH671E6">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>365.2</td>
      <td>2.2</td>
      <td>134.8</td>
      <td>8</td>
      <td>3</td>
      <td>8</td>
      <td>nan</td>
      <td>CHEK1<br>CHEK2</td>
      <td>CAMK</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=COc1cccc(c1c2cc(n[nH]2)Nc3cnc(cn3)C#N)OCCCN<br><b>InChiKey</b>=DOTGPNHGTYJDEP-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>LY-2606368 <br> Prexasertib</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Pyrotinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Pyrotinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Hengrui Therapeutics</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.52083721.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3647420">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/51039030">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB14993">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9662">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000068250550">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=CJN36EQM0H">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=139991">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>2</td>
      <td>582.2</td>
      <td>6.5</td>
      <td>112.4</td>
      <td>8</td>
      <td>2</td>
      <td>10</td>
      <td>nan</td>
      <td>EGFR<br>ERBB2</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CCOc1cc2c(cc1NC(=O)/C=C/[C@H]3CCCN3C)c(c(cn2)C#N)Nc4ccc(c(c4)Cl)OCc5ccccn5<br><b>InChiKey</b>=SADXACCFNXBCFY-IYNHSRRRSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td><br>SHR1258</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Quizartinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Quizartinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Ambit Biosciences</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.24640357.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL576982">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/24889392">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12874">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=P30">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/P30">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5658">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC43204002">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=7LA4O6Q0D3">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50300690">BindingDB</a><br></td>
      <td>'P30'</td>
      <td>4rt7 4xuf</td>
      <td>2</td>
      <td>2</td>
      <td>560.2</td>
      <td>5.9</td>
      <td>106.2</td>
      <td>9</td>
      <td>2</td>
      <td>7</td>
      <td>nan</td>
      <td>FLT3<br>CSF1R<br>KIT</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC(C)(C)c1cc(no1)NC(=O)Nc2ccc(cc2)c3cn4c5ccc(cc5sc4n3)OCCN6CCOCC6<br><b>InChiKey</b>=CVWXJKQAOSCOAB-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>ASP-2689 <br> AC220 <br> Quizartinib <br> AC010220 <br> AC-220</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Rabusertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Rabusertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Eli Lilly</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.10130131.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3039517">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11955855">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11662">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7960">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000070466463">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=3S9L1NU6U7">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>435.1</td>
      <td>2.9</td>
      <td>97.4</td>
      <td>6</td>
      <td>3</td>
      <td>5</td>
      <td>nan</td>
      <td>CHEK1</td>
      <td>CAMK</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1cc(c(cc1Br)NC(=O)Nc2cnc(cn2)C)OC[C@@H]3CNCCO3<br><b>InChiKey</b>=SYYBDNPGDKKJDU-ZDUSSCGKSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>Rabusertib <br> LY-2603618 <br> IC-83</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Radotinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Radotinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Il-Yang Pharmaceutical</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.17222861.html">ChemSpider</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/16063245">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12323">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7814">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000059749972">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=I284LJY110">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>2</td>
      <td>530.2</td>
      <td>5.8</td>
      <td>110.5</td>
      <td>8</td>
      <td>2</td>
      <td>6</td>
      <td><input type="checkbox" class="read-more-state" id="post-217531050"><p class="read-more-wrap">Radotinib
 is indicated for the treatment of different types of cancer, most 
notably Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia 
(C<span class="read-more-target">ML) with resistance or intolerance of 
other Bcr-Abl tyrosine-kinase inhibitors, such as patients resistant or 
intolerant to imatinib.</span></p><label for="post-217531050" class="read-more-trigger"></label></td>
      <td>ABL1<br>PDGFRB</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1ccc(cc1Nc2nccc(n2)c3cnccn3)C(=O)Nc4cc(cc(c4)n5cc(nc5)C)C(F)(F)F<br><b>InChiKey</b>=DUPWHXBITIZIKZ-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td><br>SUPEC<br>IY5511HCL</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Ralimetinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Ralimetinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Eli Lilly</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9713805.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2364626">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11539025">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11787">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7959">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC34630490">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=73I34XW4HD">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>420.2</td>
      <td>5.6</td>
      <td>85.4</td>
      <td>5</td>
      <td>2</td>
      <td>3</td>
      <td>nan</td>
      <td>MAPK14<br>MAPK11</td>
      <td>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC(C)(C)Cn1c2c(ccc(n2)c3c(nc([nH]3)C(C)(C)C)c4ccc(cc4)F)nc1N<br><b>InChiKey</b>=XPPBBJCBDOEXDN-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>LY-2228820 <br> LY-22288220 <br> Ralimetinib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Ravoxertinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Ravoxertinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>1</td>
      <td>Genentech</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.32501977.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3544964">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/71727581">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB15281">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=6QB">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/6QB">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9229">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000144904566">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=R6AXV96CRH">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=120095">BindingDB</a><br></td>
      <td>'6QB'</td>
      <td>5k4i 5k4j 6oph</td>
      <td>nan</td>
      <td>0</td>
      <td>440.1</td>
      <td>3.2</td>
      <td>97.9</td>
      <td>8</td>
      <td>2</td>
      <td>6</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cn1c(ccn1)Nc2nccc(n2)c3ccn(c(=O)c3)[C@H](CO)c4ccc(c(c4)F)Cl<br><b>InChiKey</b>=RZUOCXOYPYGSKL-GOSISDBHSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>Ravoxertinib <br> RG-7842 <br> GDC-0994</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Rebastinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Rebastinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Deciphera Pharmaceuticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.26325986.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1738757">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/25066467">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB13005">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=919">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/919">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9173">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC63933734">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=75017Q6I97">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=185674">BindingDB</a><br></td>
      <td>'919'</td>
      <td>3qri 3qrj 5g6v 6cnh 6mwe</td>
      <td>2</td>
      <td>2</td>
      <td>553.2</td>
      <td>6</td>
      <td>123.1</td>
      <td>7</td>
      <td>3</td>
      <td>6</td>
      <td>nan</td>
      <td>FLT3<br>TEK<br>KDR<br>LYN<br>BCR<br>ABL1<br>NTRK1</td>
      <td>Atypical<br>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC(C)(C)c1cc(n(n1)c2ccc3c(c2)cccn3)NC(=O)Nc4ccc(cc4F)Oc5ccnc(c5)C(=O)NC<br><b>InChiKey</b>=WVXNSAVVKYZVOE-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>DP-1919 <br> DP-1919 <br> DCC-2036 <br> Rebastinib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Recilisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Recilisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Ex-RAD</td>
      <td>1</td>
      <td>Onconova Therapeutics</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.8059894.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2219421">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/9884220">PubChem</a><br><a href="http://zinc15.docking.org/substances/ZINC000034007613">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=F5V4K11SYV">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>336</td>
      <td>3.6</td>
      <td>71.4</td>
      <td>3</td>
      <td>1</td>
      <td>5</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1cc(ccc1CS(=O)(=O)/C=C/c2ccc(cc2)C(=O)O)Cl<br><b>InChiKey</b>=KBEKQQJUNVQLDZ-MDZDMXLPSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>Ex-RAD <br> ON-01210 <br> ON-01210.Na <br> Recilisib</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Refametinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Refametinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Bayer</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.25058723.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1236682">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/44182295">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB06309">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=VRA">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/VRA">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7942">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC39187987">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=JPX07AFM0N">FDA SRS</a><br></td>
      <td>'VRA'</td>
      <td>3e8n</td>
      <td>nan</td>
      <td>1</td>
      <td>572</td>
      <td>3.5</td>
      <td>107.9</td>
      <td>6</td>
      <td>4</td>
      <td>9</td>
      <td>nan</td>
      <td>MAP2K1</td>
      <td>STE</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=COc1cc(c(c(c1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)Nc3ccc(cc3F)I)F)F<br><b>InChiKey</b>=RDSACQWTXKSHJT-NSHDSACASA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>BAY-86-9766 <br> Refametinib <br> RDEA-119</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Regorafenib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Regorafenib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Stivarga</td>
      <td>4</td>
      <td>Bayer</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9342697.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1946170">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11167602">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB08896">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5891">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC06745272">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=24T2A1DOYB">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50363397">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>2</td>
      <td>1</td>
      <td>482.1</td>
      <td>5.7</td>
      <td>92.3</td>
      <td>4</td>
      <td>3</td>
      <td>5</td>
      <td><input type="checkbox" class="read-more-state" id="post-851582167"><p class="read-more-wrap">Regorafenib
 is indicated for the treatment of patients with metastatic colorectal 
cancer (CRC) who have been previously treated with fluoropyrimidine-<span class="read-more-target">,
 oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF therapy, 
and, if KRAS wild type, an anti-EGFR therapy. Regorafenib is also 
indicated for the treatment of patients with locally advanced, 
unresectable or metastatic gastrointestinal stromal tumor (GIST) who 
have been previously treated with imatinib mesylate and sunitinib 
malate.</span></p><label for="post-851582167" class="read-more-trigger"></label></td>
      <td>FLT1<br>KDR<br>FLT4<br>KIT<br>PDGFRA<br>PDGFRB<br>FGFR1<br>FGFR2<br>TEK<br>DDR2<br>NTRK1<br>EPHA2<br>RAF1<br>BRAF<br>MAPK11<br>FRK<br>ABL1<br>RET</td>
      <td>TKL<br>Tyr<br>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CNC(=O)c1cc(ccn1)Oc2ccc(c(c2)F)NC(=O)Nc3ccc(c(c3)C(F)(F)F)Cl<br><b>InChiKey</b>=FNHKPVJBJVTLMP-UHFFFAOYSA-N</td>
      <td>2012</td>
      <td>US-7351834-B1</td>
      <td>Achiral Molecule</td>
      <td>Stivarga <br> Regorafenib <br> BAY-734506 monohydrate <br> BAY-73-4506</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Ribociclib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Ribociclib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Kisqali</td>
      <td>4</td>
      <td>Novartis</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.30798107.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545110">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/44631912">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11730">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=6ZZ">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/6ZZ">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7383">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000072316335">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=TK8ERE8P56">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=148264">BindingDB</a><br></td>
      <td>'6ZZ'</td>
      <td>5l2t</td>
      <td>1</td>
      <td>0</td>
      <td>434.3</td>
      <td>2.8</td>
      <td>91.2</td>
      <td>8</td>
      <td>2</td>
      <td>5</td>
      <td><input type="checkbox" class="read-more-state" id="post-863995371"><p class="read-more-wrap">Kisqali
 (ribociclib) is a selective cyclin-dependent kinase inhibitor, a class 
of drugs that help slow the progression of cancer by inhibiting two pro<span class="read-more-target">teins
 called cyclin-dependent kinase 4 and 6 (CDK4/6). These proteins, when 
over-activated, can enable cancer cells to grow and divide too quickly. 
Targeting CDK4/6 with enhanced precision may play a role in ensuring 
that cancer cells do not continue to replicate uncontrollably.</span></p><label for="post-863995371" class="read-more-trigger"></label></td>
      <td>CDK4<br>CDK6</td>
      <td>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN(C)C(=O)c1cc2cnc(nc2n1C3CCCC3)Nc4ccc(cn4)N5CCNCC5<br><b>InChiKey</b>=RHXHGRAEPCAFML-UHFFFAOYSA-N</td>
      <td>2017</td>
      <td>US-8324225-B2</td>
      <td>Achiral Molecule</td>
      <td>Ribociclib <br> LEE-011 <br> NVP-LEE011</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Rigosertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Rigosertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Onconova Therapeutics</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.5293927.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1241855">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/6918736">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12146">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=6FS">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/6FS">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7833">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000003942646">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=67DOW7F9GL">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50060917">BindingDB</a><br></td>
      <td>'6FS'</td>
      <td>5j18 5j2r 5ov7</td>
      <td>3</td>
      <td>0</td>
      <td>451.1</td>
      <td>2.8</td>
      <td>120.4</td>
      <td>8</td>
      <td>2</td>
      <td>11</td>
      <td>nan</td>
      <td>PIK3CA<br>PLK1</td>
      <td>Atypical<br>Other</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=COc1ccc(cc1NCC(=O)O)CS(=O)(=O)/C=C/c2c(cc(cc2OC)OC)OC<br><b>InChiKey</b>=OWBFCJROIKNMGD-BQYQJAHWSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>Rigosertib <br> ON-01910</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Ripasudil</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Ripasudil.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Kowa Pharmaceutical</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.8039366.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3426621">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/9863672">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB13165">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10423">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000003940873">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=11978226XX">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50087135">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>323.1</td>
      <td>1.7</td>
      <td>62.3</td>
      <td>4</td>
      <td>1</td>
      <td>2</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C[C@H]1CNCCCN1S(=O)(=O)c2cccc3c2c(cnc3)F<br><b>InChiKey</b>=QSKQVZWVLOIIEV-NSHDSACASA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td><br>RIPASUDIL</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Ripretinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Ripretinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Deciphera Pharmaceuticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.67886378.html">ChemSpider</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/71584930">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB14840">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9175">Guide to Pharmacology</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=9XW757O13D">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>2</td>
      <td>509.1</td>
      <td>5.7</td>
      <td>88</td>
      <td>5</td>
      <td>3</td>
      <td>5</td>
      <td><input type="checkbox" class="read-more-state" id="post-181376154"><p class="read-more-wrap">Ripretinib
 (DCC-2618) is an orally bioavailable, potent pan-KIT and PDGFRα kinase 
inhibitor being developed by Dicephera Pharmaceuticals.  It is<span class="read-more-target">
 in clinical development for the treatment of  malignancies that are 
driven by KIT and/or PDGFRα, for example gastrointestinal stromal 
tumors, glioblastoma multiforme and systemic mastocytosis. Ripretinib 
has activity across a broad range of resistance mutations in its target 
kinases, that emerge in response to imatinib treatment. Ripretinib binds
 to the 'switch pocket' of KIT, a domain that regulates the enzyme's 
catalytic conformation. Compounds that act in this way are often 
referred to as switch control inhibitors.</span></p><label for="post-181376154" class="read-more-trigger"></label></td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CCn1c2cc(ncc2cc(c1=O)c3cc(c(cc3Br)F)NC(=O)Nc4ccccc4)NC<br><b>InChiKey</b>=CEFJVGZHQAGLHS-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td><br>DCC-2618<br>RIPRETINIB</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Riviciclib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Riviciclib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Piramal Enterprises</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.29165868.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3969723">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/23643976">PubChem</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7934">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000003937395">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=9EK26WE8QN">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50193086">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>401.1</td>
      <td>3.3</td>
      <td>94.1</td>
      <td>6</td>
      <td>3</td>
      <td>3</td>
      <td>nan</td>
      <td>CDK1<br>CDK4<br>CDK9</td>
      <td>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN1CC[C@H]([C@@H]1CO)c2c(cc(c3c2oc(cc3=O)c4ccccc4Cl)O)O<br><b>InChiKey</b>=QLUYMIVVAYRECT-OCCSQVGLSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Racemic Mixture</td>
      <td></td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Rivoceranib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Rivoceranib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>1</td>
      <td>Advenchen Laboratories</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.28294976.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545414">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/45139106">PubChem</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=TK02X14ASJ">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50152828">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>493.2</td>
      <td>4.2</td>
      <td>145.1</td>
      <td>7</td>
      <td>3</td>
      <td>6</td>
      <td>Rivoceranib Mesylate is a novel selective inhibitor of vascular endothelial growth factor receptor 2 (vegfr2)</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CS(=O)(=O)O.c1cc(c(nc1)NCc2ccncc2)C(=O)Nc3ccc(cc3)C4(CCCC4)C#N<br><b>InChiKey</b>=FYJROXRIVQPKRY-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td>YN-968D1</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Rociletinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Rociletinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Clovis Oncology</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.30646712.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545308">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/57335384">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11907">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=8JC">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/8JC">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7966">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000098043800">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=72AH61702G">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=149404">BindingDB</a><br></td>
      <td>'8JC'</td>
      <td>5xdk 5xdl</td>
      <td>1</td>
      <td>1</td>
      <td>555.2</td>
      <td>4.8</td>
      <td>111.7</td>
      <td>8</td>
      <td>3</td>
      <td>8</td>
      <td>nan</td>
      <td>EGFR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC(=O)N1CCN(CC1)c2ccc(c(c2)OC)Nc3ncc(c(n3)Nc4cccc(c4)NC(=O)C=C)C(F)(F)F<br><b>InChiKey</b>=HUFOZJXAKZVRNJ-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>CNX-419 <br> AVL-301 <br> CO-1686 <br> Rociletinib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Rogaratinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Rogaratinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Bayer</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.58828032.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3963485">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/71611869">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB15078">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9789">Guide to Pharmacology</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=98BSN6N516">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=194820">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>466.2</td>
      <td>2.6</td>
      <td>107</td>
      <td>9</td>
      <td>2</td>
      <td>6</td>
      <td>Rogaratinib (BAY-1163877) is a FGFR-selective kinase inhibitor that is being investigated for antineoplastic activity.</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1cc2cc(sc2c(c1)OC)c3c(c(n4c3c(ncn4)N)CN5CCNC(=O)C5)COC<br><b>InChiKey</b>=HNLRRJSKGXOYNO-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td><br>ROGARATINIB<br>BAY 1163877</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Roniciclib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Roniciclib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Bayer</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.32697590.html">ChemSpider</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/71494949">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12974">DrugBank</a><br><a href="http://zinc15.docking.org/substances/ZINC000095616570">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=0W9Q8U337A">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>430.1</td>
      <td>4</td>
      <td>108.2</td>
      <td>7</td>
      <td>3</td>
      <td>7</td>
      <td>nan</td>
      <td>CDK1<br>CDK2<br>CDK4<br>CDK9</td>
      <td>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C[C@H]([C@@H](C)Oc1c(cnc(n1)Nc2ccc(cc2)[S@](=N)(=O)C3CC3)C(F)(F)F)O<br><b>InChiKey</b>=UELYDGOOJPRWGF-SRQXXRKNSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td></td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Ruboxistaurin</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Ruboxistaurin.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Arxxant</td>
      <td>3</td>
      <td>Eli Lilly</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.135727.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL91829">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/153999">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11829">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=LY4">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/LY4">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5263">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000003812168">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=721809WQCP">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50128281">BindingDB</a><br></td>
      <td>'LY4'</td>
      <td>1uu3 2j2i</td>
      <td>nan</td>
      <td>0</td>
      <td>468.2</td>
      <td>3.5</td>
      <td>68.5</td>
      <td>6</td>
      <td>1</td>
      <td>2</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN(C)C[C@@H]1CCn2cc(c3c2cccc3)C4=C(c5cn(c6c5cccc6)CCO1)C(=O)NC4=O<br><b>InChiKey</b>=ZCBUQCWBWNUWSU-SFHVURJKSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>Arxxant <br> LY-333531 <br> Ruboxistaurin</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Ruxolitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Ruxolitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Jakafi</td>
      <td>4</td>
      <td>Incyte Corporation</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.25027389.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1789941">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/25126798">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB08877">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=RXT">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/RXT">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5688">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC43207851">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=82S8X8XX8H">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355501">BindingDB</a><br></td>
      <td>'RXT'</td>
      <td>4u5j</td>
      <td>1</td>
      <td>0</td>
      <td>306.2</td>
      <td>3.5</td>
      <td>83.2</td>
      <td>5</td>
      <td>1</td>
      <td>4</td>
      <td><input type="checkbox" class="read-more-state" id="post-910299233"><p class="read-more-wrap">Treatment
 of intermediate or high-risk myelofibrosis, including primary 
myelofibrosis, post-polycythemia vera (post-PV) myelofibrosis and 
post-essenti<span class="read-more-target">al thrombocythemia (post-ET) 
myelofibrosis. [Lexicomp] Myeolofibrosis is the proliferation of 
abnormal bone marrow stem cells which cause fibrosis (the excessive 
formation of connective tissue).</span></p><label for="post-910299233" class="read-more-trigger"></label></td>
      <td>JAK1<br>JAK2</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1c[nH]c2c1c(ncn2)c3cnn(c3)[C@H](CC#N)C4CCCC4<br><b>InChiKey</b>=HFNKQEVNSGCOJV-OAHLLOKOSA-N</td>
      <td>2011</td>
      <td>US-7598257-B2</td>
      <td>Single Stereoisomer</td>
      <td>Jakavi <br> INCB-018424 <br> Ruxolitinib</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Samotolisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Samotolisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Eli Lilly</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.35142771.html">ChemSpider</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/57519748">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12167">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8918">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000143116580">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=C88817F47Y">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>406.2</td>
      <td>3.2</td>
      <td>82.2</td>
      <td>7</td>
      <td>1</td>
      <td>5</td>
      <td><input type="checkbox" class="read-more-state" id="post-502445448"><p class="read-more-wrap">LY3023414
 is a dual inhibitor of phosphoinositide 3-kinase α (PI3Kα) and the 
serine/threonine kinase mTOR (mechanistic target of rapamycin<span class="read-more-target">), with potential antineoplastic activity.</span></p><label for="post-502445448" class="read-more-trigger"></label></td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C[C@@H](Cn1c2c3cc(ccc3ncc2n(c1=O)C)c4cc(cnc4)C(C)(C)O)OC<br><b>InChiKey</b>=ACCFLVVUVBJNGT-AWEZNQCLSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td><br>LY-3023414<br>LY 3023414<br>WHO 10889<br>LY3023414</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Sapanisertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Sapanisertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Takeda</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.28189069.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545097">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/45375953">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11836">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=FE5">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/FE5">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7933">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000073069271">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=JGH0DF1U03">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315477">BindingDB</a><br></td>
      <td>'FE5'</td>
      <td>6gvf</td>
      <td>nan</td>
      <td>0</td>
      <td>309.1</td>
      <td>2.4</td>
      <td>121.7</td>
      <td>8</td>
      <td>2</td>
      <td>2</td>
      <td>nan</td>
      <td>MTOR</td>
      <td>Atypical</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC(C)n1c2c(c(n1)c3ccc4c(c3)nc(o4)N)c(ncn2)N<br><b>InChiKey</b>=GYLDXIAOMVERTK-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>MLN-0128 <br> Sapanisertib <br> TAK-228</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Sapitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Sapitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Astrazeneca</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9663133.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2408045">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11488320">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12183">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7717">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000034587071">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=3499328002">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50437353">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>473.2</td>
      <td>3.8</td>
      <td>88.6</td>
      <td>7</td>
      <td>2</td>
      <td>7</td>
      <td>nan</td>
      <td>EGFR<br>ERBB2<br>ERBB4<br>ERBB3</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CNC(=O)CN1CCC(CC1)Oc2cc3c(cc2OC)ncnc3Nc4cccc(c4F)Cl<br><b>InChiKey</b>=DFJSJLGUIXFDJP-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>Sapitinib <br> AZD-8931</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Saracatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Saracatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Astrazeneca</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.8477917.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL217092">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/10302451">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11805">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=H8H">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/H8H">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7731">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC24811973">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=9KD24QGH76">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12255">BindingDB</a><br></td>
      <td>'H8H'</td>
      <td>2h8h 4qmx 5vcx 5vd3</td>
      <td>1</td>
      <td>1</td>
      <td>541.2</td>
      <td>3.9</td>
      <td>90.4</td>
      <td>10</td>
      <td>1</td>
      <td>8</td>
      <td>nan</td>
      <td>SRC<br>ABL1</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN1CCN(CC1)CCOc2cc3c(c(c2)OC4CCOCC4)c(ncn3)Nc5c(ccc6c5OCO6)Cl<br><b>InChiKey</b>=OUKYUETWWIPKQR-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>AZD-0530 <br> Saracatinib <br> AZ-10353926</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Savolitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Savolitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Astrazeneca</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.34501055.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3334567">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/68289010">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12048">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=V0L">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/V0L">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9918">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000149738712">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=2A2DA6857R">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50023342">BindingDB</a><br></td>
      <td>'V0L'</td>
      <td>5lbw 6sde</td>
      <td>nan</td>
      <td>0</td>
      <td>345.1</td>
      <td>1.9</td>
      <td>91.6</td>
      <td>9</td>
      <td>0</td>
      <td>3</td>
      <td>nan</td>
      <td>MET</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C[C@@H](c1ccc2nccn2c1)n3c4c(ncc(n4)c5cnn(c5)C)nn3<br><b>InChiKey</b>=XYDNMOZJKOGZLS-NSHDSACASA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>AZD-6094 <br> Savolitinib <br> HMPL-504 <br> AZD6094</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Selatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Selatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>1</td>
      <td>Qilu Pharmaceutical</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.30841488.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3040548">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/51348455">PubChem</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9919">Guide to Pharmacology</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=140985">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>2</td>
      <td>564.1</td>
      <td>6.5</td>
      <td>89.3</td>
      <td>7</td>
      <td>2</td>
      <td>11</td>
      <td>nan</td>
      <td>EGFR<br>ERBB2</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CS(=O)CCNCc1ccc(o1)c2ccc3c(c2)c(ncn3)Nc4ccc(c(c4)Cl)OCc5cccc(c5)F<br><b>InChiKey</b>=OAMVGUFHZPRXOM-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Seliciclib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Seliciclib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Cyclacel pharmaceuticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.140922.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL14762">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/160355">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB06195">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=RRC">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/RRC">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6035">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC01649340">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=0ES1C2KQ94">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=7533">BindingDB</a><br></td>
      <td>'RRC'</td>
      <td>1unl 1ygk 2a4l 3ddq</td>
      <td>1</td>
      <td>0</td>
      <td>354.2</td>
      <td>3.2</td>
      <td>87.9</td>
      <td>7</td>
      <td>3</td>
      <td>8</td>
      <td>nan</td>
      <td>CDK2<br>CDK7<br>CDK9</td>
      <td>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1<br><b>InChiKey</b>=BTIHMVBBUGXLCJ-OAHLLOKOSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>Seliciclib <br> CYC-202 <br> AL-39256</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Selonsertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Selonsertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Gilead Sciences</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.44209497.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3916717">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/71245288">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB14916">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=NJV">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/NJV">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9040">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000149387856">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=NS3988A2TC">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50212258">BindingDB</a><br></td>
      <td>'NJV'</td>
      <td>6oyt</td>
      <td>nan</td>
      <td>0</td>
      <td>445.2</td>
      <td>4.7</td>
      <td>90.5</td>
      <td>7</td>
      <td>1</td>
      <td>6</td>
      <td>nan</td>
      <td>MAP3K5</td>
      <td>STE</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1cc(c(cc1n2cc(nc2)C3CC3)C(=O)Nc4cccc(n4)c5nncn5C(C)C)F<br><b>InChiKey</b>=YIDDLAAKOYYGJG-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>GS-4997 <br> Selonsertib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Selumetinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Selumetinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Astrazeneca</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.8303141.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1614701">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/10127622">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11689">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=3EW">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/3EW">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5665">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC31773258">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=6UH91I579U">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355497">BindingDB</a><br></td>
      <td>'3EW'</td>
      <td>4u7z</td>
      <td>3</td>
      <td>0</td>
      <td>456</td>
      <td>3.5</td>
      <td>88.4</td>
      <td>6</td>
      <td>3</td>
      <td>6</td>
      <td>nan</td>
      <td>MAP2K1<br>MAP2K2</td>
      <td>STE</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cn1cnc2c1cc(c(c2F)Nc3ccc(cc3Cl)Br)C(=O)NOCCO<br><b>InChiKey</b>=CYOHGALHFOKKQC-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>ARRY-142886 <br> AZD-6244 <br> ARRY-886 <br> Selumetinib</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Semaxanib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Semaxanib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Sugen</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.4486260.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL276711">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/5329098">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB06436">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=X2M">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/X2M">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5056">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC12410091">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=71IA9S35AJ">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4810">BindingDB</a><br></td>
      <td>'X2M'</td>
      <td>2x2m</td>
      <td>1</td>
      <td>0</td>
      <td>238.1</td>
      <td>3.1</td>
      <td>44.9</td>
      <td>1</td>
      <td>2</td>
      <td>1</td>
      <td>Investigated for use/treatment in colorectal cancer and lung cancer.</td>
      <td>KDR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1cc([nH]c1/C=C\2/c3ccccc3NC2=O)C<br><b>InChiKey</b>=WUWDLXZGHZSWQZ-WQLSENKSSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>SU-5416 <br> Semaxinib <br> Semaxanib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Silmitasertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Silmitasertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Senhwa Biosciences</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.25057795.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1230165">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/24748573">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB15408">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=3NG">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/3NG">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8126">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000058638454">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=C6RWP0N0L2">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50335638">BindingDB</a><br></td>
      <td>'3NG'</td>
      <td>3nga 3pe1 5o11 6fyl 6fyp 6fyv 6hmb 6isj 6k3l 6khd 6khe 6khf 6p5s</td>
      <td>1</td>
      <td>0</td>
      <td>349.1</td>
      <td>4.9</td>
      <td>75.1</td>
      <td>4</td>
      <td>2</td>
      <td>3</td>
      <td>nan</td>
      <td>CSNK2A1<br>CSNK2A2</td>
      <td>Other</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1cc(cc(c1)Cl)Nc2c3ccncc3c4ccc(cc4n2)C(=O)O<br><b>InChiKey</b>=MUOKSQABCJCOPU-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>Silmitasertib <br> CX-4945</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Simotinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Simotinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Advenchen Laboratories</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.20566604.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545235">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/16735117">PubChem</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7640">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000137136675">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=58K797D5IK">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>500.2</td>
      <td>4.4</td>
      <td>78</td>
      <td>8</td>
      <td>1</td>
      <td>7</td>
      <td>nan</td>
      <td>EGFR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=COc1cc2c(cc1OCCN3CC4(CC4)C5(C3)OCCO5)c(ncn2)Nc6ccc(c(c6)Cl)F<br><b>InChiKey</b>=OXWUWXCJDBRCCG-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td>SIM-6802</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Sitravatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Sitravatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Mirati Therapeutics</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.52083477.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3989926">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/25212148">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB15036">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9920">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000164334830">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=CWG62Q1VTB">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>2</td>
      <td>629.2</td>
      <td>6.5</td>
      <td>114.5</td>
      <td>8</td>
      <td>3</td>
      <td>12</td>
      <td>nan</td>
      <td>RET<br>DDR2<br>NTRK1<br>NTRK2<br>NTRK3</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=COCCNCc1ccc(nc1)c2cc3c(s2)c(ccn3)Oc4ccc(cc4F)NC(=O)C5(CC5)C(=O)Nc6ccc(cc6)F<br><b>InChiKey</b>=WLAVZAAODLTUSW-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>MGCD516 <br> Sitravatinib</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Solcitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Solcitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>GlaxoSmithKline</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.31389944.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3301606">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/44603362">PubChem</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9697">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000118401631">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=3V7GQ1260K">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=128101">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>389.2</td>
      <td>3.2</td>
      <td>79.6</td>
      <td>5</td>
      <td>1</td>
      <td>4</td>
      <td>nan</td>
      <td>JAK1</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC1(CN(C1)C(=O)c2ccc(cc2)c3cccc4n3nc(n4)NC(=O)C5CC5)C<br><b>InChiKey</b>=MPYACSQFXVMWNO-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>GLPG-0788 <br> GSK2586184A <br> Solcitinib <br> GSK2586184 <br> G-154578 <br> GLPG-0778</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Sonolisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Sonolisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Cascadian Therapeutics</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.8025448.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL411907">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/9849735">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12601">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7941">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000029134545">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=987796874T">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>525.2</td>
      <td>3.1</td>
      <td>119.4</td>
      <td>9</td>
      <td>1</td>
      <td>8</td>
      <td>nan</td>
      <td>PIK3CA<br>PIK3CB<br>PIK3CG</td>
      <td>Atypical</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC(=O)O[C@@H]1C[C@]2([C@@H](CCC2=O)C3=C1[C@]4([C@H](OC(=O)/C(=C/N(CC=C)CC=C)/C4=C(C3=O)O)COC)C)C<br><b>InChiKey</b>=QIUASFSNWYMDFS-NILGECQDSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>Sonolisib <br> PX-866</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Sorafenib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Sorafenib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Nexavar</td>
      <td>4</td>
      <td>Bayer</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.187440.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1336">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/216239">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB07438">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=BAX">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/BAX">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5711">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC01493878">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=9ZOQ3TZI87">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16673">BindingDB</a><br></td>
      <td>'BAX'</td>
      <td>1uwh 1uwj 3gcs 3heg 3rgf 3wze 4asd 5hi2</td>
      <td>2</td>
      <td>1</td>
      <td>464.1</td>
      <td>5.5</td>
      <td>92.3</td>
      <td>4</td>
      <td>3</td>
      <td>5</td>
      <td>Sorafenib is indicated for the treatment of unresectable hepatocellular carcinoma and advanced renal cell carcinoma.</td>
      <td>BRAF<br>RAF1<br>FLT4<br>KDR<br>FLT3<br>PDGFRB<br>KIT<br>FGFR1<br>RET<br>FLT1</td>
      <td>TKL<br>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CNC(=O)c1cc(ccn1)Oc2ccc(cc2)NC(=O)Nc3ccc(c(c3)C(F)(F)F)Cl<br><b>InChiKey</b>=MLDQJTXFUGDVEO-UHFFFAOYSA-N</td>
      <td>2005</td>
      <td>US-7235576-B1</td>
      <td>Achiral Molecule</td>
      <td>Nexavar <br> Sorafenib <br> BAY-43-9006</td>
      <td>Y</td>
      <td>205.6</td>
    </tr><tr class="even">
      <td><b>Sotrastaurin</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Sotrastaurin.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Novartis</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.8472351.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL565612">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/10296883">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12369">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=LW4">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/LW4">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7946">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000003973984">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=7I279E1NZ8">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=33971">BindingDB</a><br></td>
      <td>'LW4'</td>
      <td>3iw4</td>
      <td>nan</td>
      <td>0</td>
      <td>438.2</td>
      <td>2.4</td>
      <td>94.2</td>
      <td>6</td>
      <td>2</td>
      <td>3</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN1CCN(CC1)c2nc3ccccc3c(n2)C4=C(C(=O)NC4=O)c5c[nH]c6c5cccc6<br><b>InChiKey</b>=OAVGBZOFDPFGPJ-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>AEB-071 <br> NVP-AEB071 <br> AEB071 <br> Sotrastaurin</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Spebrutinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Spebrutinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Celgene</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.29361342.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3301625">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/59174488">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11764">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7837">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000072319585">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=DRU6NG543J">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>423.2</td>
      <td>4.3</td>
      <td>97.4</td>
      <td>7</td>
      <td>3</td>
      <td>10</td>
      <td>nan</td>
      <td>BTK</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=COCCOc1ccc(cc1)Nc2ncc(c(n2)Nc3cccc(c3)NC(=O)C=C)F<br><b>InChiKey</b>=KXBDTLQSDKGAEB-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>CC-292 <br> AVL-292 <br> Spebrutinib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Sunitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Sunitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Sutent</td>
      <td>4</td>
      <td>Cp Pharmaceuticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.4486264.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL535">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/5329102">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB07417">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=B49">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/B49">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5713">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000003964325">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=V99T50803M">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4814">BindingDB</a><br></td>
      <td>'B49'</td>
      <td>2y7j 3g0e 3g0f 3miy 3ti1 4agd 4ks8 4qmz 6nfy 6nfz 6ng0</td>
      <td>1</td>
      <td>0</td>
      <td>398.2</td>
      <td>3.3</td>
      <td>77.2</td>
      <td>3</td>
      <td>3</td>
      <td>7</td>
      <td><input type="checkbox" class="read-more-state" id="post-989064142"><p class="read-more-wrap">For
 the treatment of advanced renal cell carcinoma as well as the treatment
 of gastrointestinal stromal tumor after disease progression on or 
intolera<span class="read-more-target">nce to imatinib mesylate.</span></p><label for="post-989064142" class="read-more-trigger"></label></td>
      <td>PDGFRB<br>FLT1<br>KIT<br>KDR<br>FLT4<br>FLT3<br>CSF1R<br>PDGFRA</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CCN(CC)CCNC(=O)c1c(c([nH]c1C)/C=C\2/c3cc(ccc3NC2=O)F)C<br><b>InChiKey</b>=WINHZLLDWRZWRT-ATVHPVEESA-N</td>
      <td>2006</td>
      <td>US-6573293-B2</td>
      <td>Achiral Molecule</td>
      <td>Sutent <br> Sunitinib <br> SU-11248 <br> Sutent</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Tafetinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Tafetinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>1</td>
      <td>Nanjing Yoko Biomedical</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.28664989.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2180602">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/56935577">PubChem</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9921">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000095575309">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=H4X2M2NN5N">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50399535">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>424.2</td>
      <td>3.7</td>
      <td>77.2</td>
      <td>3</td>
      <td>3</td>
      <td>6</td>
      <td>nan</td>
      <td>KDR<br>FLT4<br>FLT1</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CCN(CC)CCNC(=O)c1c([nH]c\2c1CCC/C2=C/3\c4cc(ccc4NC3=O)F)C<br><b>InChiKey</b>=KGSRYTUWXUESJK-FXBPSFAMSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Talmapimod</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Talmapimod.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Scios inc</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.8046764.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL514201">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/9871074">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB05412">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=469">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/469">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7817">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000034001955">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=B1E00KQ6NT">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50266947">BindingDB</a><br></td>
      <td>'469'</td>
      <td>3hub 3zsh</td>
      <td>1</td>
      <td>1</td>
      <td>512.2</td>
      <td>4</td>
      <td>65.9</td>
      <td>5</td>
      <td>0</td>
      <td>5</td>
      <td>Investigated for use/treatment in pain (acute or chronic) and rheumatoid arthritis.</td>
      <td>MAPK14</td>
      <td>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C[C@@H]1CN([C@H](CN1C(=O)c2cc3c(cc2Cl)n(cc3C(=O)C(=O)N(C)C)C)C)Cc4ccc(cc4)F<br><b>InChiKey</b>=ZMELOYOKMZBMRB-DLBZAZTESA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>Talmapimod <br> SCIO-469</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Tamatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Tamatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Rigel Pharmaceuticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9388620.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL475251">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11213558">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB07159">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=585">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/585">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7425">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC06745792">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=RC3A285J2G">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=60665">BindingDB</a><br></td>
      <td>'585'</td>
      <td>3fqs 3piy</td>
      <td>1</td>
      <td>0</td>
      <td>470.2</td>
      <td>3.6</td>
      <td>128.8</td>
      <td>10</td>
      <td>3</td>
      <td>7</td>
      <td>nan</td>
      <td>SYK</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC1(C(=O)Nc2c(ccc(n2)Nc3c(cnc(n3)Nc4cc(c(c(c4)OC)OC)OC)F)O1)C<br><b>InChiKey</b>=NHHQJBCNYHBUSI-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td>R-406</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Tandutinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Tandutinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Takeda</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.2302085.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL124660">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/3038522">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB05465">DrugBank</a><br><a href="http://zinc15.docking.org/substances/ZINC000003966243">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=E1IO3ICJ9A">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13535">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>2</td>
      <td>562.3</td>
      <td>5</td>
      <td>92.3</td>
      <td>8</td>
      <td>1</td>
      <td>10</td>
      <td>Investigated for use/treatment in leukemia (myeloid).</td>
      <td>FLT3<br>PDGFD</td>
      <td>(*)<br>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC(C)Oc1ccc(cc1)NC(=O)N2CCN(CC2)c3c4cc(c(cc4ncn3)OCCCN5CCCCC5)OC<br><b>InChiKey</b>=UXXQOJXBIDBUAC-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>Tandutinib <br> MLN-0518 <br> CT-53518 <br> MLN-518</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Tanzisertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Tanzisertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Celgene</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.28492361.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1950289">ChEMBL</a><br><a href="http://www.drugbank.ca/drugs/DB11798">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=KBI">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/KBI">PDBe</a><br><a href="http://zinc15.docking.org/substances/ZINC000102930548">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=M5O06306UO">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50364378">BindingDB</a><br></td>
      <td>'KBI'</td>
      <td>3tti</td>
      <td>1</td>
      <td>0</td>
      <td>448.2</td>
      <td>3.7</td>
      <td>97.1</td>
      <td>8</td>
      <td>3</td>
      <td>5</td>
      <td>nan</td>
      <td>MAPK8</td>
      <td>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1c(c(c(cc1F)F)Nc2n(c3nc(ncc3n2)N[C@H]4CC[C@@H](CC4)O)[C@@H]5COCC5)F<br><b>InChiKey</b>=IBGLGMOPHJQDJB-IHRRRGAJSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>Tanzisertib <br> JNK-930 <br> CC-930</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Tarloxotinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Tarloxotinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Threshold Pharmaceuticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.46518771.html">ChemSpider</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/51038315">PubChem</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=3Y31FJ8K50">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>679</td>
      <td>1.6</td>
      <td>140.8</td>
      <td>9</td>
      <td>2</td>
      <td>9</td>
      <td>nan</td>
      <td>EGFR</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cn1cnc(c1C[N+](C)(C)C/C=C/C(=O)Nc2cc3c(cn2)ncnc3Nc4ccc(c(c4)Br)Cl)[N+](=O)[O-].[Br-]<br><b>InChiKey</b>=WAKIMVYUBWMMHJ-FXRZFVDSSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Taselisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Taselisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Hoffmann-La Roche</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.29315044.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2387080">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/51001932">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12108">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=799">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/799">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7794">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000068267049">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=L08J2O299M">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50434806">BindingDB</a><br></td>
      <td>'799'</td>
      <td>5t8f</td>
      <td>1</td>
      <td>0</td>
      <td>460.2</td>
      <td>3.2</td>
      <td>118.7</td>
      <td>9</td>
      <td>1</td>
      <td>5</td>
      <td>nan</td>
      <td>PIK3CA<br>PIK3CD<br>PIK3CG</td>
      <td>Atypical</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1nc(n(n1)C(C)C)c2cn3c(n2)-c4ccc(cc4OCC3)c5cnn(c5)C(C)(C)C(=O)N<br><b>InChiKey</b>=BEUQXVWXFDOSAQ-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Racemic Mixture</td>
      <td>RG-7604 <br> Taselisib <br> GDC-0032</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Telatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Telatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Bayer</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.7984603.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2079588">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/9808844">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB15393">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10476">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC00590964">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=18P7197Q7J">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50399538">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>409.1</td>
      <td>4</td>
      <td>102.2</td>
      <td>7</td>
      <td>2</td>
      <td>6</td>
      <td>nan</td>
      <td>KDR<br>FLT4</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CNC(=O)c1cc(ccn1)COc2c3c(cco3)c(nn2)Nc4ccc(cc4)Cl<br><b>InChiKey</b>=QFCXANHHBCGMAS-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>BAY-57-9352 <br> Telatinib <br> BAY-579352</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Tepotinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Tepotinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Merck</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.28637823.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3402762">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/25171648">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB15133">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=3E8">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/3E8">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8293">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000043202335">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=1IJV77EI07">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50065457">BindingDB</a><br></td>
      <td>'3E8'</td>
      <td>4r1v</td>
      <td>1</td>
      <td>0</td>
      <td>492.2</td>
      <td>4</td>
      <td>96.9</td>
      <td>8</td>
      <td>0</td>
      <td>7</td>
      <td>nan</td>
      <td>MET</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN1CCC(CC1)COc2cnc(nc2)c3cccc(c3)Cn4c(=O)ccc(n4)c5cccc(c5)C#N<br><b>InChiKey</b>=AHYMHWXQRWRBKT-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>MSC-2156119 <br> Tepotinib <br> MSC-2156119J <br> EMD-1214063</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Tesevatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Tesevatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Kadmon Corporation</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.32699556.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3544983">ChEMBL</a><br><a href="http://www.drugbank.ca/drugs/DB11973">DrugBank</a><br><a href="http://zinc15.docking.org/substances/ZINC000114456300">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=F6XM2TN5A1">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>490.1</td>
      <td>5.8</td>
      <td>59.5</td>
      <td>6</td>
      <td>1</td>
      <td>6</td>
      <td>nan</td>
      <td>EGFR<br>ERBB2<br>KDR<br>FLT4<br>EPHB4</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN1C[C@H]2C[C@H](C[C@H]2C1)COc3cc4c(cc3OC)c(ncn4)Nc5ccc(c(c5F)Cl)Cl<br><b>InChiKey</b>=HVXKQKFEHMGHSL-QKDCVEJESA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Racemic Mixture</td>
      <td>Tesevatinib <br> XL-647 <br> KD-020 <br> KD-019</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Tivantinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Tivantinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Daiichi Sankyo</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9669218.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2103882">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11494412">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12200">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=TIV">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/TIV">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7948">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000100016063">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=PJ4H73IL17">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50146168">BindingDB</a><br></td>
      <td>'TIV'</td>
      <td>5cb4</td>
      <td>nan</td>
      <td>0</td>
      <td>369.1</td>
      <td>3.6</td>
      <td>66.9</td>
      <td>3</td>
      <td>2</td>
      <td>2</td>
      <td>nan</td>
      <td>MET</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1ccc2c(c1)c(c[nH]2)[C@H]3[C@@H](C(=O)NC3=O)c4cn5c6c4cccc6CCC5<br><b>InChiKey</b>=UCEQXRCJXIVODC-PMACEKPBSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>ARQ-197 <br> Tivantinib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Tivozanib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Tivozanib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>4</td>
      <td>Aveo Pharmaceuticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.8087481.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1289494">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/9911830">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11800">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=AV9">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/AV9">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6058">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC01489430">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=172030934T">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50331095">BindingDB</a><br></td>
      <td>'AV9'</td>
      <td>4ase</td>
      <td>2</td>
      <td>1</td>
      <td>454.1</td>
      <td>5.6</td>
      <td>107.7</td>
      <td>7</td>
      <td>2</td>
      <td>6</td>
      <td>Tivozanib is an oral VEGF receptor tyrosine kinase inhibitor.</td>
      <td>FLT1<br>KDR<br>FLT4</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1cc(no1)NC(=O)Nc2ccc(cc2Cl)Oc3ccnc4c3cc(c(c4)OC)OC<br><b>InChiKey</b>=SPMVMDHWKHCIDT-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>AV-951 <br> Tivozanib <br> Kil-8951 <br> Kil8951 <br> ASP-4130 <br> KRN-951</td>
      <td>N</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Toceranib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Toceranib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>0</td>
      <td>Pfizer</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.4486268.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL13608">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/5329106">PubChem</a><br><a href="http://zinc15.docking.org/substances/ZINC000003989258">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=59L7Y0530C">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4818">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>396.2</td>
      <td>3.1</td>
      <td>77.2</td>
      <td>3</td>
      <td>3</td>
      <td>5</td>
      <td>nan</td>
      <td>KIT</td>
      <td>KIT</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1c([nH]c(c1C(=O)NCCN2CCCC2)C)/C=C\3/c4cc(ccc4NC3=O)F<br><b>InChiKey</b>=SRSGVKWWVXWSJT-ATVHPVEESA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>PHA-291639 <br> Toceranib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Tofacitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Tofacitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Xeljanz</td>
      <td>4</td>
      <td>Pfizer</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.8102425.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL221959">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/9926791">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB08895">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=MI1">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/MI1">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5677">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC03818808">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=87LA6FU830">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50193995">BindingDB</a><br></td>
      <td>'MI1'</td>
      <td>3eyg 3fup 3lxk 3lxn 4oti</td>
      <td>1</td>
      <td>0</td>
      <td>312.2</td>
      <td>1.5</td>
      <td>88.9</td>
      <td>5</td>
      <td>1</td>
      <td>3</td>
      <td><input type="checkbox" class="read-more-state" id="post-367532447"><p class="read-more-wrap">For
 the treatment of moderate to severe rheumatoid arthritis which is 
resistant or intolerant to methotrexate therapy. It may also be used as 
an adjun<span class="read-more-target">ct to methotrexate therapy, or 
other non-biologic disease-modifying antirheumatic drugs (DMARDS), when 
methotrexate alone is not sufficient. Tofacitinib has also been 
investigated as a preventative therapy for kidney transplant rejections,
 and as a treatment for psoriasis, ulcerative colitis, and ankylosing 
spondylitis. It is not to be initiated in patients with a history of 
chronic or recurrent infections, or in the presence of active infection,
 even if localized, due to reports of serious and sometimes fatal 
infections (commonly pneumonia, herpes zoster and urinary tract 
infections). Use of tofacitinib is also discouraged in those who have 
been, or are likely to be, exposed to TB. An increased likelihood of 
exposure may be encountered by traveling to certain areas. In addition, 
tofacitinib is not to be used in patients with severe hepatic 
impairment, or low hemoglobin (less than 9g/dL). Cautioned is advised 
when using tofacitinib in patients at risk of gastrointestinal 
perforation, and in the elderly who are more susceptible to infection.</span></p><label for="post-367532447" class="read-more-trigger"></label></td>
      <td>JAK1<br>JAK2<br>JAK3<br>TYK2</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C[C@@H]1CCN(C[C@@H]1N(C)c2c3cc[nH]c3ncn2)C(=O)CC#N<br><b>InChiKey</b>=UJLAWZDWDVHWOW-YPMHNXCESA-N</td>
      <td>2012</td>
      <td>US-6956041-B2</td>
      <td>Single Stereoisomer</td>
      <td>Tasocitinib <br> 550 <br> CP-690550 <br> CP-690 <br> Tofacitinib</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Tomivosertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Tomivosertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Effector Therapeutics</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.57617704.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL4073443">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/118598754">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB15219">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=N45">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/N45">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10167">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000575623807">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=U2H19X4WBV">FDA SRS</a><br></td>
      <td>'N45'</td>
      <td>6ck6</td>
      <td>nan</td>
      <td>0</td>
      <td>340.2</td>
      <td>1.6</td>
      <td>114.9</td>
      <td>7</td>
      <td>3</td>
      <td>2</td>
      <td><input type="checkbox" class="read-more-state" id="post-110247470"><p class="read-more-wrap">Tomivosertib,
 also known as eFT508 is a MNK1/2 inhibitor. Tomivosertib binds to and 
inhibits the activity of MNK1 and 2. This prevents MNK1/2-mediated<span class="read-more-target">
 signaling, and inhibits the phosphorylation of certain regulatory 
proteins, including eukaryotic translation initiation factor 4E (eIF4E),
 that regulate the translation of messenger RNAs (mRNAs) involved in 
tumor cell proliferation, angiogenesis, survival and immune signaling</span></p><label for="post-110247470" class="read-more-trigger"></label></td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1cc(c(=O)n2c1C(=O)NC23CCCCC3)Nc4cc(ncn4)N<br><b>InChiKey</b>=HKTBYUWLRDZAJK-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td>NK1 AND MNK2<br></td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Tozasertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Tozasertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Merck</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.4591897.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL572878">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/5494449">PubChem</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=VX6">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/VX6">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5718">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC13125756">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=234335M86K">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50004205">BindingDB</a><br></td>
      <td>'VX6'</td>
      <td>2f4j 2xyn 3amb 3e5a 4af3 4b8m 4jbq 4zog 5wnm 6brj 6gr9</td>
      <td>1</td>
      <td>0</td>
      <td>464.2</td>
      <td>3.5</td>
      <td>102.1</td>
      <td>8</td>
      <td>3</td>
      <td>7</td>
      <td>nan</td>
      <td>AURKA<br>AURKB<br>AURKC</td>
      <td>Other</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1cc(n[nH]1)Nc2cc(nc(n2)Sc3ccc(cc3)NC(=O)C4CC4)N5CCN(CC5)C<br><b>InChiKey</b>=GCIKSSRWRFVXBI-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>VX-680 <br> MK-0457 <br> Tozasertib <br> VX-68 <br> MK-045</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Trametinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Trametinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Mekinist</td>
      <td>4</td>
      <td>GlaxoSmithKline</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9881833.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2103875">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11707110">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB08911">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6495">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC43100709">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=33E86K87QN">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>3</td>
      <td>1</td>
      <td>615.1</td>
      <td>3.9</td>
      <td>107.1</td>
      <td>8</td>
      <td>2</td>
      <td>5</td>
      <td><input type="checkbox" class="read-more-state" id="post-504362617"><p class="read-more-wrap">Trametinib
 is indicated for the treatment of unresectable or metastatic melanoma 
with BRAF V600E or V600K mutations, as detected by an FDA-approved te<span class="read-more-target">st.</span></p><label for="post-504362617" class="read-more-trigger"></label></td>
      <td>BRAF<br>MAP2K1<br>MAP2K2</td>
      <td>TKL<br>STE</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1c2c(c(n(c1=O)C)Nc3ccc(cc3F)I)c(=O)n(c(=O)n2c4cccc(c4)NC(=O)C)C5CC5<br><b>InChiKey</b>=LIRYPHYGHXZJBZ-UHFFFAOYSA-N</td>
      <td>2013</td>
      <td>US-7378423-B2</td>
      <td>Achiral Molecule</td>
      <td>Mekinist <br> GSK1120212 <br> Trametinib</td>
      <td>Y</td>
      <td>293-303</td>
    </tr><tr class="even">
      <td><b>Trilaciclib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Trilaciclib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>G1 Therapeutics</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.58825997.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3894860">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/68029831">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB15442">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9626">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000143683854">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=U6072DO9XG">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=253928">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>446.3</td>
      <td>2.7</td>
      <td>91.2</td>
      <td>8</td>
      <td>2</td>
      <td>3</td>
      <td>nan</td>
      <td>CDK4<br>CDK6</td>
      <td>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN1CCN(CC1)c2ccc(nc2)Nc3ncc4cc5n(c4n3)C6(CCCCC6)CNC5=O<br><b>InChiKey</b>=PDGKHKMBHVFCMG-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>G1T28 <br> Trilaciclib</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Tucatinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Tucatinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Array BioPharma</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.34995558.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3989868">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/51039094">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11652">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9922">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000068250462">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=234248D0HH">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>480.2</td>
      <td>5.1</td>
      <td>110.9</td>
      <td>10</td>
      <td>2</td>
      <td>5</td>
      <td>nan</td>
      <td>ERBB2</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1cc(ccc1Oc2ccn3c(c2)ncn3)Nc4c5cc(ccc5ncn4)NC6=NC(CO6)(C)C<br><b>InChiKey</b>=SDEAXTCZPQIFQM-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>Tucatinib <br> ONT-380 <br> ARRY-380</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Ulixertinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Ulixertinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>BioMed Valley Discoveries</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.9893722.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3590106">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/11719003">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB13930">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=EVK">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/EVK">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9210">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000034642570">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=16ZDH50O1U">FDA SRS</a><br></td>
      <td>'EVK'</td>
      <td>6gdq</td>
      <td>nan</td>
      <td>0</td>
      <td>432.1</td>
      <td>4.7</td>
      <td>90</td>
      <td>4</td>
      <td>4</td>
      <td>7</td>
      <td>nan</td>
      <td>MAPK1<br>MAPK3</td>
      <td>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC(C)Nc1cc(c(cn1)Cl)c2cc([nH]c2)C(=O)N[C@H](CO)c3cccc(c3)Cl<br><b>InChiKey</b>=KSERXGMCDHOLSS-LJQANCHMSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>VRT752271<br>VRT-752271<br>BVD-523</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Umbralisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Umbralisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>TG Therapeutics</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.34979945.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3948730">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/72950888">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB14989">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8916">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000141831516">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=38073MQB2A">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=184556">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>2</td>
      <td>571.2</td>
      <td>6.7</td>
      <td>109.1</td>
      <td>8</td>
      <td>1</td>
      <td>6</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C[C@@H](c1c(c(=O)c2cc(ccc2o1)F)c3cccc(c3)F)n4c5c(c(n4)c6ccc(c(c6)F)OC(C)C)c(ncn5)N<br><b>InChiKey</b>=IUVCFHHAEHNCFT-INIZCTEOSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>Umbralisib <br> TGR-1202 base <br> RP-5264</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Upadacitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Upadacitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Rinvoq</td>
      <td>4</td>
      <td>Abbvie</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.44210449.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3622821">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/58557659">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB15091">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9246">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000147180128">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=4RA0KN46E0">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>380.2</td>
      <td>2.9</td>
      <td>78.3</td>
      <td>4</td>
      <td>2</td>
      <td>3</td>
      <td>On august 2019, FDA approved fedratinib to treat adults with moderately to severely active rheumatoid arthritis</td>
      <td>JAK1</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC[C@@H]1CN(C[C@@H]1c2cnc3n2c4cc[nH]c4nc3)C(=O)NCC(F)(F)F<br><b>InChiKey</b>=WYQFJHHDOKWSHR-MNOVXSKESA-N</td>
      <td>2019</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>ABT-494 <br> Upadacitinib</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Uprosertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Uprosertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>GlaxoSmithKline</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.32701836.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3137336">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/51042438">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11969">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7902">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000043197676">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=ZXM835LQ5E">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50170284">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>428.1</td>
      <td>3.6</td>
      <td>86.1</td>
      <td>5</td>
      <td>2</td>
      <td>6</td>
      <td>nan</td>
      <td>AKT1<br>AKT2<br>AKT3</td>
      <td>AGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cn1c(c(cn1)Cl)c2cc(oc2Cl)C(=O)N[C@@H](Cc3ccc(c(c3)F)F)CN<br><b>InChiKey</b>=AXTAPYRUEKNRBA-JTQLQIEISA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>Uprosertib <br> GSK2141795C <br> GSK2141795</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Vactosertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Vactosertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>1.5</td>
      <td>MedPacto</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.32813335.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3260567">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/54766013">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB15310">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8107">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000113391423">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=6T4O391P5Y">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50015639">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>399.2</td>
      <td>4.2</td>
      <td>83.8</td>
      <td>6</td>
      <td>2</td>
      <td>5</td>
      <td><input type="checkbox" class="read-more-state" id="post-836173775"><p class="read-more-wrap">Vactosertib
 (EW-7197) acts as in inhibitor of transforming growth factor beta 
receptor 1B (ALK5) and activin A receptor type IB (ALK4). The compound i<span class="read-more-target">s potent, selective, and orally bioavailable, and exhibits experimental anti-tumour activity.</span></p><label for="post-836173775" class="read-more-trigger"></label></td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=Cc1cccc(n1)c2c(nc([nH]2)CNc3ccccc3F)c4ccc5ncnn5c4<br><b>InChiKey</b>=FJCDSQATIJKQKA-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Vandetanib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Vandetanib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Caprelsa;Zactima</td>
      <td>4</td>
      <td>Ipr Pharmaceuticals</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.2338979.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL24828">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/3081361">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB08764">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=ZD6">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/ZD6">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5717">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000053683345">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=YO460OQ37K">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21">BindingDB</a><br></td>
      <td>'ZD6'</td>
      <td>2ivu</td>
      <td>1.5</td>
      <td>1</td>
      <td>474.1</td>
      <td>5</td>
      <td>59.5</td>
      <td>6</td>
      <td>1</td>
      <td>6</td>
      <td><input type="checkbox" class="read-more-state" id="post-283336393"><p class="read-more-wrap">Vandetanib
 is currently approved as an alternative to local therapies for both 
unresectable and disseminated disease. Because Vandetanib can prolong t<span class="read-more-target">he
 Q-T interval, it is contraindicated for use in patients with serious 
cardiac complications such as congenital long QT syndrome and 
uncompensated heart failure.</span></p><label for="post-283336393" class="read-more-trigger"></label></td>
      <td>VEGFA<br>EGFR<br>PTK6<br>TEK<br>RET</td>
      <td>(*)<br>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN1CCC(CC1)COc2cc3c(cc2OC)c(ncn3)Nc4ccc(cc4F)Br<br><b>InChiKey</b>=UHTHHESEBZOYNR-UHFFFAOYSA-N</td>
      <td>2011</td>
      <td>US-RE42353-E1</td>
      <td>Achiral Molecule</td>
      <td>Caprelsa;Zactima <br> GNF-Pf-2188 <br> ZD-6474 <br> Vandetanib <br> ZD-64</td>
      <td>Y</td>
      <td></td>
    </tr><tr class="even">
      <td><b>Varlitinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Varlitinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2.5</td>
      <td>Array Biopharma</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.25027380.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2103842">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/42642648">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB05944">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7645">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000013980035">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=846Y8197W1">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50205268">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>466.1</td>
      <td>5.2</td>
      <td>93.5</td>
      <td>9</td>
      <td>2</td>
      <td>6</td>
      <td>Investigated for use/treatment in cancer/tumors (unspecified).</td>
      <td>EGFR<br>ERBB2</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C[C@@H]1COC(=N1)Nc2ccc3c(c2)c(ncn3)Nc4ccc(c(c4)Cl)OCc5nccs5<br><b>InChiKey</b>=UWXSAYUXVSFDBQ-CYBMUJFWSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>ARRY-543 <br> ASLAN-001 <br> Varlitinib <br> ARRY-334543</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Vatalanib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Vatalanib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Novartis</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.133257.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL101253">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/151194">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB04879">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5705">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC00007460">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=5DX9U76296">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=4851">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>1</td>
      <td>346.1</td>
      <td>5</td>
      <td>50.7</td>
      <td>4</td>
      <td>1</td>
      <td>4</td>
      <td>Used in combination with first- and second-line chemotherapy 
for the treatment of metastatic colorectal cancer and non-small cell 
lung cancer (NSCLC).</td>
      <td>FLT1<br>KDR<br>FLT4</td>
      <td>Tyr</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=c1ccc2c(c1)c(nnc2Nc3ccc(cc3)Cl)Cc4ccncc4<br><b>InChiKey</b>=YCOYDOIWSSHVCK-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>BAY-86-5127 <br> PTK-787 <br> NVP-PTK787 <br> ZK-222584 <br> K-222584 <br> CGP-79787 <br> PTK787 <br> Vatalanib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Vemurafenib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Vemurafenib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>Zelboraf</td>
      <td>4</td>
      <td>Hoffmann-La Roche</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.24747352.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1229517">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/42611257">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB08881">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=032">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/032">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5893">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000052509366">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=207SMY3FQT">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50396483">BindingDB</a><br></td>
      <td>'032'</td>
      <td>3og7 4rzv 5hes</td>
      <td>1.5</td>
      <td>1</td>
      <td>489.1</td>
      <td>5.5</td>
      <td>91.9</td>
      <td>4</td>
      <td>2</td>
      <td>7</td>
      <td><input type="checkbox" class="read-more-state" id="post-320081541"><p class="read-more-wrap">Vemurafenib
 is approved since 2011 for the treatment of metastatic melanoma with a 
mutation on BRAF in the valine located in the exon 15 at codon 600,<span class="read-more-target"> this mutation is denominated as V600E.</span></p><label for="post-320081541" class="read-more-trigger"></label></td>
      <td>BRAF</td>
      <td>TKL</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c2c[nH]c3c2cc(cn3)c4ccc(cc4)Cl)F<br><b>InChiKey</b>=GPXBXXGIAQBQNI-UHFFFAOYSA-N</td>
      <td>2011</td>
      <td>US-7504509-B2</td>
      <td>Achiral Molecule</td>
      <td>Zelboraf <br> Vemurafenib <br> PLX-4032 <br> Ro-5185426 <br> RG-7204</td>
      <td>Y</td>
      <td>272</td>
    </tr><tr class="odd">
      <td><b>Verosudil</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Verosudil.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Aerie Pharmaceutical</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.32742441.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545065">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/66906051">PubChem</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8911">Guide to Pharmacology</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>327.1</td>
      <td>2.8</td>
      <td>65.2</td>
      <td>4</td>
      <td>2</td>
      <td>4</td>
      <td>nan</td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN(C)C(c1ccsc1)C(=O)Nc2ccc3c(c2)cc[nH]c3=O<br><b>InChiKey</b>=VDYRZXYYQMMFJW-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Racemic Mixture</td>
      <td>Verosudil <br> AR-12286</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Vistusertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Vistusertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Astrazeneca</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.28294977.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL2336325">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/25262792">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB11925">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7699">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000059258964">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=0BSC3P4H5X">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50429701">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>462.2</td>
      <td>2.5</td>
      <td>92.7</td>
      <td>8</td>
      <td>1</td>
      <td>4</td>
      <td>nan</td>
      <td>MTOR</td>
      <td>Atypical</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C[C@H]1COCCN1c2c3ccc(nc3nc(n2)N4CCOC[C@@H]4C)c5cccc(c5)C(=O)NC<br><b>InChiKey</b>=JUSFANSTBFGBAF-IRXDYDNUSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>AZD-2014 <br> AZD2014 <br> Vistusertib</td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Volasertib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Volasertib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>3</td>
      <td>Boehringer Ingelheim</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.26327706.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL1233528">ChEMBL</a><br><a href="http://www.drugbank.ca/drugs/DB12062">DrugBank</a><br><a href="http://www.rcsb.org/pdb/ligand/ligandsummary.do?hetId=IBI">RCSB</a><br><a href="http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/IBI">PDBe</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7947">Guide to Pharmacology</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=6EM57086EA">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50402023">BindingDB</a><br></td>
      <td>'IBI'</td>
      <td>3fc2 5v67 5vbr</td>
      <td>1</td>
      <td>1</td>
      <td>618.4</td>
      <td>4.3</td>
      <td>106.2</td>
      <td>9</td>
      <td>2</td>
      <td>10</td>
      <td>nan</td>
      <td>PLK1</td>
      <td>Other</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CC[C@H]1N(c2nc(ncc2N(C1=O)C)Nc3c(cc(cc3)C(=O)N[C@H]4CC[C@@H](CC4)N5CCN(CC5)CC6CC6)OC)C(C)C<br><b>InChiKey</b>=SXNJFOWDRLKDSF-STROYTFGSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td>BI-6727 <br> Volasertib</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Voruciclib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Voruciclib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Piramal Enterprises</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.29165867.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3905910">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/67409219">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB15157">DrugBank</a><br><a href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9923">Guide to Pharmacology</a><br><a href="http://zinc15.docking.org/substances/ZINC000118905502">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=W66XP666AM">FDA SRS</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50193104">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>469.1</td>
      <td>4.3</td>
      <td>94.1</td>
      <td>6</td>
      <td>3</td>
      <td>3</td>
      <td>nan</td>
      <td>CDK4</td>
      <td>CMGC</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CN1CC[C@H]([C@@H]1CO)c2c(cc(c3c2oc(cc3=O)c4ccc(cc4Cl)C(F)(F)F)O)O<br><b>InChiKey</b>=MRPGRAKIAJJGMM-OCCSQVGLSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Single Stereoisomer</td>
      <td></td>
      <td></td>
      <td></td>
    </tr><tr class="odd">
      <td><b>Voxtalisib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Voxtalisib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>2</td>
      <td>Sanofi</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.17279963.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3545366">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/16123056">PubChem</a><br><a href="http://www.drugbank.ca/drugs/DB12400">DrugBank</a><br><a href="http://zinc15.docking.org/substances/ZINC000035308805">ZINC</a><br><a href="http://fdasis.nlm.nih.gov/srs/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=fdasrs&amp;actionHandle=default&amp;nextPage=jsp/srs/ResultScreen.jsp&amp;TXTSUPERLISTID=CVL1685GPH">FDA SRS</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>270.1</td>
      <td>1.1</td>
      <td>102.5</td>
      <td>6</td>
      <td>2</td>
      <td>2</td>
      <td>nan</td>
      <td>PIK3CA<br>MTOR</td>
      <td>Atypical</td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=CCn1c2c(cc(c1=O)c3ccn[nH]3)c(nc(n2)N)C<br><b>InChiKey</b>=RGHYDLZMTYDBDT-UHFFFAOYSA-N</td>
      <td>nan</td>
      <td>nan</td>
      <td>Achiral Molecule</td>
      <td>SAR-245409 <br> Voxtalisib <br> XL-765</td>
      <td></td>
      <td></td>
    </tr><tr class="even">
      <td><b>Zanubrutinib</b><br><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/Zanubrutinib.svg" heigth="150" onmouseover="this.width=450; this.heigth=450;" onmouseout="this.width=150; this.heigth=150;" width="150"></td>
      <td>nan</td>
      <td>4</td>
      <td>BeiGene</td>
      <td><a href="http://www.chemspider.com/Chemical-Structure.60600294.html">ChemSpider</a><br><a href="https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL3973435">ChEMBL</a><br><a href="http://pubchem.ncbi.nlm.nih.gov/compound/135905454">PubChem</a><br><a href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=249900">BindingDB</a><br></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>nan</td>
      <td>0</td>
      <td>471.2</td>
      <td>4.2</td>
      <td>102.5</td>
      <td>6</td>
      <td>2</td>
      <td>6</td>
      <td><input type="checkbox" class="read-more-state" id="post-965269094"><p class="read-more-wrap">Zanubrutinib
 (BGB-3111) is a potent, selective and and irreversible BTK inhibitor 
that is being investigated for clinical utility in the treatment of <span class="read-more-target">hematological cancers, such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia (CLL) [<a href='javascript:callRef("ReferenceDisplayForward?referenceId=34570,34571&amp;displayId=1,2", 960, 600)' title="1. Robak P, Robak T. (2017) Expert Opin Investig Drugs. 26 (11): 1249-1265; 2. Thompson PA, Burger JA. (2018) Expert Opin Investig Drugs. 27 (1): 31-42">1-2</a>].</span></p><label for="post-965269094" class="read-more-trigger"></label></td>
      <td>nan</td>
      <td></td>
      <td style="word-wrap: break-word; max-width: 250px;"><b>Smiles</b>=C=CC(=O)N1CCC(CC1)C2CCNc3n2nc(c3C(=O)N)c4ccc(cc4)Oc5ccccc5<br><b>InChiKey</b>=RNOAOAWBMHREKO-UHFFFAOYSA-N</td>
      <td>2019</td>
      <td>nan</td>
      <td>nan</td>
      <td><br>BGB-3111<br>ZANUBRUTINIB</td>
      <td>Y</td>
      <td></td>
    </tr></tbody>
</table>

        <p>(*) indicates that the target is not a kinase</p>

        <script type="text/javascript">
        $(function() {
            $("#customers").tablesorter({sortList:[[0,0],[2,1]], widgets: ['zebra']});
            $("#options").tablesorter({sortList: [[0,0]], headers: { 3:{sorter: false}, 4:{sorter: false}}});
        });
        </script>

        <script data-config="">
        var tf = new TableFilter('customers', {
              base_path: 'static/tablefilter/',
              col_width: [
                  "100%", "100%", "100%", "100%", "100%",
                  "100%", "100%", "100%", "100%", "100%",
                  "100%", "100%", "100%", "100%", "100%",
                  "100%", "100%", "100%", "100%", "100%",
                  "100%", "100%", "100%", "100%", "100%"
              ],
              rows_counter: true
          });
          tf.init();
        </script>

      </div>
    </div>
  </div>


<!-- Footer -->
  <footer class="w3-center w3-green w3-padding-16">
    <div class="w3-bar-item">
      <p>Copyright © 2018, Institute of Organic and Analytical Chemistry - ICOA UMR 7311 - SB&amp;C <br>
        Under the authority of
        <a href="http://www.univ-orleans.fr/" target="_blank"><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/logo_univ.png" style="width:80px; height:50px;" alt="logo_univ.png"></a>
        <a href="http://www.cnrs.fr/" target="_blank"><img src="PKIDB%20|%20A%20Curated,%20Annotated%20and%20Updated%20Database%20of%20Protein%20Kinase%20Inhibitors%20in%20Clinical%20Trials_files/logo_cnrs.png" style="width:50px; height:50px;" alt="logo_cnrs.png"></a>
        - Theme powered by <a href="https://www.w3schools.com/w3css/default.asp" title="W3.CSS" target="_blank">w3.css</a>
      </p>
  </div></footer>



</body></html>
